Humana Walmart-Preferred Formulary - Q1Medicare

160
2012 Y0040_PDG12b_Final_510C CMS Approved 08092011 S5884145PDG1226512C_v5 Prescription Drug Guide Humana Formulary List of covered drugs Humana Walmart-Preferred Rx Plan (PDP) Region 25 States of IA, MN, MT, ND, NE, SD, WY PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Other pharmacies are available in our network. Other plans may be available in the service area.

Transcript of Humana Walmart-Preferred Formulary - Q1Medicare

Page 1: Humana Walmart-Preferred Formulary - Q1Medicare

2012

Y0040_PDG12b_Final_510C CMS Approved 08092011 S5884145PDG1226512C_v5

Prescription Drug Guide

Humana FormularyList of covered drugs

Humana Walmart-Preferred Rx Plan (PDP)Region 25

States of IA, MN, MT, ND, NE, SD, WY

PLEASE READ: THIS DOCUMENT CONTAINS INFORMATIONABOUT THE DRUGS WE COVER IN THIS PLAN.

Other pharmacies are available in our network.Other plans may be available in the service area.

Page 2: Humana Walmart-Preferred Formulary - Q1Medicare

Blank Page

Page 3: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 3

PDG021

Welcome to Humana!

Note to existing members: This formulary has changed since last year. Please review this document to make sure thatit still contains the drugs you take.

What is the formulary? A formulary is a list of covered drugs selected by Humana who worked with a team of health care providers, whichrepresents the prescription therapies believed to be a necessary part of a quality treatment program. Humana will generallycover the drugs listed in our formulary as long as the drug is medically necessary, the prescription is filled at a Humananetwork pharmacy, and other plan rules are followed. For more information on how to fill your prescriptions, please reviewyour Evidence of Coverage.

Can the formulary change?Generally, if you take a drug on our 2012 formulary that was covered at the beginning of the year, we won’t discontinue orreduce coverage of the drug during the 2012 coverage year except when a new, less-expensive generic drug becomesavailable or when new adverse information about the safety or effectiveness of a drug is released. Other types of formularychanges, such as removing a drug from our formulary, won’t affect members who currently take the drug. It will remainavailable at the same cost-sharing for those members taking it for the remainder of the coverage year. We feel it’simportant that you have continued access for the remainder of the coverage year to the formulary drugs that were availablewhen you chose our plan, except for cases in which you can save additional money or we can ensure your safety.

If we remove drugs from our formulary, or add prior authorization, quantity limits, or step therapy restrictions on a drug ormove a drug to a higher cost-sharing tier, we must notify affected members of the change at least 60 days before thechange becomes effective, or at the time the member requests a refill of the drug, at which time the member will receive a60-day supply of the drug. If the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug’smanufacturer removes the drug from the market, we’ll immediately remove the drug from our formulary and provide noticeto members who take the drug. The enclosed formulary is current as of January 1, 2012. Our printed formularies will beupdated each month and will be available on Humana.com.

To get updated information about the drugs covered by Humana, please visit Humana.com. Simply select "MedicareDrug List" from the Humana Medicare Plans tab at the top left of the website. The Medicare Drug List search tool lets yousearch for your drug by name or drug type.

For help and information, call Humana Customer Care at 1-800-281-6918. If you use a TTY, call 711. You can call sevendays a week from 8 a.m. to 8 p.m. From February 15th until the following Annual Election Period (AEP), you can leave us avoice mail message after hours, Saturdays, Sundays and some public holidays. Just leave a message and select the reasonfor your call from the automated list. We’ll call back by the end of the next business day. Please have your Humana ID cardwith you when you call.

Page 4: Humana Walmart-Preferred Formulary - Q1Medicare

4 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

How do I use the formulary? There are two ways to find your drug within the formulary:

Medical Condition

conditions that they are used to treat. For example, drugs used to treat a heart condition are listed under the category,"Cardiovascular Drugs". If you know what your drug is used for, look for the category name in the list that begins on page

Requirements for each drug.

Alphabetical Listing

Index provides an alphabetical list of all of the drugs included in this document. Both brand name drugs and generic drugsare listed in the Index. Look in the Index and find your drug. Next to your drug, you will see the page number where you canfind coverage information. Turn to the page listed in the Index and find the name of your drug in the first column of the list.

The formulary begins on page 9. The drugs in this formulary are grouped into categories depending on the type of medical

9. Then look under the category name for your drug. The formulary also lists the Tier and Utilization Management

If you are not sure what category to look under, you should look for your drug in the Index that begins on page 122. The

Drugs are grouped into one of four tiers - 1, 2, 3, or 4.• Tier 1 - Preferred Generic: Drugs that have the same active ingredients as brand drugs and are prescribed for the

same reasons. The Food and Drug Administration (FDA) requires generic drugs to have the same quality, strength, purity,and stability as brand drugs. Your cost for generic drugs is usually lower than your cost for brand drugs.

• Tier 2 - Non-Preferred Generic: Drugs that Humana offers at a higher cost to you than preferred generics.• Tier 3 - Preferred Brand: Drugs that Humana offers at a lower cost to you than non-preferred brand drugs.• Tier 4 - Non-Preferred Brand: Drugs that Humana offers at a higher cost to you than preferred brands.

How much will I pay for Covered Drugs? If you qualified for extra help with your drug costs, your costs may be different from those described above. Please refer toyour Evidence of Coverage or call Customer Care to find out what your costs are. Humana pays part of the costs for yourcovered drugs and you pay part of the costs, as well.

The amount you pay depends on which drug category your drug falls under in the formulary and whether you fill yourprescription at a network pharmacy.

Are there any restrictions on my coverage? Some covered drugs may have additional requirements or limits on coverage. These requirements and limits may include: • Prior Authorization (PA): Humana requires you or your doctor to get prior authorization for certain drugs. This

means that you will need to get approval from Humana before you fill your prescriptions. If you don’t get approval,Humana may not cover the drug.

• Quantity Limits (QL): For certain drugs, Humana limits the amount of the drug that we’ll cover. Humana might limithow many refills you can get, or how much of a drug you can get each time you fill your prescription. For example, if it isnormally considered safe to take only one pill per day for a certain drug, we may limit coverage for your prescription tono more than one pill per day. Specialty drugs are limited to a 30-day supply regardless of tier placement.

• Step Therapy (ST): In some cases, Humana requires you to first try certain drugs to treat your medical conditionbefore we’ll cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition,Humana may not cover Drug B unless you try Drug A first. If Drug A does not work for you, Humana will then cover DrugB.

• Part B versus Part D (B vs D): This drug may be covered under Medicare Part B or D depending upon thecircumstances. Information may need to be submitted describing the use and setting of the drug so we can make thedetermination.

For drugs that require prior authorization, step therapy, or fall outside of the noted quantity limits, the doctor must fax therequest to Humana at 1-877-486-2621. Representatives are available Monday through Friday, 8 a.m. to 6 p.m.

You can find out if your drug has any additional requirements or limits by looking in the formulary that begins on page 9.

Page 5: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 5

You also can get more information about the restrictions applied to specific covered drugs by visiting our website at Humana.com. Simply select "Medicare Drug List" from the Humana Medicare Plans tab at the top left of the website.The Medicare Drug List search tool lets you search for your drug by name or drug type.

You can ask Humana to make an exception to these restrictions or limits. See the section, "How do I request an exception to the formulary?" on page 5 for information about how to request an exception.

Does healthcare reform impact my coverage?Medicare Coverage Gap Discount Program beginning in 2011: Starting Jan.1, 2011, Medicare made changes to help withthe cost of medicines while members are in the Prescription Drug Plan coverage gap, often called the "donut hole." TheCenters for Medicare & Medicaid Services (CMS) will work with the companies that make prescription medicines to give youup to 50 percent off on covered brand-name prescriptions while you are in the coverage gap. Note that Medicare memberswho now receive the low-income subsidy ("Extra Help") or are covered by a qualified, commercial prescription plan throughan employer will not receive this discount.

Coverage in the "gap" for generic prescription medicines: Starting Jan. 1, 2011, Medicare made changes to help with thecost of medicines while members are in the Prescription Drug Plan coverage gap, often called the "donut hole." The Centersfor Medicare & Medicaid Services (CMS) work with health plans to provide more generic drug coverage while you are in thecoverage gap.

What if my drug is not on the formulary? If your drug isn’t included in this list of covered drugs, you should visit Humana.com to see if your drug is covered. Orcontact Customer Care and ask if your drug is covered.

If you learn that Humana does not cover your drug, you have two options: • You can ask Customer Care for a list of similar drugs that are covered by Humana. When you receive the list, show it to

your doctor and ask him or her to prescribe a similar drug that is covered by Humana. • You can ask Humana to make an exception and cover your drug. See below for information about how to request an

exception.

How do I request an exception to the formulary? You can ask Humana to make an exception to our coverage rules. There are several types of exceptions that you can ask usto make. • You can ask us to cover your drug even if it’s not on our formulary. • You can ask us to waive coverage restrictions or limits on your drug. For example, for certain drugs, Humana limits the

amount of the drug that we’ll cover. If your drug has a quantity limit, you can ask us to waive the limit and cover more.• You can ask us to provide a higher level of coverage for your drug. If your drug is usually considered a non-preferred

drug, you can ask us to cover it as a preferred instead. This would lower the amount you must pay for your drug. Pleasenote, if we grant your request to cover a drug that is not on our formulary, you may not ask us to provide a higher levelof coverage for the drug.

Generally, Humana will only approve your request for an exception if the alternative drugs included on the plan’s formulary,the lower-tiered drug or additional utilization restrictions wouldn’t be as effective in treating your condition and/or wouldcause you to have adverse medical effects.

You should contact us to ask us for an initial coverage decision for a formulary, tier or utilization restriction exception. Whenyou’re requesting a formulary tier or utilization restriction exception you should submit a statement from your doctorsupporting your request. Generally, we must make our decision within 72 hours of getting your prescribing doctor’ssupporting statement. You can request an expedited (fast) exception if you or your doctor believe that your health could beseriously harmed by waiting up to 72 hours for a decision. If your request to expedite is granted, we must give you adecision no later than 24 hours after we get your prescribing doctor’s supporting statement.

Page 6: Humana Walmart-Preferred Formulary - Q1Medicare

6 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

What do I do before I can talk to my doctor about changing my drugs or requesting an exception?As a new or continuing member in our plan you may be taking drugs that aren’t on our formulary. Or, you may be taking a drug that is on our formulary but your ability to get it is limited. For example, you may need a prior authorization from us before you can fill your prescription. You should talk to your doctor to decide if you should switch to an appropriate drug that we cover or request a formulary exception so that we’ll cover the drug you take. While you talk to your doctor to determine the right course of action for you, we may cover your drug in certain cases during the first 90 days you’re a member of our plan.

For each of your current Part D drugs that are not on our formulary or if your ability to get your drugs is limited, we’ll cover a temporary 30-day supply (unless you have a prescription written for fewer days in which case we’ll allow multiple fills to provide up to a total of 30 days of medication) when you go to a pharmacy. After your first 30-day supply, we won’t pay for these drugs, even if you have been a member of the plan less than 90 days unless a formulary exception has otherwise been granted.

If you’re a resident of a long-term care facility, we’ll cover a temporary 102-day transition supply of your current drug therapy (unless you have a prescription written for fewer days). We’ll cover more than one refill of these drugs for the first 90 days you’re a member of our plan. If you need a drug that is not on our formulary or if your ability to get your drugs is limited and you’re past the first 90 days of membership in our plan, we’ll cover a 34-day emergency supply of that drug (unless you have a prescription for fewer days) while you pursue a formulary exception.

Throughout the plan year, you may have a change in your treatment setting due to the level of care you require. Such transitions include: • Members who are discharged from a hospital or skilled nursing facility to a home setting. • Members who are admitted to a hospital or skilled nursing facility from a home setting. • Members who transfer from one skilled nursing facility to another and are served by a different pharmacy. • Members who end their skilled nursing facility Medicare Part A stay (where payments include all pharmacy charges) and

who need to now use their Part D plan benefit. • Members who give up Hospice Status and revert back to standard Medicare Part A and B coverage. • Members discharged from chronic psychiatric hospitals with highly individualized drug regimens.

For these changes in treatment settings, Humana will cover up to a 34-day temporary supply of a Part D covered drug when your prescription is filled at a pharmacy. If you change treatment settings multiple times within the same month, you may have to request an exception or prior authorization and receive approval for continued coverage of your drug. Humana will review these requests for continuation of therapy on a case-by-case basis when you’re on a stabilized drug regimen that, if altered, is known to have risks.

Transition ExtensionHumana makes arrangements to continue to provide necessary drugs to you via an extension of the transition period, on acase-by case basis, when your exception request or appeal has not been processed by the end of your transition period.

A member Transition Policy is available on Humana’s Medicare website, Humana.com, in the same area where the Part Dformulary is displayed.

Humana-Medicare.com - Explore Your OptionsFor help selecting the plan that’s right for you, use our online comparison tools at Humana-Medicare.com. You canresearch your coverage options, compare benefits, and estimate your annual costs with various plans. Also, you can use theRx Calculator on the website to: • Estimate your monthly drug costs and how long it will take you to reach the various cost "stages" for your prescription

drug plan. • Get information about pricing, coverage, usage, dosage, interactions, and other details on more than 10,000 drugs. • Find out whether a generic alternative might save you money.

Page 7: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 7

For More Information

For more detailed information about your Humana prescription drug coverage, please review your Evidence of Coverage andother plan materials.

If you have questions about Humana, please visit our website at Humana.com. Simply select "Medicare Drug List" fromthe Humana Medicare Plans tab at the top left of the website. The Medicare Drug List search tool lets you search for yourdrug by name or drug type.

You can also call Humana Customer Care at 1-800-281-6918. If you use a TTY, call 711. You can call seven days a weekfrom 8 a.m. to 8 p.m. From February 15th until the following Annual Election Period (AEP), you can leave us a voice mailmessage after hours, Saturdays, Sundays and some public holidays. Just leave a message and select the reason for your callfrom the automated list. We’ll call back by the end of the next business day. Please have your Humana ID card with youwhen you call.

If you have general questions about Medicare prescription drug coverage, please call Medicare at 1-800-MEDICARE (1-800-633-4227) 24 hours a day, seven days a week. TTY users should call 1-877-486-2048. Or, visit www.medicare.gov.

Page 8: Humana Walmart-Preferred Formulary - Q1Medicare

8 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

Humana Formulary

The formulary that begins on the next page provides coverage information about some of the drugs covered by Humana. If you have trouble finding your drug in the list, turn to the Index that begins on page 122.

How to read your formularyThe first column of the chart lists categories of medical condition in alphabetical order. The drug names are then listed inalphabetical order within each category. Brand name drugs are CAPITALIZED and generic drugs are listed in lower case.Next to the drug name you may see an indicator to tell you about additional coverage for that drug. The following indicatorsmay be displayed:SP - Drugs that are typically available through a specialty pharmacy. Please check with your specialty pharmacy to makesure your drug is available.MO - Drugs that are typically available through mail-order. Please check with your mail-order pharmacy to make sure yourdrug is available.

The third column shows the Utilization Management Requirements for the drug. Humana may have special requirements forcovering that drug. If the column is blank, then there are no utilization requirements for that drug. The supply is based onbenefits and whether your doctor prescribes a 30-, 60-, or 90-day supply. The amount of any quantity limits will also be in

The second column lists the tier of the drug. See page 4 for more details on the drug tiers in your plan.

this column (Example: QL - 30 for 30 days). See page 4 for more details on these requirements for your plan.

Page 9: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 9

Formulary Start Cross Reference

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ANTINEOPLASTIC AGENTSABRAXANE 100 MG IV SOLUTION SP 4 PA,QL (700 per 21 days)adriamycin 10 mg iv solution MO 3 B vs Dadriamycin 10 mg/5 ml iv MO 3 B vs Dadriamycin 20 mg iv solution MO 3 B vs Dadriamycin 20 mg/10 ml iv MO 3 B vs DADRIAMYCIN 50 MG IV SOLUTION MO 3 B vs Dadriamycin 50 mg/25 ml iv MO 3 B vs Dadriamycin pfs 2 mg/ml iv MO 3 B vs DAFINITOR 10 MG TAB SP 4 PA,QL (30 per 30 days)AFINITOR 2.5 MG TAB SP 4 PA,QL (30 per 30 days)AFINITOR 5 MG TAB SP 4 PA,QL (30 per 30 days)ALIMTA 100 MG IV SOLUTION SP 4 PAALIMTA 500 MG IV SOLUTION SP 4 PAALKERAN 2 MG TAB MO 4 B vs DALKERAN 50 MG IV SOLUTION SP 4 B vs Danastrozole 1 mg tablet MO 2 QL (30 per 30 days)ARIMIDEX 1 MG TAB MO 4 PA,QL (30 per 30 days)AROMASIN 25 MG TAB MO 4 PAARRANON 250 MG/50 ML IV SP 4 PAARZERRA 1,000 MG/50 ML IV SP 4 PA,QL (400 per 28 days)ARZERRA 100 MG/5 ML IV SP 4 PA,QL (80 per 30 days)AVASTIN 25 MG/ML IV SP 4 PAbicalutamide 50 mg tablet MO 2 QL (30 per 30 days)BICNU 100 MG IV SOLUTION SP 4 B vs Dbleomycin sulfate 15 unit vial MO 3 B vs Dbleomycin sulfate 30 unit vial MO 3 B vs DBUSULFEX 60 MG/10 ML IV MO 4 B vs DCAMPATH 30 MG/ML IV SP 4CAPRELSA 100 MG TAB SP 4 PA,QL (60 per 30 days)CAPRELSA 300 MG TAB SP 4 PA,QL (30 per 30 days)carboplatin 150 mg vial MO 3 B vs Dcarboplatin 450 mg vial MO 3 B vs Dcarboplatin 50 mg/5 ml vial MO 3 B vs DCEENU 10 MG CAP SP 4CEENU 100 MG CAP SP 4CEENU 40 MG CAP SP 4CERUBIDINE 20 MG IV SOLUTION MO 4 B vs Dcisplatin 1 mg/ml vial MO 3 B vs Dcladribine 10 mg/10 ml vial SP 2 B vs DCLOLAR 20 MG/20 ML IV SP 4 B vs D

Page 10: Humana Walmart-Preferred Formulary - Q1Medicare

10 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

COSMEGEN 0.5 MG IV SOLUTION SP 4 B vs Dcyclophosphamide 1 gm vial MO 3 B vs Dcyclophosphamide 2 gm vial MO 3 B vs Dcyclophosphamide 25 mg tab MO 3 B vs Dcyclophosphamide 50 mg tablet MO 3 B vs Dcyclophosphamide 500 mg vial MO 3 B vs Dcytarabine 1 gm vial MO 2 B vs Dcytarabine 100 mg vial MO 2 B vs Dcytarabine 100 mg/ml vial MO 2 B vs Dcytarabine 2 gm vial MO 2 B vs Dcytarabine 20 mg/ml vial MO 2 B vs Dcytarabine 500 mg vial MO 2 B vs Ddacarbazine 100 mg vial MO 2 B vs Ddacarbazine 200 mg vial MO 2 B vs DDACOGEN 50 MG IV SOLUTION SP 4 PAdactinomycin 0.5 mg vial SP 3 B vs Ddaunorubicin 20 mg vial MO 2 B vs Ddaunorubicin 50 mg/10 ml vial MO 2 B vs DDAUNOXOME 2 MG/ML IV SP 4 B vs DDEPOCYT 50 MG/5 ML (10 MG/ML) SUSP, INTRATHECAL SP 4 B vs DDOCEFREZ 20 MG IV SOLUTION SP 4 B vs DDOCEFREZ 80 MG IV SOLUTION SP 4 B vs Ddocetaxel 160 mg/16 ml vial SP 4 B vs Ddocetaxel 20 mg/0.5 ml vial SP 4 B vs Ddocetaxel 20 mg/2 ml vial SP 4 B vs Ddocetaxel 20 mg/ml vial SP 4 B vs Ddocetaxel 80 mg/2 ml vial SP 4 B vs Ddocetaxel 80 mg/4 ml vial SP 4 B vs Ddocetaxel 80 mg/8 ml vial SP 4 B vs Ddoxorubicin 10 mg vial MO 3 B vs Ddoxorubicin 10 mg/5 ml vial MO 3 B vs Ddoxorubicin 20 mg/10 ml vial MO 3 B vs Ddoxorubicin 200 mg/100 ml vial MO 3 B vs Ddoxorubicin 50 mg vial MO 3 B vs Ddoxorubicin 50 mg/25 ml vial MO 3 B vs DDROXIA 200 MG CAP MO 4DROXIA 300 MG CAP MO 4DROXIA 400 MG CAP MO 4ELOXATIN 100 MG/20 ML SOLN SP 4 B vs DELOXATIN 200 MG/40 ML SOLN SP 4 B vs DELOXATIN 50 MG/10 ML (5 MG/ML) SOLN SP 4 B vs D

Page 11: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 11

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

EMCYT 140 MG CAP MO 4epirubicin 10 mg/5 ml vial MO 3 B vs Depirubicin 150 mg/75 ml vial MO 3 B vs Depirubicin 200 mg/100 ml vial MO 3 B vs Depirubicin 50 mg/25 ml vial MO 3 B vs Depirubicin hcl 200 mg vial MO 3 B vs Depirubicin hcl 50 mg vial MO 3 B vs DERBITUX 100 MG/50 ML IV SP 4 PAERBITUX 200 MG/100 ML IV SP 4 PAETOPOPHOS 100 MG IV SOLUTION MO 4 B vs Detoposide 100 mg/5 ml vial MO 3etoposide 50 mg capsule MO 4exemestane 25 mg tablet MO 3FARESTON 60 MG TAB MO 4 QL (30 per 30 days)FASLODEX 125 MG/2.5 ML SYRNGE MO 4 B vs D,QL (10 per 30 days)FASLODEX 250 MG/5 ML IM SYRINGE SP 4 B vs D,QL (10 per 30 days)FEMARA 2.5 MG TAB MO 4 PA,QL (30 per 30 days)FIRMAGON 120 MG SUB-Q SOLN SP 4 PA,QL (6 per 365 days)FIRMAGON 80 MG SUB-Q SOLN SP 4 PA,QL (4 per 28 days)floxuridine 500 mg vial MO 2 B vs Dfludarabine 50 mg vial MO 2 B vs Dfludarabine 50 mg/2 ml vial MO 2 B vs Dfluorouracil 1,000 mg/20 ml vl MO 3 B vs Dfluorouracil 2,500 mg/50 ml vl MO 3 B vs Dfluorouracil 5,000 mg/100 ml MO 3 B vs Dfluorouracil 500 mg/10 ml vial MO 3 B vs Dflutamide 125 mg capsule MO 3gemcitabine hcl 1 gram vial SP 4 B vs Dgemcitabine hcl 2 gram vial SP 4 B vs Dgemcitabine hcl 200 mg vial SP 4 B vs DGEMZAR 1 GRAM IV SOLUTION SP 4 B vs DGEMZAR 200 MG IV SOLUTION SP 4 B vs DGLEEVEC 100 MG TAB SP 4 PA,QL (180 per 30 days)GLEEVEC 400 MG TAB SP 4 PA,QL (60 per 30 days)HALAVEN 1 MG/2 ML (0.5 MG/ML) IV SP 4 PA,QL (6 per 21 days)HERCEPTIN 440 MG IV SOLUTION SP 4 PAHEXALEN 50 MG CAP MO 4HYCAMTIN 0.25 MG CAP SP 4 B vs DHYCAMTIN 1 MG CAP SP 4 B vs DHYCAMTIN 4 MG IV SOLUTION SP 4 B vs Dhydroxyurea 500 mg capsule MO 2

Page 12: Humana Walmart-Preferred Formulary - Q1Medicare

12 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

IDAMYCIN PFS 1 MG/ML IV MO 4 B vs Didarubicin hcl 5 mg/5 ml vial MO 4 B vs DIFEX 1 GRAM IV SOLUTION MO 4 B vs DIFEX 3 GRAM IV SOLUTION MO 4 B vs Difosfamide 1 gm vial MO 3 B vs Difosfamide 1 gm/ 20 ml vial MO 3 B vs Difosfamide 3 gm vial MO 3 B vs Difosfamide 3 gm/ 60 ml vial MO 3 B vs Difosfamide-mesna kit MO 3 B vs DIRESSA 250 MG TAB SP 3 QL (30 per 30 days)irinotecan hcl 100 mg/5 ml vl SP 3 B vs Dirinotecan hcl 40 mg/2 ml vial SP 3 B vs Dirinotecan hcl 500 mg/25 ml vl SP 3 B vs DISTODAX 10 MG/2 ML IV SOLUTION SP 4 PAIXEMPRA 15 MG IV SOLUTION SP 4 PAIXEMPRA 45 MG IV SOLUTION SP 4 PAletrozole 2.5 mg tablet MO 3 QL (30 per 30 days)LEUKERAN 2 MG TAB MO 3leuprolide 2wk 1 mg/0.2 ml kt SP 3 PA,QL (3 per 14 days)LEUSTATIN 10 MG/10 ML IV SP 4 B vs DLUPRON DEPOT (3 MONTH) 11.25 MG IM KIT SP 4 PA,QL (1 per 90 days)LUPRON DEPOT (3 MONTH) 22.5 MG IM SYRINGE KIT SP 4 PA,QL (1 per 90 days)LUPRON DEPOT (4 MONTH) 30 MG IM SYRINGE KIT SP 4 PA,QL (1 per 120 days)LUPRON DEPOT (6 MONTH) 45 MG IM SYRINGE KIT SP 4 PA,QL (1 per 180 days)LUPRON DEPOT 3.75 MG IM KIT SP 4 PA,QL (1 per 30 days)LUPRON DEPOT 7.5 MG IM SYRINGE KIT MO 4 PA,QL (1 per 30 days)LUPRON DEPOT-PED (3 MONTH) 11.25 MG IM SYRINGE KIT MO 4 PA,QL (1 per 90 days)LUPRON DEPOT-PED (3 MONTH) 30 MG IM SYRINGE KIT MO 4 PA,QL (1 per 90 days)LUPRON DEPOT-PED 11.25 MG IM KIT SP 4 PA,QL (1 per 28 days)LUPRON DEPOT-PED 15 MG IM KIT SP 4 PA,QL (1 per 28 days)LUPRON DEPOT-PED 7.5 MG (PED) IM KIT SP 4 PA,QL (1 per 28 days)LYSODREN 500 MG TAB MO 3MATULANE 50 MG CAP SP 4megestrol 20 mg tablet MO 1megestrol 40 mg tablet MO 3megestrol acet 40 mg/ml susp MO 3melphalan hcl 50 mg vial SP 2 B vs Dmercaptopurine 50 mg tablet MO 3methotrexate 1 gm vial MO 2methotrexate 1 gm/40 ml vial MO 2methotrexate 2.5 mg tablet MO 2

Page 13: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 13

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

methotrexate 25 mg/ml vial MO 2mitomycin 20 mg vial MO 4 B vs Dmitomycin 40 mg vial MO 4 B vs Dmitomycin 5 mg vial MO 4 B vs Dmitoxantrone 20 mg/10 ml vial SP 3 B vs DMUSTARGEN 10 MG SOLUTION FOR INJECTION SP 4 B vs DMYLERAN 2 MG TAB MO 4MYLOTARG 5 MG VIAL SP 4NEXAVAR 200 MG TAB SP 4 PA,QL (120 per 30 days)NILANDRON 150 MG TAB MO 4 QL (60 per 30 days)NIPENT 10 MG IV SOLUTION SP 4 B vs DNOVANTRONE 2 MG/ML VIAL SP 4 B vs DOFORTA 10 MG TABLET SP 4ONCASPAR 750 UNIT/ML INJECTION SP 4 B vs DONTAK 150 MCG/ML IV SP 4onxol 6 mg/ml concentrate, iv SP 4 B vs Doxaliplatin 100 mg vial MO 2 B vs Doxaliplatin 100 mg/20 ml vial SP 2 B vs Doxaliplatin 50 mg vial MO 2 B vs Doxaliplatin 50 mg/10 ml vial SP 2 B vs Dpaclitaxel 100 mg/16.7 ml vial SP 3 B vs Dpentostatin 10 mg vial SP 2 B vs DPHOTOFRIN 75 MG IV SOLUTION MO 4 B vs DPROLEUKIN 22 MILLION UNIT IV SOLUTION SP 4REVLIMID 10 MG CAP SP 4 PA,QL (21 per 28 days)REVLIMID 15 MG CAP SP 4 PA,QL (21 per 28 days)REVLIMID 25 MG CAP SP 4 PA,QL (21 per 28 days)REVLIMID 5 MG CAP SP 4 PA,QL (21 per 28 days)RHEUMATREX 2.5 MG TABS IN A DOSE PACK MO 4RITUXAN 10 MG/ML CONCENTRATE, IV SP 3 PASPRYCEL 100 MG TAB SP 4 PA,QL (60 per 30 days)SPRYCEL 140 MG TAB SP 4 PA,QL (30 per 30 days)SPRYCEL 20 MG TAB SP 4 PA,QL (90 per 30 days)SPRYCEL 50 MG TAB SP 4 PA,QL (60 per 30 days)SPRYCEL 70 MG TAB SP 4 PA,QL (60 per 30 days)SPRYCEL 80 MG TAB SP 4 PA,QL (60 per 30 days)SUTENT 12.5 MG CAP SP 4 PA,QL (28 per 28 days)SUTENT 25 MG CAP SP 4 PA,QL (28 per 28 days)SUTENT 50 MG CAP SP 4 PA,QL (28 per 28 days)TABLOID 40 MG TAB MO 2tamoxifen 10 mg tablet MO 1

Page 14: Humana Walmart-Preferred Formulary - Q1Medicare

14 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

tamoxifen 20 mg tablet MO 1TARCEVA 100 MG TAB SP 4 PA,QL (30 per 30 days)TARCEVA 150 MG TAB SP 4 PA,QL (30 per 30 days)TARCEVA 25 MG TAB SP 4 PA,QL (90 per 30 days)TARGRETIN 75 MG CAP SP 4 PATASIGNA 150 MG CAP SP 4 PA,QL (120 per 30 days)TASIGNA 200 MG CAP SP 4 PA,QL (120 per 30 days)TAXOTERE 20 MG/2 ML (FINAL CONC.) IV SP 4 B vs DTAXOTERE 20 MG/ML (1 ML) IV SP 4 B vs DTAXOTERE 80 MG/4 ML (20 MG/ML) IV SP 4 B vs DTAXOTERE 80 MG/8 ML (FINAL CONC.) IV SP 4 B vs DTEMODAR 100 MG CAP SP 4 PA,QL (60 per 30 days)TEMODAR 100 MG IV SOLUTION SP 4 PA,QL (27 per 30 days)TEMODAR 140 MG CAP SP 4 PA,QL (30 per 30 days)TEMODAR 180 MG CAP SP 4 PA,QL (30 per 30 days)TEMODAR 20 MG CAP SP 4 PA,QL (270 per 30 days)TEMODAR 250 MG CAP SP 4 PA,QL (10 per 30 days)TEMODAR 5 MG CAP SP 4 PA,QL (90 per 30 days)thiotepa 15 mg vial MO 2 B vs Dtoposar 20 mg/ml iv MO 4topotecan hcl 4 mg vial SP 4 B vs Dtopotecan hcl 4 mg/4 ml vial SP 4 B vs DTORISEL 30 MG/3 ML (10 MG/ML) (FINAL) IV SOLUTION SP 4 PA,QL (100 per 28 days)TREANDA 100 MG IV SOLUTION SP 4 PA,QL (600 per 21 days)TREANDA 25 MG IV SOLUTION SP 4 PA,QL (300 per 21 days)TRELSTAR 11.25 MG/2 ML IM SYRINGE SP 4 PA,QL (1 per 84 days)TRELSTAR 22.5 MG IM SUSP SP 4 PA,QL (1 per 168 days)TRELSTAR 22.5 MG/2 ML IM SYRINGE SP 4 PA,QL (1 per 168 days)TRELSTAR 3.75 MG/2 ML IM SYRINGE SP 4 PA,QL (1 per 28 days)TRELSTAR DEPOT 3.75 MG IM SUSP MO 4 PA,QL (1 per 28 days)TRELSTAR LA 11.25 MG IM SUSP MO 4 PA,QL (1 per 84 days)tretinoin 10 mg capsule SP 3TREXALL 10 MG TAB MO 4TREXALL 15 MG TAB MO 4TREXALL 5 MG TAB MO 4TREXALL 7.5 MG TAB MO 4TRISENOX 10 MG/10 ML IV SP 4 B vs DTYKERB 250 MG TAB SP 4 PA,QL (150 per 30 days)VALSTAR 40 MG/ML INTRAVESICAL SP 4VANDETANIB 100 MG TABLET SP 4 PA,QL (60 per 30 days)VANDETANIB 300 MG TABLET SP 4 PA,QL (30 per 30 days)

Page 15: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 15

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

VECTIBIX 100 MG/5 ML (20 MG/ML) IV SP 4 PAVECTIBIX 200 MG/10 ML VIAL MO 4 PAVECTIBIX 400 MG/20 ML (20 MG/ML) IV SP 4 PAVELCADE 3.5 MG IV SOLUTION SP 4 PAVIDAZA 100 MG SUB-Q SOLN SP 4 PAvinblastine 1 mg/ml vial MO 2 B vs Dvinblastine sulf 10 mg vial MO 2 B vs Dvincristine 1 mg/ml vial MO 2 B vs Dvincristine 2 mg/2 ml vial MO 2 B vs Dvinorelbine 10 mg/ml vial MO 3 B vs Dvinorelbine 50 mg/5 ml vial MO 3VOTRIENT 200 MG TAB SP 4 PA,QL (120 per 30 days)VUMON 10 MG/ML IV MO 4 B vs DXALKORI 200 MG CAP MO 4 PA,QL (60 per 30 days)XALKORI 250 MG CAP MO 4 PA,QL (60 per 30 days)XELODA 150 MG TAB SP 4XELODA 500 MG TAB SP 4YERVOY 200 MG/40 ML (5 MG/ML) IV SP 4 PA,QL (1 per 21 days)YERVOY 50 MG/10 ML (5 MG/ML) IV SP 4 PA,QL (3 per 21 days)ZANOSAR 1 GRAM IV SOLUTION SP 4 B vs DZELBORAF 240 MG TAB MO 4 PA,QL (240 per 30 days)ZOLADEX 10.8 MG SUBQ IMPLANT SP 4 PA,QL (1 per 84 days)ZOLADEX 3.6 MG SUBQ IMPLANT SP 4 PA,QL (1 per 28 days)ZOLINZA 100 MG CAP SP 4 PA,QL (120 per 30 days)ZYTIGA 250 MG TAB SP 4 PA,QL (120 per 30 days)AUTONOMIC DRUGSAH-CHEW D SUSPENSION MO 4AH-CHEW D TABLET CHEW MO 4albuterol 0.083% inhal soln MO 1 B vs Dalbuterol 2.5 mg/0.5 ml sol MO 2 B vs Dalbuterol 5 mg/ml solution MO 1 B vs Dalbuterol sul 0.63 mg/3 ml sol MO 2 B vs Dalbuterol sul 1.25 mg/3 ml sol MO 2 B vs Dalbuterol sulf 2 mg/5 ml syrup MO 1albuterol sulfate 2 mg tab MO 1albuterol sulfate 4 mg tab MO 1albuterol sulfate er 4 mg tab MO 3albuterol sulfate er 8 mg tab MO 3alfuzosin hcl er 10 mg tablet MO 3 QL (30 per 30 days)ANASPAZ 0.125 MG TAB, RAPID DISSOLVE MO 4 PAatracurium 10 mg/ml vial MO 2

Page 16: Humana Walmart-Preferred Formulary - Q1Medicare

16 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

atropine 0.05 mg/ml syringe MO 2atropine 0.1 mg/ml syringe MO 2atropine 0.4 mg/0.5 ml ampul MO 2atropine 0.4 mg/ml vial MO 2atropine 1 mg/ml vial MO 2ATROVENT HFA 17 MCG/ACTUATION AEROSOL INHALER MO 4 QL (30 per 30 days)baclofen 10 mg tablet MO 1baclofen 20 mg tablet MO 2bethanechol 10 mg tablet MO 3bethanechol 25 mg tablet MO 3bethanechol 5 mg tablet MO 3bethanechol 50 mg tablet MO 3carisoprodol 350 mg tablet MO 2 PAcarisoprodol compound tab MO 2 PAcarisoprodol cpd-codeine tab MO 3 PACHANTIX 0.5 MG TAB MO 4 QL (56 per 28 days)CHANTIX 1 MG TAB MO 4 QL (56 per 28 days)CHANTIX CONTINUING MONTH PAK 1 MG TAB MO 4 QL (56 per 28 days)CHANTIX STARTING MONTH PAK 0.5 MG (11)-1 MG (3X14) TABS IN ADOSE PACK MO

4 QL (56 per 28 days)

dantrolene sodium 100 mg cap MO 3dantrolene sodium 25 mg cap MO 3dantrolene sodium 50 mg cap MO 3dihydroergotamine 1 mg/ml am MO 3dobutamine 1 gm-d5w 250 ml MO 2dobutamine 12.5 mg/ml vial MO 2dobutamine 250 mg-d5w 250 ml MO 2dobutamine 250 mg-d5w 500 ml MO 2dobutamine 500 mg-d5w 250 ml MO 2dobutamine 500 mg-d5w 500 ml MO 2donepezil hcl 10 mg tablet MO 2 QL (30 per 30 days)donepezil hcl 5 mg tablet MO 2 QL (30 per 30 days)donepezil hcl odt 10 mg tablet MO 2 QL (30 per 30 days)donepezil hcl odt 5 mg tablet MO 2 QL (30 per 30 days)dopamine 160 mg/ml vial MO 2dopamine 200 mg-d5w 250 ml MO 2dopamine 40 mg/ml vial MO 2dopamine 400 mg-d5w 250 ml MO 2dopamine 400 mg-d5w 500 ml MO 2dopamine 80 mg/ml vial MO 2dopamine 800 mg-d5w 250 ml MO 2

Page 17: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 17

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

dopamine 800 mg-d5w 500 ml MO 2DUONEB 0.5 MG-3 MG(2.5 MG BASE)/3 ML NEB SOLUTION MO 4 B vs Ded-spaz 0.125 mg tab, rapid dissolve MO 2 PAephedrine su 50 mg/ml vial MO 2epinephrine 0.1 mg/ml syringe MO 2epinephrine 0.15 mg auto-injct MO 2epinephrine 0.3 mg auto-inject MO 3epinephrine 1 mg/ml ampul MO 2epinephrine 1 mg/ml vial MO 2EPIPEN 0.3 MG/0.3 ML (1:1,000) IM INJECTOR MO 3EPIPEN JR 0.15 MG/0.3 ML (1:2,000) IM INJECTOR MO 3ERGOMAR 2 MG SUBLINGUAL TAB MO 2ergotamine-caffeine tablet MO 2EXELON 2 MG/ML ORAL SOLN MO 4 QL (240 per 30 days)EXELON 4.6 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)EXELON 9.5 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)FORADIL AEROLIZER 12 MCG INHALATION CAPS MO 4 QL (60 per 30 days)galantamine 4 mg/ml oral soln MO 2 QL (200 per 30 days)galantamine er 16 mg capsule MO 2 QL (30 per 30 days)galantamine er 24 mg capsule MO 2 QL (30 per 30 days)galantamine er 8 mg capsule MO 2 QL (30 per 30 days)galantamine hbr 12 mg tablet MO 3 QL (60 per 30 days)galantamine hbr 4 mg tablet MO 3 QL (60 per 30 days)galantamine hbr 8 mg tablet MO 3 QL (60 per 30 days)glycopyrrolate 0.2 mg/ml vial MO 2glycopyrrolate 1 mg tablet MO 2glycopyrrolate 2 mg tablet MO 2guanidine hcl 125 mg tablet MO 3iprat-albut 0.5-3(2.5) mg/3 ml MO 3 B vs Dipratropium br 0.02% soln MO 1 B vs Disoproterenol 0.2 mg/ml syrn MO 2ISUPREL 0.2 MG/ML INJECTION MO 4levalbuterol conc 1.25 mg/0.5 MO 2 B vs DLIORESAL 2,000 MCG/ML INTRATHECAL MO 4LIORESAL 50 MCG/ML INTRATHECAL MO 4LIORESAL 500 MCG/ML INTRATHECAL MO 4metaproterenol 10 mg tablet MO 2metaproterenol 10 mg/5 ml syr MO 3metaproterenol 20 mg tablet MO 2metaxalone 800 mg tablet MO 3 QL (120 per 30 days)methocarbamol 500 mg tablet MO 2 PA

Page 18: Humana Walmart-Preferred Formulary - Q1Medicare

18 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

methocarbamol 750 mg tablet MO 2 PAmethscopolamine brom 2.5 mg tb MO 3methscopolamine brom 5 mg tab MO 3midodrine hcl 10 mg tablet MO 3midodrine hcl 2.5 mg tablet MO 3midodrine hcl 5 mg tablet MO 3migergot 2 mg-100 mg rectal suppository MO 4NEO-SYNEPHRINE 10 MG/ML INJECTION MO 4neostigmine 1:1,000 vial MO 2neostigmine 1:2,000 vial MO 2NICOTROL NS 10 MG/ML NASAL SPRAY MO 4NIMBEX 10 MG/ML IV MO 4NIMBEX 2 MG/ML IV MO 4norepinephrine 1 mg/ml vial MO 2NORFLEX 30 MG/ML INJECTION MO 4nulev 0.125 mg tab, rapid dissolve MO 4 PAorphenadrine 30 mg/ml ampule MO 3orphenadrine er 100 mg tablet MO 3pancuronium 1 mg/ml vial MO 2pancuronium 2 mg/ml vial MO 2phentolamine 5 mg vial MO 2phenylephrine 10 mg/ml vial MO 2pilocarpine hcl 5 mg tablet MO 3pilocarpine hcl 7.5 mg tablet MO 3pro-hyo chewable melt tablet MO 2PROAIR HFA 90 MCG/ACTUATION AEROSOL INHALER MO 3 QL (36 per 30 days)propantheline 15 mg tablet MO 2 PAPROSTIGMIN 15 MG TAB MO 4pyridostigmine br 60 mg tablet MO 2revonto 20 mg iv solution MO 3rivastigmine 1.5 mg cap MO 2 QL (90 per 30 days)rivastigmine 3 mg capsule MO 2 QL (90 per 30 days)rivastigmine 4.5 mg capsule MO 2 QL (60 per 30 days)rivastigmine 6 mg capsule MO 2 QL (60 per 30 days)rocuronium 100 mg/10 ml vial MO 2SEREVENT DISKUS 50 MCG/DOSE FOR INHALATION MO 3 QL (60 per 30 days)SPIRIVA WITH HANDIHALER 18 MCG & INHALATION CAPS MO 3 QL (30 per 30 days)tamsulosin hcl 0.4 mg capsule MO 2 QL (60 per 30 days)terbutaline sulf 1 mg/ml vial MO 3terbutaline sulfate 2.5 mg tab MO 3terbutaline sulfate 5 mg tab MO 3

Page 19: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 19

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

tizanidine hcl 2 mg tablet MO 2tizanidine hcl 4 mg tablet MO 2tubocurarine cl 3 mg/ml syrn MO 2TWINJECT AUTOINJECTOR 0.15 MG/0.15 ML (1:1,000) IM PEN MO 4TWINJECT AUTOINJECTOR 0.3 MG/0.3 ML (1:1,000) IM PEN MO 4vecuronium 10 mg vial MO 2vecuronium 20 mg vial MO 2VENTOLIN HFA 90 MCG/ACTUATION AEROSOL INHALER MO 3 QL (36 per 30 days)ZEMURON 10 MG/ML IV MO 4BLOOD FORMATION,COAGULATION & THROMBOSISACTIVASE 100 MG SOLUTION MO 4 B vs DACTIVASE 50 MG SOLUTION MO 4 B vs DADVATE 1,000 (+/-) UNIT IV SOLUTION SP 4ADVATE 1,500 (+/-) UNIT IV SOLUTION SP 4ADVATE 2,000 (+/-) UNIT IV SOLUTION SP 4ADVATE 250 (+/-) UNIT IV SOLUTION SP 4ADVATE 3,000 (+/-) UNIT IV SOLUTION SP 4ADVATE 500 (+/-) UNIT IV SOLUTION SP 4ALPHANATE 1,000 (400 VWF) UNIT/10 ML IV SOLUTION SP 4ALPHANATE 1,500 (600 VWF) UNIT/10 ML IV SOLUTION SP 4ALPHANATE 250 (100 VWF) UNIT/5 ML IV SOLUTION SP 4ALPHANATE 500 (200 VWF) UNIT/5 ML IV SOLUTION SP 4ALPHANINE SD 1,000 (+/-) UNIT IV SOLUTION SP 4ALPHANINE SD 1,500 (+/-) UNIT IV SOLUTION SP 4ALPHANINE SD 500 (+/-) UNIT IV SOLUTION SP 4ALPHANINE SD 812 (+/-) UNIT IV SOLUTION SP 4AMICAR 1,000 MG TAB MO 4AMICAR 25 % ORAL SOLN MO 4AMICAR 500 MG TAB MO 4aminocaproic acid 25% solution MO 2aminocaproic acid 250 mg/ml MO 2aminocaproic acid 500 mg tab MO 2anagrelide hcl 0.5 mg capsule MO 2anagrelide hcl 1 mg capsule MO 2argatroban 100 mg/ml vial MO 2 B vs DARIXTRA 10 MG/0.8 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)ARIXTRA 2.5 MG/0.5 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)ARIXTRA 5 MG/0.4 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)ARIXTRA 7.5 MG/0.6 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)BEBULIN VH 700 (+/-) UNIT IV SOLUTION SP 4BENEFIX 1,000 UNIT IV KIT SP 4

Page 20: Humana Walmart-Preferred Formulary - Q1Medicare

20 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

BENEFIX 2,000 UNIT IV KIT SP 4BENEFIX 250 UNIT IV KIT SP 4BENEFIX 500 UNIT IV KIT SP 4CATHFLO ACTIVASE 2 MG SOLUTION FOR INJECTION MO 4 B vs DCEPROTIN (BLUE BAR) 500 UNIT IV SOLUTION MO 4CEPROTIN (GREEN BAR) 1,000 UNIT IV SOLUTION MO 4cilostazol 100 mg tablet MO 2cilostazol 50 mg tablet MO 2COUMADIN 1 MG TAB MO 4COUMADIN 10 MG TAB MO 4COUMADIN 2 MG TAB MO 4COUMADIN 2.5 MG TAB MO 4COUMADIN 3 MG TAB MO 4COUMADIN 4 MG TAB MO 4COUMADIN 5 MG IV SOLUTION MO 4COUMADIN 5 MG TAB MO 4COUMADIN 6 MG TAB MO 4COUMADIN 7.5 MG TAB MO 4CYKLOKAPRON 100 MG/ML IV MO 3EFFIENT 10 MG TAB MO 4 QL (30 per 30 days)EFFIENT 5 MG TAB MO 4 QL (30 per 30 days)enoxaparin 100 mg/ml syr MO 3 QL (14 per 30 days)enoxaparin 120 mg/0.8 ml syr MO 3 QL (14 per 30 days)enoxaparin 150 mg/ml syr MO 3 QL (14 per 30 days)enoxaparin 30 mg/0.3 ml syr MO 3 QL (28 per 30 days)enoxaparin 40 mg/0.4 ml syr MO 3 QL (14 per 30 days)enoxaparin 60 mg/0.6 ml syr MO 3 QL (14 per 30 days)enoxaparin 80 mg/0.8 ml syr MO 3 QL (14 per 30 days)EPOGEN 10,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)EPOGEN 2,000 UNIT/ML INJECTION SP 3 PA,QL (14 per 30 days)EPOGEN 20,000 UNIT/2 ML INJECTION SP 4 PA,QL (14 per 30 days)EPOGEN 20,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)EPOGEN 3,000 UNIT/ML INJECTION SP 3 PA,QL (14 per 30 days)EPOGEN 4,000 UNIT/ML INJECTION SP 3 PA,QL (14 per 30 days)EPOGEN 40,000 UNITS/ML VIAL SP 4 PA,QL (4 per 30 days)FEIBA VH IMMUNO 1,750 UNIT-3,250 UNIT IV SOLUTION SP 4FEIBA VH IMMUNO 400 UNIT-650 UNIT IV SOLUTION SP 4FEIBA VH IMMUNO 651 UNIT-1,200 UNIT IV SOLUTION SP 4fondaparinux 10 mg/0.8 ml syr MO 4 QL (14 per 30 days)fondaparinux 2.5 mg/0.5 ml syr MO 4 QL (14 per 30 days)fondaparinux 5 mg/0.4 ml syr MO 4 QL (14 per 30 days)

Page 21: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 21

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

fondaparinux 7.5 mg/0.6 ml syr MO 4 QL (14 per 30 days)FRAGMIN 10,000 UNIT/ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)FRAGMIN 10,000 UNITS/ML VIAL MO 4 QL (14 per 30 days)FRAGMIN 12,500 UNIT/0.5 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)FRAGMIN 15,000 UNIT/0.6 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)FRAGMIN 18,000 UNIT/0.72 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)FRAGMIN 2,500 UNIT/0.2 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)FRAGMIN 25,000 UNIT/ML SUB-Q MO 4 QL (2 per 30 days)FRAGMIN 5,000 UNIT/0.2 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)FRAGMIN 7,500 UNIT/0.3 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)HELIXATE FS 1,000 (+/-) UNIT IV SOLUTION SP 3HELIXATE FS 250 (+/-) UNIT IV SOLUTION SP 3HELIXATE FS 3,000 (+/-) UNIT IV SOLUTION SP 3HELIXATE FS 500 (+/-) UNIT IV SOLUTION SP 3HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M HIGH 801 UNIT-1,500 UNIT IV SOLUTION MO 4HEMOFIL M LOW 220 UNIT-400 UNIT IV SOLUTION SP 4HEMOFIL M MID 401 UNIT-800 UNIT IV SOLUTION SP 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4HEMOFIL M SUPER HIGH 1,501 UNIT-2,000 UNIT IV SOLUTION MO 4hep flush-10 10 unit/ml iv MO 3HEP-LOCK 100 UNITS/ML VIAL MO 3HEP-LOCK U-P 10 UNITS/ML VIAL MO 3HEP-LOCK U-P 100 UNITS/ML VIAL MO 3heparin iv flush 10 unit/ml sy MO 3heparin lock 10 unit/ml iv MO 3heparin lock 100 unit/ml iv MO 3heparin lock flush (porcine) (pf) 10 unit/ml iv syringe MO 3heparin lock flush 10 unit/ml iv MO 3

Page 22: Humana Walmart-Preferred Formulary - Q1Medicare

22 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

heparin lock flush 10 unit/ml iv syringe MO 3heparin lock flush 10 units/ml MO 3heparin lock flush 100 unit/ml MO 3heparin na 1,000 units/ml vial MO 3 B vs Dheparin sod 1,000 unit/ml vial MO 3 B vs Dheparin sod 10,000 unit/ml vl MO 3 B vs Dheparin sod 2,000 unit/ml vial MO 3 B vs Dheparin sod 2,500 unit/ml vial MO 3 B vs Dheparin sod 20,000 unit/ml vl MO 3 B vs Dheparin sod 5,000 unit/ 0.5 ml MO 3 B vs Dheparin sod 5,000 unit/0.5 ml MO 3heparin sod 5,000 unit/ml syr MO 3heparin sod 5,000 unit/ml vial MO 3 B vs Dheparin-1/2ns 12,500 unit/250 MO 2heparin-1/2ns 25,000 unit/250 MO 2heparin-1/2ns 25,000 unit/500 MO 2heparin-d5w 10,000 unit/100 ml MO 2heparin-d5w 12,500 unit/250 ml MO 2heparin-d5w 20,000 unit/500 ml MO 2heparin-d5w 25,000 unit/250 ml MO 2heparin-d5w 25,000 unit/500 ml MO 2heparin-ns 1,000 unit/500 ml MO 2heparin-ns 2,000 unit/1,000 ml MO 2INNOHEP 20,000 ANTI-XA UNIT/ML SUB-Q MO 4 QL (14 per 30 days)INTEGRILIN 0.75 MG/ML IV MO 4INTEGRILIN 2 MG/ML IV MO 4jantoven 1 mg tab MO 2jantoven 10 mg tab MO 2jantoven 2 mg tab MO 2jantoven 2.5 mg tab MO 2jantoven 3 mg tab MO 2jantoven 4 mg tab MO 2jantoven 5 mg tab MO 2jantoven 6 mg tab MO 2jantoven 7.5 mg tab MO 2KINLYTIC 250,000 UNITS VIAL MO 4 B vs DKOATE-DVI 1,000 (+/-) UNIT IV KIT SP 4KOATE-DVI 250 (+/-) UNIT IV KIT SP 4KOATE-DVI 500 (+/-) UNIT IV KIT SP 4KOGENATE FS 1,000 (+/-) UNIT IV SOLUTION SP 3KOGENATE FS 250 (+/-) UNIT IV SOLUTION SP 3

Page 23: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 23

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

KOGENATE FS 3,000 (+/-) UNIT IV SOLUTION SP 3KOGENATE FS 500 (+/-) UNIT IV SOLUTION SP 3LEUKINE 250 MCG SOLUTION FOR INJECTION SP 4 PALEUKINE 500 MCG/ML INJECTION SP 4 PALOVENOX 100 MG/ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)LOVENOX 120 MG/0.8 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)LOVENOX 150 MG/ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)LOVENOX 30 MG/0.3 ML SUB-Q SYRINGE MO 4 QL (28 per 30 days)LOVENOX 300 MG/3 ML SUB-Q MO 4 QL (14 per 30 days)LOVENOX 40 MG/0.4 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)LOVENOX 60 MG/0.6 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)LOVENOX 80 MG/0.8 ML SUB-Q SYRINGE MO 4 QL (14 per 30 days)MONOCLATE-P 1,000 (+/-) UNIT IV KIT SP 4MONOCLATE-P 1,500 (+/-) UNIT IV KIT SP 4MONOCLATE-P 250 (+/-) UNIT IV KIT SP 4MONOCLATE-P 500 (+/-) UNIT IV KIT SP 4monoject prefill advanced 10 unit/ml iv syringe MO 3MOZOBIL 24 MG/1.2 ML (20 MG/ML) SUB-Q SP 4 PA,QL (8 per 30 days)NEULASTA 6 MG/0.6 ML SUB-Q SYRINGE SP 4 PA,QL (2 per 28 days)NEUMEGA 5 MG SUB-Q SOLN SP 4 QL (42 per 30 days)NEUPOGEN 300 MCG/0.5 ML SYRINGE SP 4 PA,QL (14 per 30 days)NEUPOGEN 300 MCG/ML INJECTION SP 4 PA,QL (14 per 30 days)NEUPOGEN 480 MCG/0.8 ML SYRINGE SP 4 PA,QL (14 per 30 days)NEUPOGEN 480 MCG/1.6 ML INJECTION SP 4 PA,QL (14 per 30 days)NOVOSEVEN 1,200 MCG VIAL SP 4NOVOSEVEN 2,400 MCG VIAL SP 4NOVOSEVEN 4,800 MCG VIAL SP 4NOVOSEVEN RT 1 MG (1,000 MCG) IV SOLUTION SP 4NOVOSEVEN RT 2 MG (2,000 MCG) IV SOLUTION SP 4NOVOSEVEN RT 5 MG (5,000 MCG) IV SOLUTION SP 4pentoxifylline er 400 mg tab MO 2pentoxil er 400 mg tablet MO 2PLAVIX 300 MG TAB MO 4 QL (1 per 30 days)PLAVIX 75 MG TAB MO 4 QL (30 per 30 days)PRADAXA 150 MG CAP MO 4 QL (60 per 30 days)PRADAXA 75 MG CAP MO 4 QL (60 per 30 days)PROCRIT 10,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)PROCRIT 2,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)PROCRIT 20,000 UNIT/2 ML INJECTION SP 4 PA,QL (14 per 30 days)PROCRIT 20,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)PROCRIT 3,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)

Page 24: Humana Walmart-Preferred Formulary - Q1Medicare

24 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

PROCRIT 4,000 UNIT/ML INJECTION SP 4 PA,QL (14 per 30 days)PROCRIT 40,000 UNIT/ML INJECTION SP 4 PA,QL (4 per 30 days)PROFILNINE SD 1,000 (+/-) UNIT IV SOLUTION SP 4PROFILNINE SD 1,200 (+/-) UNIT IV SOLUTION SP 4PROFILNINE SD 1,500 (+/-) UNIT IV SOLUTION SP 4PROFILNINE SD 500 (+/-) UNIT IV SOLUTION SP 4PROMACTA 25 MG TAB SP 4 PA,QL (30 per 30 days)PROMACTA 50 MG TAB SP 4 PA,QL (30 per 30 days)PROMACTA 75 MG TAB SP 4 PA,QL (30 per 30 days)protamine 10 mg/ml vial MO 2 B vs DRECOMBINATE 1,000 (+/-) UNIT IV SOLUTION SP 3RECOMBINATE 250 (+/-) UNIT IV SOLUTION SP 3RECOMBINATE 500 (+/-) UNIT IV SOLUTION SP 3REFLUDAN 50 MG IV SOLUTION MO 4 B vs DREOPRO 10 MG/5 ML IV MO 4RIASTAP 1 GRAM (900 MG-1,300 MG) IV SOLUTION MO 4ticlopidine 250 mg tablet MO 2TNKASE 50 MG IV KIT MO 4warfarin sodium 1 mg tablet MO 1warfarin sodium 10 mg tablet MO 1warfarin sodium 2 mg tablet MO 1warfarin sodium 2.5 mg tablet MO 1warfarin sodium 3 mg tablet MO 1warfarin sodium 4 mg tablet MO 1warfarin sodium 5 mg tablet MO 1warfarin sodium 6 mg tablet MO 1warfarin sodium 7.5 mg tablet MO 1WILATE 450 UNIT-450 UNIT IV KIT SP 4WILATE 900 UNIT-900 UNIT IV KIT SP 4XARELTO 10 MG TAB MO 4 QL (35 per 60 days)XYNTHA 1,000 (+/-) UNIT IV KIT SP 4XYNTHA 2,000 (+/-) UNIT IV KIT SP 4XYNTHA 250 (+/-) UNIT IV KIT SP 4XYNTHA 500 (+/-) UNIT IV KIT SP 4CARDIOVASCULAR DRUGSacebutolol 200 mg capsule MO 2acebutolol 400 mg capsule MO 2ADCIRCA 20 MG TAB SP 4 PA,QL (60 per 30 days)ADENOCARD 3 MG/ML IV SYRINGE MO 4adenosine 12 mg/4 ml syringe MO 2adenosine 6 mg/2 ml vial MO 2

Page 25: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 25

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

afeditab cr 30 mg MO 3 QL (60 per 30 days)afeditab cr 60 mg MO 3 QL (60 per 30 days)AGGRENOX 200 MG-25 MG 12 HR CAP MO 4amiodarone 150 mg/3 ml syringe MO 2amiodarone 900 mg/18 ml vial MO 2amiodarone hcl 200 mg tablet MO 2amiodarone hcl 400 mg tablet MO 2amlodipine besylate 10 mg tab MO 2amlodipine besylate 2.5 mg tab MO 2amlodipine besylate 5 mg tab MO 2amlodipine-benazepril 10-20 mg MO 3 QL (60 per 30 days)amlodipine-benazepril 10-40 mg MO 3 QL (30 per 30 days)amlodipine-benazepril 2.5-10 MO 3 QL (60 per 30 days)amlodipine-benazepril 5-10 mg MO 3 QL (60 per 30 days)amlodipine-benazepril 5-20 mg MO 3 QL (60 per 30 days)amlodipine-benazepril 5-40 mg MO 3 QL (30 per 30 days)AMTURNIDE 150 MG-5 MG-12.5 MG TAB MO 3 QL (30 per 30 days)AMTURNIDE 300 MG-10 MG-12.5 MG TAB MO 3 QL (30 per 30 days)AMTURNIDE 300 MG-10 MG-25 MG TAB MO 3 QL (30 per 30 days)AMTURNIDE 300 MG-5 MG-12.5 MG TAB MO 3 QL (30 per 30 days)AMTURNIDE 300 MG-5 MG-25 MG TAB MO 3 QL (30 per 30 days)amyl nitrite ampul MO 2atenolol 100 mg tablet MO 1atenolol 25 mg tablet MO 1atenolol 50 mg tablet MO 1atenolol-chlorthal 50-25 tb MO 1atenolol-chlorthalidone 100-25 MO 1AVALIDE 150 MG-12.5 MG TAB MO 3 QL (30 per 30 days)AVALIDE 300 MG-12.5 MG TAB MO 3 QL (30 per 30 days)AVALIDE 300-25 MG TABLET MO 3 QL (30 per 30 days)AVAPRO 150 MG TAB MO 3 QL (30 per 30 days)AVAPRO 300 MG TAB MO 3 QL (30 per 30 days)AVAPRO 75 MG TAB MO 3 QL (30 per 30 days)benazepril hcl 10 mg tablet MO 1benazepril hcl 20 mg tablet MO 1benazepril hcl 40 mg tablet MO 1benazepril hcl 5 mg tablet MO 1benazepril-hctz 10-12.5 mg tab MO 2benazepril-hctz 20-12.5 mg tab MO 2benazepril-hctz 20-25 mg tab MO 2benazepril-hctz 5-6.25 mg tab MO 2

Page 26: Humana Walmart-Preferred Formulary - Q1Medicare

26 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

betaxolol 10 mg tablet MO 2betaxolol 20 mg tablet MO 2BIDIL 20 MG-37.5 MG TAB MO 3 QL (180 per 30 days)bisoprolol fumarate 10 mg tab MO 2bisoprolol fumarate 5 mg tab MO 2bisoprolol-hctz 10-6.25 mg tab MO 1bisoprolol-hctz 2.5-6.25 mg tb MO 1bisoprolol-hctz 5-6.25 mg tab MO 1BREVIBLOC 100 MG/10 ML (10 MG/ML) IV MO 4BREVIBLOC IN SODIUM CHLORIDE (ISO-OSM) 2,000 MG/100 ML (20MG/ML) IV MO

4

BREVIBLOC IN SODIUM CHLORIDE (ISO-OSM) 2,500 MG/250 ML (10MG/ML) IV MO

4

captopril 100 mg tablet MO 1captopril 12.5 mg tablet MO 1captopril 25 mg tablet MO 1captopril 50 mg tablet MO 1captopril-hctz 25-15 mg tablet MO 2captopril-hctz 25-25 mg tablet MO 2captopril-hctz 50-15 mg tablet MO 2captopril-hctz 50-25 mg tablet MO 2cartia xt 120 mg 24 hr cap MO 2 QL (60 per 30 days)cartia xt 180 mg 24 hr cap MO 2 QL (60 per 30 days)cartia xt 240 mg 24 hr cap MO 2 QL (60 per 30 days)cartia xt 300 mg 24 hr cap MO 2 QL (30 per 30 days)carvedilol 12.5 mg tablet MO 1carvedilol 25 mg tablet MO 1carvedilol 3.125 mg tablet MO 1carvedilol 6.25 mg tablet MO 1CATAPRES-TTS-1 0.1 MG/24 HR TRANSDERM PATCH MO 4 QL (4 per 28 days)CATAPRES-TTS-2 0.2 MG/24 HR TRANSDERM PATCH MO 4 QL (4 per 28 days)CATAPRES-TTS-3 0.3 MG/24 HR TRANSDERM PATCH MO 4 QL (4 per 28 days)cholestyramine light 4 gram oral powder MO 3cholestyramine light 4 gram packet MO 3cholestyramine packet MO 3cholestyramine powder MO 3CLEVIPREX 25 MG/50 ML IV MO 4CLEVIPREX 50 MG/100 ML IV MO 4clonidine 0.1 mg/day patch MO 3 QL (4 per 28 days)clonidine 0.2 mg/day patch MO 3 QL (4 per 28 days)clonidine 0.3 mg/day patch MO 3 QL (4 per 28 days)

Page 27: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 27

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

clonidine hcl 0.1 mg tablet MO 1clonidine hcl 0.2 mg tablet MO 1clonidine hcl 0.3 mg tablet MO 3clorpres 0.1 mg-15 mg tab MO 4clorpres 0.2 mg-15 mg tab MO 4clorpres 0.3 mg-15 mg tab MO 4colestipol hcl 1 gm tablet MO 3colestipol hcl granules MO 3colestipol hcl granules packet MO 3CORVERT 0.1 MG/ML IV MO 4COVERA-HS 180 MG 24 HR TAB MO 4 QL (90 per 30 days)COVERA-HS 240 MG 24 HR TAB MO 4 QL (60 per 30 days)CRESTOR 10 MG TAB MO 3 QL (30 per 30 days)CRESTOR 20 MG TAB MO 3 QL (30 per 30 days)CRESTOR 40 MG TAB MO 3 QL (30 per 30 days)CRESTOR 5 MG TAB MO 3 QL (30 per 30 days)digoxin 0.25 mg/ml ampul MO 2digoxin 0.25 mg/ml syringe MO 2digoxin 125 mcg tablet MO 1digoxin 250 mcg tablet MO 1digoxin 50 mcg/ml solution MO 2DILATRATE-SR 40 MG CAP MO 4dilt-cd 120 mg 24 hr cap MO 2 QL (60 per 30 days)dilt-cd 180 mg 24 hr cap MO 3 QL (60 per 30 days)dilt-cd 240 mg 24 hr cap MO 3 QL (60 per 30 days)dilt-cd 300 mg 24 hr cap MO 3 QL (30 per 30 days)dilt-xr 120 mg cap MO 3 QL (60 per 30 days)dilt-xr 180 mg cap MO 3 QL (60 per 30 days)dilt-xr 240 mg cap MO 3 QL (60 per 30 days)diltia xt 120 mg cap MO 4 QL (60 per 30 days)diltia xt 180 mg cap MO 4 QL (60 per 30 days)diltia xt 240 mg cap MO 4 QL (60 per 30 days)diltiazem 120 mg tablet MO 1diltiazem 125 mg/25 ml vial MO 2diltiazem 24hr cd 120 mg cap MO 2 QL (60 per 30 days)diltiazem 24hr cd 180 mg cap MO 2 QL (60 per 30 days)diltiazem 24hr cd 240 mg cap MO 2 QL (60 per 30 days)diltiazem 24hr cd 300 mg cap MO 2 QL (30 per 30 days)diltiazem 25 mg/5 ml carpuject MO 2diltiazem 30 mg tablet MO 1diltiazem 60 mg tablet MO 1

Page 28: Humana Walmart-Preferred Formulary - Q1Medicare

28 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

diltiazem 90 mg tablet MO 1diltiazem er 120 mg 12-hr cap MO 3diltiazem er 120 mg capsule MO 3 QL (60 per 30 days)diltiazem er 180 mg capsule MO 3 QL (60 per 30 days)diltiazem er 240 mg capsule MO 3 QL (60 per 30 days)diltiazem er 60 mg 12-hr cap MO 3diltiazem er 90 mg 12-hr cap MO 3diltiazem hcl 100 mg vial MO 2diltiazem hcl er 240 mg cap MO 3 QL (60 per 30 days)diltiazem hcl er 300 mg cap MO 3 QL (30 per 30 days)diltiazem hcl er 360 mg cap MO 3 QL (30 per 30 days)diltiazem hcl er 420 mg cap MO 3 QL (30 per 30 days)diltzac er 120 mg cap MO 3 QL (60 per 30 days)diltzac er 180 mg cap MO 3 QL (60 per 30 days)diltzac er 240 mg cap MO 3 QL (60 per 30 days)diltzac er 300 mg cap MO 3 QL (30 per 30 days)diltzac er 360 mg cap MO 3 QL (30 per 30 days)DIOVAN 160 MG TAB MO 3 QL (60 per 30 days)DIOVAN 320 MG TAB MO 3 QL (60 per 30 days)DIOVAN 40 MG TAB MO 3 QL (60 per 30 days)DIOVAN 80 MG TAB MO 3 QL (60 per 30 days)DIOVAN HCT 160 MG-12.5 MG TAB MO 3 QL (30 per 30 days)DIOVAN HCT 160 MG-25 MG TAB MO 3 QL (30 per 30 days)DIOVAN HCT 320 MG-12.5 MG TAB MO 3 QL (30 per 30 days)DIOVAN HCT 320 MG-25 MG TAB MO 3 QL (30 per 30 days)DIOVAN HCT 80 MG-12.5 MG TAB MO 3 QL (30 per 30 days)disopyramide 100 mg capsule MO 2disopyramide 150 mg cap sa MO 2disopyramide 150 mg capsule MO 2doxazosin mesylate 1 mg tab MO 1doxazosin mesylate 2 mg tab MO 1doxazosin mesylate 4 mg tab MO 1doxazosin mesylate 8 mg tab MO 1enalapril maleate 10 mg tab MO 1enalapril maleate 2.5 mg tab MO 1enalapril maleate 20 mg tab MO 1enalapril maleate 5 mg tablet MO 1enalapril-hctz 10-25 mg tablet MO 2enalapril-hctz 5-12.5 mg tab MO 1enalaprilat 1.25 mg/ml vial MO 2eplerenone 25 mg tablet MO 3

Page 29: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 29

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

eplerenone 50 mg tablet MO 3epoprostenol sodium 0.5 mg vl SP 4 PAepoprostenol sodium 1.5 mg vl SP 4 PAesmolol hcl 10 mg/ml vial MO 2EXFORGE 10 MG-160 MG TAB MO 3 QL (30 per 30 days)EXFORGE 10 MG-320 MG TAB MO 3 QL (30 per 30 days)EXFORGE 5 MG-160 MG TAB MO 3 QL (30 per 30 days)EXFORGE 5 MG-320 MG TAB MO 3 QL (30 per 30 days)EXFORGE HCT 10 MG-160 MG-12.5 MG TAB MO 3 QL (30 per 30 days)EXFORGE HCT 10 MG-160 MG-25 MG TAB MO 3 QL (30 per 30 days)EXFORGE HCT 10 MG-320 MG-25 MG TAB MO 3 QL (30 per 30 days)EXFORGE HCT 5 MG-160 MG-12.5 MG TAB MO 3 QL (30 per 30 days)EXFORGE HCT 5 MG-160 MG-25 MG TAB MO 3 QL (30 per 30 days)felodipine er 10 mg tablet MO 3 QL (30 per 30 days)felodipine er 2.5 mg tablet MO 3 QL (30 per 30 days)felodipine er 5 mg tablet MO 3 QL (30 per 30 days)fenofibrate 134 mg capsule MO 3 QL (30 per 30 days)fenofibrate 160 mg tablet MO 3 QL (30 per 30 days)fenofibrate 200 mg capsule MO 3 QL (30 per 30 days)fenofibrate 54 mg tablet MO 3 QL (60 per 30 days)fenofibrate 67 mg capsule MO 3 QL (60 per 30 days)fenoldopam 10 mg/ml ampule MO 2flecainide acetate 100 mg tab MO 3flecainide acetate 150 mg tab MO 3flecainide acetate 50 mg tab MO 3fosinopril sodium 10 mg tab MO 3fosinopril sodium 20 mg tab MO 3fosinopril sodium 40 mg tab MO 3fosinopril-hctz 10-12.5 mg tab MO 3fosinopril-hctz 20-12.5 mg tab MO 3gemfibrozil 600 mg tablet MO 2 QL (60 per 30 days)guanabenz acetate 4 mg tab MO 3guanabenz acetate 8 mg tab MO 3guanfacine 1 mg tablet MO 1guanfacine 2 mg tablet MO 2hydralazine 10 mg tablet MO 1hydralazine 100 mg tablet MO 3hydralazine 20 mg/ml vial MO 3hydralazine 25 mg tablet MO 1hydralazine 50 mg tablet MO 3ibutilide fum 1 mg/10 ml vial MO 2

Page 30: Humana Walmart-Preferred Formulary - Q1Medicare

30 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

inamrinone 100 mg/20 ml vial MO 2isoditrate 40 mg tab MO 3ISORDIL 40 MG TAB MO 4isosorbide dn 10 mg tablet MO 2isosorbide dn 2.5 mg tab sl MO 2isosorbide dn 20 mg tablet MO 2isosorbide dn 30 mg tablet MO 2isosorbide dn 5 mg tablet MO 2isosorbide dn 5 mg tablet sl MO 2isosorbide dn er 40 mg tablet MO 3isosorbide mn 10 mg tablet MO 2isosorbide mn 20 mg tablet MO 2isosorbide mn er 120 mg tab MO 2isosorbide mn er 30 mg tablet MO 1isosorbide mn er 60 mg tablet MO 1isradipine 2.5 mg capsule MO 3isradipine 5 mg capsule MO 3KAPVAY 0.1 MG 12 HR TAB MO 4 ST,QL (60 per 30 days)labetalol hcl 100 mg tablet MO 2labetalol hcl 200 mg tablet MO 2labetalol hcl 300 mg tablet MO 2labetalol hcl 5 mg/ml crpj MO 2labetalol hcl 5 mg/ml vial MO 2LANOXIN 125 MCG TAB MO 4LANOXIN 250 MCG TAB MO 4LANOXIN 250 MCG/ML INJECTION MO 4LANOXIN PEDIATRIC 100 MCG/ML INJECTION MO 4LETAIRIS 10 MG TAB SP 4 PA,QL (30 per 30 days)LETAIRIS 5 MG TAB SP 4 PA,QL (30 per 30 days)lidocaine 0.4% in d5w soln MO 2lidocaine 0.8% in d5w soln MO 2lidocaine hcl 1% syringe MO 2lidocaine hcl 2% abboject MO 2LIPITOR 10 MG TAB MO 3 QL (30 per 30 days)LIPITOR 20 MG TAB MO 3 QL (30 per 30 days)LIPITOR 40 MG TAB MO 3 QL (30 per 30 days)LIPITOR 80 MG TAB MO 3 QL (30 per 30 days)lisinopril 10 mg tablet MO 1lisinopril 2.5 mg tablet MO 1lisinopril 20 mg tablet MO 1lisinopril 30 mg tablet MO 2

Page 31: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 31

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

lisinopril 40 mg tablet MO 2lisinopril 5 mg tablet MO 1lisinopril-hctz 10-12.5 mg tab MO 1lisinopril-hctz 20-12.5 mg tab MO 1lisinopril-hctz 20-25 mg tab MO 1losartan potassium 100 mg tab MO 2 QL (60 per 30 days)losartan potassium 25 mg tab MO 2 QL (60 per 30 days)losartan potassium 50 mg tab MO 2 QL (60 per 30 days)losartan-hctz 100-12.5 mg tab MO 2 QL (60 per 30 days)losartan-hctz 100-25 mg tab MO 2 QL (60 per 30 days)losartan-hctz 50-12.5 mg tab MO 2 QL (60 per 30 days)lovastatin 10 mg tablet MO 1 QL (60 per 30 days)lovastatin 20 mg tablet MO 1 QL (60 per 30 days)lovastatin 40 mg tablet MO 2 QL (60 per 30 days)LOVAZA 1 GRAM CAP MO 3 QL (120 per 30 days)methyldopa 250 mg tablet MO 1methyldopa 500 mg tablet MO 1methyldopa-hctz 250-15 mg tab MO 2methyldopa-hctz 250-25 mg tab MO 2methyldopate 250 mg/5 ml vial MO 2metoprolol 1 mg/ml carpuject MO 2metoprolol succ er 100 mg tab MO 2 QL (60 per 30 days)metoprolol succ er 200 mg tab MO 2 QL (60 per 30 days)metoprolol succ er 25 mg tab MO 2 QL (60 per 30 days)metoprolol succ er 50 mg tab MO 2 QL (60 per 30 days)metoprolol tart 5 mg/5 ml vial MO 2metoprolol tartrate 100 mg tab MO 1metoprolol tartrate 25 mg tab MO 1metoprolol tartrate 50 mg tab MO 1metoprolol-hctz 100-25 mg tab MO 3metoprolol-hctz 100-50 mg tab MO 3metoprolol-hctz 50-25 mg tab MO 3mexiletine 150 mg capsule MO 2mexiletine 200 mg capsule MO 2mexiletine 250 mg capsule MO 2milrinone lact 50 mg/50 ml vl MO 2milrinone-d5w 20 mg/100 ml MO 2milrinone-d5w 40 mg/200 ml MO 2minitran 0.1 mg/hr transderm 24 hr patch MO 3 QL (30 per 30 days)minitran 0.2 mg/hr transderm 24 hr patch MO 3 QL (30 per 30 days)minitran 0.4 mg/hr transderm 24 hr patch MO 3 QL (60 per 30 days)

Page 32: Humana Walmart-Preferred Formulary - Q1Medicare

32 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

minitran 0.6 mg/hr transderm 24 hr patch MO 3 QL (30 per 30 days)minoxidil 10 mg tablet MO 2minoxidil 2.5 mg tablet MO 2moexipril hcl 15 mg tablet MO 2moexipril hcl 7.5 mg tablet MO 2moexipril-hctz 15-12.5 mg tab MO 2moexipril-hctz 15-25 mg tablet MO 2moexipril-hctz 7.5-12.5 mg tab MO 2MULTAQ 400 MG TAB MO 3 QL (60 per 30 days)nadolol 20 mg tablet MO 1nadolol 40 mg tablet MO 1nadolol 80 mg tablet MO 2nadolol-bendroflu 40-5 mg tab MO 3nadolol-bendroflu 80-5 mg tab MO 3NATRECOR 1.5 MG IV SOLUTION MO 4NEXTERONE 150 MG/100 ML (1.5 MG/ML) IV MO 4NEXTERONE 360 MG/200 ML (1.8 MG/ML) IV MO 4niacor 500 mg tab MO 2NIASPAN EXTENDED-RELEASE 1,000 MG 24 HR TAB MO 3NIASPAN EXTENDED-RELEASE 500 MG 24 HR TAB MO 3NIASPAN EXTENDED-RELEASE 750 MG 24 HR TAB MO 3nicardipine 20 mg capsule MO 2nicardipine 25 mg/10 ml ampule MO 2nicardipine 30 mg capsule MO 2nifediac cc 30 mg tab MO 3 QL (60 per 30 days)nifediac cc 60 mg tab MO 3 QL (60 per 30 days)nifediac cc 90 mg tab MO 3 QL (60 per 30 days)nifedical xl 30 mg 24 hr tab MO 3 QL (60 per 30 days)nifedical xl 60 mg 24 hr tab MO 3 QL (60 per 30 days)nifedipine er 30 mg tablet MO 3 QL (60 per 30 days)nifedipine er 60 mg tablet MO 3 QL (60 per 30 days)nifedipine er 90 mg tablet MO 3 QL (60 per 30 days)nimodipine 30 mg capsule MO 4nisoldipine er 17 mg tablet MO 3 QL (30 per 30 days)nisoldipine er 20 mg tablet MO 3 QL (30 per 30 days)nisoldipine er 25.5 mg tablet MO 3 QL (60 per 30 days)nisoldipine er 30 mg tablet MO 3 QL (60 per 30 days)nisoldipine er 34 mg tablet MO 3 QL (30 per 30 days)nisoldipine er 40 mg tablet MO 3 QL (30 per 30 days)nisoldipine er 8.5 mg tablet MO 3 QL (30 per 30 days)NITRO-DUR 0.1 MG/HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)

Page 33: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 33

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

NITRO-DUR 0.2 MG/HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)NITRO-DUR 0.3 MG/HR TRANSDERM 24 HR PATCH MO 4NITRO-DUR 0.4 MG/HR TRANSDERM 24 HR PATCH MO 4 QL (60 per 30 days)NITRO-DUR 0.6 MG/HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)NITRO-DUR 0.8 MG/HR TRANSDERM 24 HR PATCH MO 4nitroglycerin 0.1 mg/hr patch MO 2 QL (30 per 30 days)nitroglycerin 0.2 mg/hr patch MO 2 QL (30 per 30 days)nitroglycerin 0.3 mg tab sl MO 2nitroglycerin 0.4 mg tablet sl MO 2nitroglycerin 0.4 mg/hr patch MO 2 QL (60 per 30 days)nitroglycerin 0.6 mg tab sl MO 2nitroglycerin 0.6 mg/hr patch MO 2 QL (30 per 30 days)nitroglycerin 5 mg/ml vial MO 2nitroglycerin lingual 0.4 mg MO 3NITROLINGUAL 0.4 MG/DOSE SPRAY MO 4NITROPRESS 25 MG/ML IV MO 4NITROSTAT 0.3 MG SUBLINGUAL TAB MO 3NITROSTAT 0.4 MG SUBLINGUAL TAB MO 3NITROSTAT 0.6 MG SUBLINGUAL TAB MO 3NORPACE CR 100 MG CAP MO 4NORPACE CR 150 MG CAP MO 4ntg 0.2 mg/ml in d5w MO 2ntg 100 mg/250 ml in d5w MO 2ntg 200 mg/500 ml in d5w MO 2ntg 25 mg/250 ml in d5w MO 2ntg 50 mg/500 ml in d5w MO 2PACERONE 100 MG TAB MO 4pacerone 200 mg tab MO 4PACERONE 400 MG TAB MO 4papaverine 150 mg capsule sa MO 2papaverine 300 mg/10 ml vial MO 2perindopril erbumine 2 mg tab MO 3perindopril erbumine 4 mg tab MO 3perindopril erbumine 8 mg tab MO 3pindolol 10 mg tablet MO 2pindolol 5 mg tablet MO 2pravastatin sodium 10 mg tab MO 1 QL (30 per 30 days)pravastatin sodium 20 mg tab MO 1 QL (30 per 30 days)pravastatin sodium 40 mg tab MO 1 QL (60 per 30 days)pravastatin sodium 80 mg tab MO 2 QL (30 per 30 days)prazosin 1 mg capsule MO 1

Page 34: Humana Walmart-Preferred Formulary - Q1Medicare

34 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

prazosin 2 mg capsule MO 1prazosin 5 mg capsule MO 1prevalite 4 gram oral packet MO 3prevalite 4 gram oral powder MO 3procainamide 100 mg/ml vial MO 2procainamide 500 mg/ml vial MO 2PROGLYCEM 50 MG/ML ORAL SUSP MO 4propafenone hcl 150 mg tablet MO 3propafenone hcl 225 mg tab MO 3propafenone hcl 300 mg tab MO 3propafenone hcl er 225 mg cap MO 3propafenone hcl sr 325 mg cap MO 3propafenone hcl sr 425 mg cap MO 3propranolol 1 mg/ml vial MO 2propranolol 10 mg tablet MO 1propranolol 20 mg tablet MO 1propranolol 20 mg/5 ml soln MO 2propranolol 40 mg tablet MO 1propranolol 40 mg/5 ml soln MO 2propranolol 60 mg tablet MO 2propranolol 80 mg tablet MO 1propranolol er 120 mg capsule MO 3propranolol er 160 mg capsule MO 3propranolol er 60 mg capsule MO 3propranolol er 80 mg capsule MO 3propranolol-hctz 40-25 mg tab MO 2propranolol-hctz 80-25 mg tab MO 2PROSTIN VR PEDIATRIC 500 MCG/ML INJECTION MO 4quinapril 10 mg tablet MO 2quinapril 20 mg tablet MO 2quinapril 40 mg tablet MO 2quinapril 5 mg tablet MO 2quinapril-hctz 10-12.5 mg tab MO 3quinapril-hctz 20-12.5 mg tab MO 3quinapril-hctz 20-25 mg tab MO 3quinidine gluc 80 mg/ml vial MO 2quinidine gluc er 324 mg tab MO 3quinidine sulf er 300 mg tab MO 2quinidine sulfate 200 mg tab MO 2quinidine sulfate 300 mg tab MO 2ramipril 1.25 mg capsule MO 2

Page 35: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 35

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ramipril 10 mg capsule MO 2ramipril 2.5 mg capsule MO 2ramipril 5 mg capsule MO 2RANEXA 1,000 MG 12 HR TAB MO 3 ST,QL (120 per 30 days)RANEXA 500 MG 12 HR TAB MO 3 ST,QL (120 per 30 days)REMODULIN 1 MG/ML INJECTION SP 4 PAREMODULIN 10 MG/ML INJECTION SP 4 PAREMODULIN 2.5 MG/ML INJECTION SP 4 PAREMODULIN 5 MG/ML INJECTION SP 4 PAreserpine 0.1 mg tablet MO 2reserpine 0.25 mg tablet MO 2REVATIO 20 MG TAB SP 3 PA,QL (90 per 30 days)simvastatin 10 mg tablet MO 2 QL (30 per 30 days)simvastatin 20 mg tablet MO 2 QL (30 per 30 days)simvastatin 40 mg tablet MO 2 QL (30 per 30 days)simvastatin 5 mg tablet MO 2 QL (30 per 30 days)simvastatin 80 mg tablet MO 2 QL (30 per 30 days)sorine 120 mg tab MO 2sorine 160 mg tab MO 2sorine 240 mg tab MO 2sorine 80 mg tab MO 2sotalol 120 mg tablet MO 2sotalol 160 mg tablet MO 2sotalol 240 mg tablet MO 2sotalol 80 mg tablet MO 1sotalol af 120 mg tab MO 2sotalol af 160 mg tab MO 2sotalol af 80 mg tab MO 2sotalol hcl 150 mg/10 ml vial MO 2spironolactone 100 mg tablet MO 2spironolactone 25 mg tablet MO 1spironolactone 50 mg tablet MO 2spironolactone-hctz 25-25 tab MO 2taztia xt 120 mg cap MO 3 QL (60 per 30 days)taztia xt 180 mg cap MO 3 QL (60 per 30 days)taztia xt 240 mg cap MO 3 QL (60 per 30 days)taztia xt 300 mg cap MO 3 QL (30 per 30 days)taztia xt 360 mg cap MO 3 QL (30 per 30 days)TEKAMLO 150 MG-10 MG TAB MO 3 QL (30 per 30 days)TEKAMLO 150 MG-5 MG TAB MO 3 QL (30 per 30 days)TEKAMLO 300 MG-10 MG TAB MO 3 QL (30 per 30 days)

Page 36: Humana Walmart-Preferred Formulary - Q1Medicare

36 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

TEKAMLO 300 MG-5 MG TAB MO 3 QL (30 per 30 days)TEKTURNA 150 MG TAB MO 3 QL (30 per 30 days)TEKTURNA 300 MG TAB MO 3 QL (30 per 30 days)TEKTURNA HCT 150 MG-12.5 MG TAB MO 3 QL (30 per 30 days)TEKTURNA HCT 150 MG-25 MG TAB MO 3 QL (30 per 30 days)TEKTURNA HCT 300 MG-12.5 MG TAB MO 3 QL (30 per 30 days)TEKTURNA HCT 300 MG-25 MG TAB MO 3 QL (30 per 30 days)terazosin 1 mg capsule MO 1terazosin 10 mg capsule MO 1terazosin 2 mg capsule MO 1terazosin 5 mg capsule MO 1TIKOSYN 125 MCG CAP SP 4 QL (240 per 30 days)TIKOSYN 250 MCG CAP SP 4 QL (120 per 30 days)TIKOSYN 500 MCG CAP SP 4 QL (60 per 30 days)timolol maleate 10 mg tablet MO 2timolol maleate 20 mg tablet MO 2timolol maleate 5 mg tablet MO 2TRACLEER 125 MG TAB SP 4 PA,QL (60 per 30 days)TRACLEER 62.5 MG TAB SP 4 PA,QL (60 per 30 days)trandolapril 1 mg tablet MO 2trandolapril 2 mg tablet MO 2trandolapril 4 mg tablet MO 2TRICOR 145 MG TAB MO 3 QL (30 per 30 days)TRICOR 48 MG TAB MO 3 QL (60 per 30 days)VALTURNA 150 MG-160 MG TAB MO 3 QL (30 per 30 days)VALTURNA 300 MG-320 MG TAB MO 3 QL (30 per 30 days)VELETRI 1.5 MG IV SOLUTION SP 4 PAverapamil 120 mg tablet MO 1verapamil 2.5 mg/ml syringe MO 2verapamil 2.5 mg/ml vial MO 2verapamil 360 mg cap pellet MO 2 QL (60 per 30 days)verapamil 40 mg tablet MO 2verapamil 80 mg tablet MO 1verapamil er 120 mg capsule MO 2 QL (60 per 30 days)verapamil er 120 mg tablet MO 2verapamil er 180 mg capsule MO 2 QL (60 per 30 days)verapamil er 180 mg tablet MO 2verapamil er 240 mg capsule MO 2 QL (60 per 30 days)verapamil er 240 mg tablet MO 2verapamil er pm 100 mg capsule MO 2 QL (30 per 30 days)verapamil er pm 200 mg capsule MO 2 QL (60 per 30 days)

Page 37: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 37

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

verapamil er pm 300 mg capsule MO 2 QL (30 per 30 days)WELCHOL 3.75 GRAM ORAL POWDER PACK MO 3WELCHOL 625 MG TAB MO 3ZETIA 10 MG TAB MO 3 ST,QL (30 per 30 days)CENTRAL NERVOUS SYSTEM AGENTSABILIFY 1 MG/ML ORAL SOLN MO 4 PAABILIFY 10 MG TAB MO 4 PA,QL (30 per 30 days)ABILIFY 15 MG TAB MO 4 PA,QL (30 per 30 days)ABILIFY 2 MG TAB MO 4 PA,QL (30 per 30 days)ABILIFY 20 MG TAB MO 4 PA,QL (30 per 30 days)ABILIFY 30 MG TAB MO 4 PA,QL (30 per 30 days)ABILIFY 5 MG TAB MO 4 PA,QL (30 per 30 days)ABILIFY 9.75 MG/1.3 ML IM MO 4 PAABILIFY DISCMELT 10 MG MO 4 PA,QL (60 per 30 days)ABILIFY DISCMELT 15 MG MO 4 PA,QL (60 per 30 days)acetaminoph-caff-dihydrocodein MO 2 QL (180 per 30 days)acetaminophen-cod #2 tablet MO 3 QL (390 per 30 days)acetaminophen-cod #3 tablet MO 3 QL (390 per 30 days)acetaminophen-cod #4 tablet MO 3 QL (390 per 30 days)acetaminophen-codeine elixir MO 3ACUFLEX CAPLET MO 4alfentanil 500 mcg/ml amp MO 3ali-flex tablet MO 2amantadine 100 mg capsule MO 2amantadine 100 mg tablet MO 2amantadine 50 mg/5 ml syrup MO 2amitriptyline hcl 10 mg tab MO 1amitriptyline hcl 100 mg tab MO 1amitriptyline hcl 150 mg tab MO 2amitriptyline hcl 25 mg tab MO 1amitriptyline hcl 50 mg tab MO 1amitriptyline hcl 75 mg tab MO 1amoxapine 100 mg tablet MO 2amoxapine 150 mg tablet MO 2amoxapine 25 mg tablet MO 2amoxapine 50 mg tablet MO 2anabar 20 mg-300 mg-200 mg tab MO 2APOKYN 10 MG/ML SUBQ CARTRIDGE MO 4 QL (60 per 30 days)ascomp w/codeine 30 mg-50 mg-325 mg-40 mg cap MO 3astramorph-pf 0.5 mg/ml injection MO 3astramorph-pf 1 mg/ml injection MO 3

Page 38: Humana Walmart-Preferred Formulary - Q1Medicare

38 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

AZILECT 0.5 MG TAB MO 3 QL (30 per 30 days)AZILECT 1 MG TAB MO 3 QL (30 per 30 days)BANZEL 200 MG TAB MO 4 PA,QL (480 per 30 days)BANZEL 40 MG/ML ORAL SUSP MO 4 PA,QL (1 per 30 days)BANZEL 400 MG TAB MO 4 PA,QL (240 per 30 days)be-flex plus capsule MO 2benztropine 2 mg/2 ml ampule MO 2benztropine mes 0.5 mg tab MO 2benztropine mes 1 mg tablet MO 2benztropine mes 2 mg tablet MO 1bioregesic tablet MO 2bp poly-650 tablet MO 2bromocriptine 2.5 mg tablet MO 3bromocriptine 5 mg capsule MO 3budeprion sr 100 mg tab MO 3 QL (120 per 30 days)budeprion sr 150 mg tab MO 3 QL (120 per 30 days)budeprion xl 150 mg 24 hr tab MO 3 QL (90 per 30 days)budeprion xl 300 mg 24 hr tab MO 3 QL (90 per 30 days)buprenorphine 0.3 mg/ml syrn MO 4 PAbuprenorphine 0.3 mg/ml vial MO 4 PAbuprenorphine 2 mg tablet sl MO 3 PA,QL (90 per 30 days)buprenorphine 8 mg tablet sl MO 3 PA,QL (90 per 30 days)buproban 150 mg tab MO 2 QL (90 per 30 days)bupropion hcl 100 mg tablet MO 2 QL (180 per 30 days)bupropion hcl 75 mg tablet MO 2bupropion hcl sr 100 mg tablet MO 3 QL (120 per 30 days)bupropion hcl sr 200 mg tab MO 3 QL (60 per 30 days)bupropion hcl xl 150 mg tablet MO 3 QL (90 per 30 days)bupropion hcl xl 300 mg tablet MO 3 QL (90 per 30 days)bupropion sr 150 mg tablet MO 2 QL (120 per 30 days)buspirone hcl 10 mg tablet MO 1buspirone hcl 15 mg tablet MO 2buspirone hcl 30 mg tablet MO 2buspirone hcl 5 mg tablet MO 1buspirone hcl 7.5 mg tablet MO 2butalb-caff-acetaminoph-codein MO 3 QL (360 per 30 days)butalbital compound w/codeine 30 mg-50 mg-325 mg-40 mg cap MO 3butorphanol 1 mg/ml syringe MO 3butorphanol 1 mg/ml vial MO 3butorphanol 10 mg/ml spray MO 3 QL (5 per 28 days)butorphanol 2 mg/ml syringe MO 3

Page 39: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 39

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

butorphanol 2 mg/ml vial MO 3cabergoline 0.5 mg tablet MO 2 QL (16 per 28 days)CAFCIT 60 MG/3 ML (20 MG/ML) IV MO 4CAFCIT 60 MG/3 ML (20 MG/ML) ORAL SOLN MO 4caff-sod benzoate 500 mg vl MO 2caffeine cit 60 mg/3 ml oral MO 2caffeine cit 60 mg/3 ml vial MO 2cafgesic 20 mg-325 mg-250 mg-50 mg cap MO 2cafgesic forte tablet MO 2CAMPRAL 333 MG TAB MO 4CAPITAL WITH CODEINE 120 MG-12 MG/5 ML ORAL SUSP MO 3carbamazepine 100 mg tab chew MO 2carbamazepine 100 mg/5 ml susp MO 2carbamazepine 200 mg tablet MO 2carbamazepine 200 mg/10 ml liq MO 2carbamazepine er 100 mg cap MO 4 QL (60 per 30 days)carbamazepine er 200 mg cap MO 4 QL (240 per 30 days)carbamazepine er 300 mg cap MO 4 QL (150 per 30 days)carbamazepine xr 200 mg tablet MO 2carbamazepine xr 400 mg tablet MO 2CARBATROL 100 MG 12 HR CAP MO 4 QL (60 per 30 days)CARBATROL 200 MG 12 HR CAP MO 4 QL (240 per 30 days)CARBATROL 300 MG 12 HR CAP MO 4 QL (150 per 30 days)carbidopa-levo 10-100 mg odt MO 3carbidopa-levo 25-100 mg odt MO 3carbidopa-levo 25-250 mg odt MO 3carbidopa-levo er 25-100 tab MO 3carbidopa-levo er 50-200 tab MO 3carbidopa-levodopa 10-100 tab MO 3carbidopa-levodopa 25-100 tab MO 3carbidopa-levodopa 25-250 tab MO 3CELONTIN 300 MG CAP MO 4chloral hydrate 500 mg/5 ml MO 2chlorpromazine 10 mg tablet MO 2 B vs Dchlorpromazine 100 mg tablet MO 2chlorpromazine 200 mg tablet MO 2chlorpromazine 25 mg tablet MO 2 B vs Dchlorpromazine 25 mg/ml amp MO 2chlorpromazine 50 mg tablet MO 2choline mag trisal 1 gm tab MO 2choline mag trisal liquid MO 2

Page 40: Humana Walmart-Preferred Formulary - Q1Medicare

40 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

choline-mag trisalicylate 500 mg tab MO 2choline-mag trisalicylate 750 mg tab MO 2citalopram 10 mg/5 ml solution MO 2citalopram hbr 10 mg tablet MO 2 QL (30 per 30 days)citalopram hbr 20 mg tablet MO 1 QL (90 per 30 days)citalopram hbr 40 mg tablet MO 1 QL (45 per 30 days)clomipramine 25 mg capsule MO 2clomipramine 50 mg capsule MO 2clomipramine 75 mg capsule MO 2clonidine 1000 mcg/10 ml vial MO 3clonidine 5,000 mcg/10 ml vial MO 3clozapine 100 mg tablet MO 3clozapine 200 mg tablet MO 3clozapine 25 mg tablet MO 3clozapine 50 mg tablet MO 3codeine ph 15 mg/ml syringe MO 2codeine ph 30 mg/ml syringe MO 2codeine sulfate 15 mg tablet MO 3codeine sulfate 30 mg tablet MO 3codeine sulfate 60 mg tablet MO 3COGENTIN 2 MG/2 ML INJECTION MO 4COMTAN 200 MG TAB MO 3 QL (300 per 30 days)CYMBALTA 20 MG CAP MO 3 QL (60 per 30 days)CYMBALTA 30 MG CAP MO 3 QL (60 per 30 days)CYMBALTA 60 MG CAP MO 3 QL (60 per 30 days)d-amphetamine er 10 mg capsule MO 3 PAd-amphetamine er 15 mg capsule MO 3 PAd-amphetamine er 5 mg capsule MO 3 PAdesipramine 10 mg tablet MO 3desipramine 100 mg tablet MO 3desipramine 150 mg tablet MO 3desipramine 25 mg tablet MO 3desipramine 50 mg tablet MO 3desipramine 75 mg tablet MO 3dexmethylphenidate 10 mg tab MO 2 PAdexmethylphenidate 2.5 mg tab MO 2 PAdexmethylphenidate 5 mg tab MO 2 PAdextroamphetamine 10 mg tab MO 3 PAdextroamphetamine 5 mg tab MO 3 PAdiclofenac pot 50 mg tablet MO 2diclofenac sod ec 25 mg tab MO 2

Page 41: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 41

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

diclofenac sod ec 50 mg tab MO 2diclofenac sod ec 75 mg tab MO 1diclofenac sod er 100 mg tab MO 3diflunisal 500 mg tablet MO 3DILANTIN 30 MG CAP MO 4DILANTIN EXTENDED 100 MG CAP MO 4dilantin infatabs 50 mg chewable MO 4DILANTIN-125 125 MG/5 ML ORAL SUSP MO 4divalproex sod dr 125 mg tab MO 3divalproex sod dr 250 mg tab MO 3divalproex sod dr 500 mg tab MO 3divalproex sod er 250 mg tab MO 2divalproex sod er 500 mg tab MO 2divalproex sodium 125 mg cap MO 3dologesic capsule MO 2DOLOGESIC LIQUID MO 4DOPRAM 20 MG/ML IV MO 4doxapram hcl 20 mg/ml vial MO 4doxepin 10 mg capsule MO 1doxepin 10 mg/ml oral conc MO 2doxepin 100 mg capsule MO 1doxepin 150 mg capsule MO 2doxepin 25 mg capsule MO 1doxepin 50 mg capsule MO 1doxepin 75 mg capsule MO 1droperidol 2.5 mg/ml vial MO 2DURACLON (PF) 1,000 MCG/10 ML EPIDURAL MO 4DURACLON (PF) 5,000 MCG/10 ML EPIDURAL MO 4DURAMORPH 0.5 MG/ML INJECTION MO 4DURAMORPH 1 MG/ML INJECTION MO 4duraxin 20 mg-300 mg-200 mg cap MO 2ed-flex 20 mg-300 mg-200 mg cap MO 2EMSAM 12 MG/24 HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)EMSAM 6 MG/24 HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)EMSAM 9 MG/24 HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)endocet 10 mg-325 mg tab MO 3 QL (360 per 30 days)endocet 10 mg-650 mg tab MO 3 QL (180 per 30 days)endocet 5 mg-325 mg tab MO 3 QL (360 per 30 days)endocet 7.5 mg-325 mg tab MO 3 QL (360 per 30 days)endocet 7.5 mg-500 mg tab MO 3 QL (240 per 30 days)epitol 200 mg tab MO 1

Page 42: Humana Walmart-Preferred Formulary - Q1Medicare

42 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

EQUETRO 100 MG 12 HR CAP MO 4EQUETRO 200 MG 12 HR CAP MO 4EQUETRO 300 MG 12 HR CAP MO 4ethosuximide 250 mg capsule MO 3ethosuximide 250 mg/5 ml syrp MO 3etodolac 200 mg capsule MO 2etodolac 300 mg capsule MO 2etodolac 400 mg tablet MO 2etodolac 500 mg tablet MO 2etodolac er 400 mg tablet MO 3etodolac er 500 mg tablet MO 3etodolac er 600 mg tablet MO 3FANAPT 1 MG TAB MO 4 PA,QL (60 per 30 days)FANAPT 10 MG TAB MO 4 PA,QL (60 per 30 days)FANAPT 12 MG TAB MO 4 PA,QL (60 per 30 days)FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) TABS IN A DOSE PACK MO 4 PA,QL (60 per 30 days)FANAPT 2 MG TAB MO 4 PA,QL (60 per 30 days)FANAPT 4 MG TAB MO 4 PA,QL (60 per 30 days)FANAPT 6 MG TAB MO 4 PA,QL (60 per 30 days)FANAPT 8 MG TAB MO 4 PA,QL (60 per 30 days)FAZACLO 100 MG TAB, RAPID DISSOLVE MO 4 STFAZACLO 12.5 MG TAB, RAPID DISSOLVE MO 4 STFAZACLO 150 MG TAB, RAPID DISSOLVE MO 4 STFAZACLO 200 MG TAB, RAPID DISSOLVE MO 4 STFAZACLO 25 MG TAB, RAPID DISSOLVE MO 4 STFELBATOL 400 MG TAB MO 4FELBATOL 600 MG TAB MO 4FELBATOL 600 MG/5 ML ORAL SUSP MO 4fenoprofen 600 mg tablet MO 2fentanyl 0.05 mg/ml ampul MO 3fentanyl 0.05 mg/ml syringe MO 3fentanyl 100 mcg/hr patch MO 3 QL (20 per 30 days)fentanyl 12 mcg/hr patch MO 3 QL (20 per 30 days)fentanyl 25 mcg/hr patch MO 3 QL (20 per 30 days)fentanyl 50 mcg/hr patch MO 3 QL (20 per 30 days)fentanyl 75 mcg/hr patch MO 3 QL (20 per 30 days)fentanyl cit otfc 1,200 mcg MO 4 PA,QL (120 per 30 days)fentanyl cit otfc 1,600 mcg MO 4 PA,QL (120 per 30 days)fentanyl citrate otfc 200 mcg MO 4 PA,QL (120 per 30 days)fentanyl citrate otfc 400 mcg MO 4 PA,QL (120 per 30 days)fentanyl citrate otfc 600 mcg MO 4 PA,QL (120 per 30 days)

Page 43: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 43

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

fentanyl citrate otfc 800 mcg MO 4 PA,QL (120 per 30 days)flumazenil 0.1 mg/ml vial MO 2fluoxetine 20 mg/5 ml solution MO 2fluoxetine dr 90 mg capsule MO 3 QL (4 per 28 days)fluoxetine hcl 10 mg capsule MO 1 QL (60 per 30 days)fluoxetine hcl 10 mg tablet MO 1fluoxetine hcl 20 mg capsule MO 1 QL (120 per 30 days)fluoxetine hcl 20 mg tablet MO 2fluoxetine hcl 40 mg capsule MO 1 QL (60 per 30 days)fluphenazine 1 mg tablet MO 1fluphenazine 10 mg tablet MO 2fluphenazine 2.5 mg tablet MO 2fluphenazine 2.5 mg/5 ml elix MO 2fluphenazine 2.5 mg/ml vial MO 2fluphenazine 5 mg tablet MO 2fluphenazine 5 mg/ml conc MO 2fluphenazine dec 25 mg/ml vl MO 2flurbiprofen 100 mg tablet MO 2flurbiprofen 50 mg tablet MO 2fluvoxamine maleate 100 mg tab MO 3 QL (90 per 30 days)fluvoxamine maleate 25 mg tab MO 3 QL (90 per 30 days)fluvoxamine maleate 50 mg tab MO 3 QL (90 per 30 days)fosphenytoin 100 mg pe/2 ml vl MO 2fosphenytoin 500 mg pe/10 ml MO 2frenadol tablet MO 2gabapentin 100 mg capsule MO 2 QL (270 per 30 days)gabapentin 250 mg/5 ml soln MO 3gabapentin 300 mg capsule MO 2 QL (270 per 30 days)gabapentin 400 mg capsule MO 2 QL (270 per 30 days)gabapentin 600 mg tablet MO 2 QL (180 per 30 days)gabapentin 800 mg tablet MO 2 QL (180 per 30 days)GABITRIL 12 MG TAB MO 4 QL (120 per 30 days)GABITRIL 16 MG TAB MO 4 QL (90 per 30 days)GABITRIL 2 MG TAB MO 4 QL (90 per 30 days)GABITRIL 4 MG TAB MO 4GEODON 20 MG CAP MO 3 QL (60 per 30 days)GEODON 20 MG IM MO 3GEODON 40 MG CAP MO 3 QL (60 per 30 days)GEODON 60 MG CAP MO 3 QL (60 per 30 days)GEODON 80 MG CAP MO 3 QL (60 per 30 days)GRALISE 30-DAY STARTER PACK 300 MG (9)-600 MG (69) 24 HR TAB MO 4 ST,QL (78 per 30 days)

Page 44: Humana Walmart-Preferred Formulary - Q1Medicare

44 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

GRALISE 300 MG 24 HR TAB MO 4 ST,QL (30 per 30 days)GRALISE 600 MG 24 HR TAB MO 4 ST,QL (90 per 30 days)HALDOL 5 MG/ML INJECTION MO 4HALDOL DECANOATE 100 MG/ML IM MO 4HALDOL DECANOATE 50 MG/ML IM MO 4haloperidol 0.5 mg tablet MO 1haloperidol 1 mg tablet MO 1haloperidol 10 mg tablet MO 2haloperidol 2 mg tablet MO 1haloperidol 20 mg tablet MO 2haloperidol 5 mg tablet MO 1haloperidol dec 100 mg/ml vial MO 2haloperidol dec 50 mg/ml vial MO 3haloperidol lac 2 mg/ml conc MO 2haloperidol lac 5 mg/ml vial MO 2HORIZANT ER 600 MG TAB MO 4 PA,QL (30 per 30 days)hydrocodon-acetaminoph 2.5-500 MO 3 QL (240 per 30 days)hydrocodon-acetaminoph 7.5-300 MO 3 QL (360 per 30 days)hydrocodon-acetaminoph 7.5-325 MO 3 QL (360 per 30 days)hydrocodon-acetaminoph 7.5-500 MO 3 QL (240 per 30 days)hydrocodon-acetaminoph 7.5-650 MO 3 QL (180 per 30 days)hydrocodon-acetaminoph 7.5-750 MO 3 QL (150 per 30 days)hydrocodon-acetaminophen 5-300 MO 3 QL (360 per 30 days)hydrocodon-acetaminophen 5-325 MO 3 QL (360 per 30 days)hydrocodon-acetaminophen 5-500 MO 3 QL (240 per 30 days)hydrocodon-acetaminophn 10-300 MO 3 QL (360 per 30 days)hydrocodon-acetaminophn 10-325 MO 3 QL (360 per 30 days)hydrocodon-acetaminophn 10-500 MO 3 QL (240 per 30 days)hydrocodon-acetaminophn 10-650 MO 3 QL (180 per 30 days)hydrocodon-acetaminophn 10-660 MO 3 QL (180 per 30 days)hydrocodon-acetaminophn 10-750 MO 3 QL (150 per 30 days)hydrocodone bt-ibuprofen tab MO 3 QL (150 per 30 days)hydromorphone 1 mg/ml syringe MO 3hydromorphone 2 mg tablet MO 3hydromorphone 2 mg/ml syringe MO 3hydromorphone 2 mg/ml vial MO 3hydromorphone 3 mg suppos MO 3hydromorphone 4 mg tablet MO 3hydromorphone 4 mg/ml syrin MO 3hydromorphone 500 mg/50 ml via MO 3hydromorphone 8 mg tablet MO 3

Page 45: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 45

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

hydromorphone hcl 1 mg/ml amp MO 3hydromorphone hcl 2 mg/ml amp MO 3hydromorphone hcl 4 mg/ml amp MO 3hydroxyzine 25 mg/ml vial MO 2 PAhydroxyzine 50 mg/ml vial MO 2 PAibuprofen 100 mg/5 ml susp MO 1ibuprofen 400 mg tablet MO 1ibuprofen 600 mg tablet MO 1ibuprofen 800 mg tablet MO 1imipramine hcl 10 mg tablet MO 2imipramine hcl 25 mg tablet MO 2imipramine hcl 50 mg tablet MO 2imipramine pamoate 100 mg cap MO 3imipramine pamoate 125 mg cap MO 3imipramine pamoate 150 mg cap MO 3imipramine pamoate 75 mg cap MO 3INDOCIN 1 MG IV SOLUTION MO 4INDOCIN 25 MG/5 ML ORAL SUSP MO 4INDOCIN 50 MG RECTAL SUPPOSITORY MO 4indomethacin 1 mg vial MO 2indomethacin 25 mg capsule MO 1indomethacin 50 mg capsule MO 2indomethacin er 75 mg capsule MO 2INFUMORPH P/F 10 MG/ML INJECTION MO 4INFUMORPH P/F 25 MG/ML INJECTION MO 4INVEGA 1.5 MG 24 HR TAB MO 4 ST,QL (30 per 30 days)INVEGA 3 MG 24 HR TAB MO 4 ST,QL (30 per 30 days)INVEGA 6 MG 24 HR TAB MO 4 ST,QL (60 per 30 days)INVEGA 9 MG 24 HR TAB MO 4 ST,QL (30 per 30 days)INVEGA SUSTENNA 117 MG/0.75 ML IM SYRINGE MO 4 QL (1 per 30 days)INVEGA SUSTENNA 156 MG/ML (1 ML) IM SYRINGE MO 4 QL (1 per 30 days)INVEGA SUSTENNA 234 MG/1.5 ML IM SYRINGE MO 4 QL (1 per 30 days)INVEGA SUSTENNA 39 MG/0.25 ML IM SYRINGE MO 4 QL (1 per 30 days)INVEGA SUSTENNA 78 MG/0.5 ML IM SYRINGE MO 4 QL (1 per 30 days)KETALAR 100 MG/ML INJECTION MO 4KETALAR 50 MG/ML INJECTION MO 4ketamine 100 mg/ml vial MO 2ketamine 50 mg/ml vial MO 2ketoprofen 50 mg capsule MO 2ketoprofen 75 mg capsule MO 2ketoprofen er 200 mg capsule MO 3

Page 46: Humana Walmart-Preferred Formulary - Q1Medicare

46 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

LAGESIC CAPLET MO 4LAMICTAL 100 MG TAB MO 4 QL (150 per 30 days)LAMICTAL 150 MG TAB MO 4 QL (90 per 30 days)LAMICTAL 200 MG TAB MO 4 QL (90 per 30 days)LAMICTAL 25 MG DISPERSIBLE TAB MO 4LAMICTAL 25 MG TAB MO 4 QL (120 per 30 days)LAMICTAL 5 MG DISPERSIBLE TAB MO 4LAMICTAL ODT 100 MG TAB MO 4 QL (120 per 30 days)LAMICTAL ODT 200 MG TAB MO 4 QL (90 per 30 days)LAMICTAL ODT 25 MG TAB MO 4 QL (120 per 30 days)LAMICTAL ODT 50 MG TAB MO 4 QL (90 per 30 days)LAMICTAL ODT STARTER (BLUE) 25 MG (21)-50 MG (7) TAB, PACK MO 4LAMICTAL ODT STARTER (GREEN) 50 MG (42)-100 MG (14) TAB, PACK MO 4LAMICTAL ODT STARTER (ORANGE) 25MG (14)-50MG (14)-100MG (7)TAB, PACK MO

4

LAMICTAL STARTER (BLUE) KIT 25 MG (35) TABS IN A DOSE PACK MO 4LAMICTAL STARTER (GREEN) KIT 25 MG (84)-100 MG (14) TABLETS, DOSEPACK MO

4

LAMICTAL STARTER (ORANGE) KIT 25 MG (42)-100 MG (7) TABLETS, DOSEPACK MO

4

LAMICTAL XR 100 MG 24 HR TAB MO 4 QL (120 per 30 days)LAMICTAL XR 200 MG 24 HR TAB MO 4 QL (90 per 30 days)LAMICTAL XR 25 MG 24 HR TAB MO 4 QL (90 per 30 days)LAMICTAL XR 300 MG 24 HR TAB MO 4 QL (60 per 30 days)LAMICTAL XR 50 MG 24 HR TAB MO 4 QL (90 per 30 days)LAMICTAL XR STARTER (BLUE) 25 MG (21)-50 MG (7) TAB, DOSE PACK MO 4LAMICTAL XR STARTER (GREEN) 50 MG(14)-100 MG(14)-200MG(7) TAB,PACK MO

4

LAMICTAL XR STARTER (ORANGE) 25MG (14)-50MG (14)-100MG (7) TAB,PACK MO

4

lamotrigine 100 mg tablet MO 2 QL (150 per 30 days)lamotrigine 150 mg tablet MO 2 QL (90 per 30 days)lamotrigine 200 mg tablet MO 2 QL (90 per 30 days)lamotrigine 25 mg disper tab MO 2lamotrigine 25 mg tablet MO 2 QL (120 per 30 days)lamotrigine 25 mg tb start kit MO 2lamotrigine 5 mg disper tablet MO 2lamotrigine tablet starter kit MO 2LATUDA 40 MG TAB MO 4 PA,QL (30 per 30 days)LATUDA 80 MG TAB MO 4 PA,QL (30 per 30 days)LEVACET 500 MG-250 MG-150 MG-32.5 MG TAB MO 4levetiracetam 1,000 mg tablet MO 2 QL (120 per 30 days)

Page 47: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 47

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

levetiracetam 100 mg/ml soln MO 2levetiracetam 250 mg tablet MO 2 QL (120 per 30 days)levetiracetam 500 mg tablet MO 2 QL (120 per 30 days)levetiracetam 500 mg/5 ml soln MO 2 QL (900 per 30 days)levetiracetam 500 mg/5 ml vial MO 2levetiracetam 750 mg tablet MO 2 QL (120 per 30 days)levorphanol 2 mg tablet MO 3LEXAPRO 10 MG TAB MO 3 QL (30 per 30 days)LEXAPRO 20 MG TAB MO 3 QL (30 per 30 days)LEXAPRO 5 MG TAB MO 3 QL (30 per 30 days)LEXAPRO 5 MG/5 ML ORAL SOLN MO 3 QL (600 per 30 days)LIMBITROL TABLET MO 4 PAlithium 8 meq/5 ml solution MO 2lithium carbonate 150 mg cap MO 2lithium carbonate 300 mg cap MO 1lithium carbonate 300 mg tab MO 2lithium carbonate 600 mg cap MO 2lithium carbonate er 300 mg tb MO 2lithium er 450 mg tablet MO 2loxapine 10 mg capsule MO 3loxapine 25 mg capsule MO 3loxapine 5 mg capsule MO 3loxapine 50 mg capsule MO 3LUVOX CR 100 MG 24 HR CAP MO 4 QL (60 per 30 days)LUVOX CR 150 MG 24 HR CAP MO 4 QL (60 per 30 days)LYRICA 100 MG CAP MO 4 ST,QL (90 per 30 days)LYRICA 150 MG CAP MO 4 ST,QL (90 per 30 days)LYRICA 200 MG CAP MO 4 ST,QL (90 per 30 days)LYRICA 225 MG CAP MO 4 ST,QL (60 per 30 days)LYRICA 25 MG CAP MO 4 ST,QL (90 per 30 days)LYRICA 300 MG CAP MO 4 ST,QL (60 per 30 days)LYRICA 50 MG CAP MO 4 ST,QL (90 per 30 days)LYRICA 75 MG CAP MO 4 ST,QL (90 per 30 days)magnesium chl 200 mg/ml vial MO 2magnesium sulf 4% iv soln MO 2magnesium sulf 8% iv soln MO 2magnesium sulfate 50% syringe MO 2magnesium sulfate 50% vial MO 2magnesium-d5w 1 gm/100 ml soln MO 2maprotiline 25 mg tablet MO 2maprotiline 50 mg tablet MO 2

Page 48: Humana Walmart-Preferred Formulary - Q1Medicare

48 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

maprotiline 75 mg tablet MO 2margesic h 5-500 capsule MO 3 QL (240 per 30 days)MARPLAN 10 MG TAB MO 4MAXALT 10 MG TAB MO 4 QL (12 per 30 days)MAXALT 5 MG TAB MO 4 QL (12 per 30 days)MAXALT-MLT 10 MG TAB, RAPID DISSOLVE MO 4 QL (12 per 30 days)MAXALT-MLT 5 MG TAB, RAPID DISSOLVE MO 4 QL (12 per 30 days)meclofenamate 100 mg capsule MO 2meclofenamate 50 mg capsule MO 2meloxicam 15 mg tablet MO 1 QL (30 per 30 days)meloxicam 7.5 mg tablet MO 1 QL (60 per 30 days)meloxicam 7.5 mg/5 ml susp MO 2 QL (300 per 30 days)methadone 10 mg/5 ml solution MO 3methadone 10 mg/ml oral conc MO 3methadone 5 mg/5 ml solution MO 3methadone hcl 10 mg tablet MO 3methadone hcl 10 mg/ml vial MO 3methadone hcl 5 mg tablet MO 3methadone intensol 10 mg/ml oral concentrate MO 2methadose 10 mg tab MO 3METHADOSE 10 MG/ML ORAL CONCENTRATE MO 3methamphetamine 5 mg tablet MO 3methyl salicylate liquid MO 2methylphenidate 10 mg tablet MO 2 PAmethylphenidate 20 mg tablet MO 2 PAmethylphenidate 5 mg tablet MO 2 PAmirtazapine 15 mg odt MO 3 QL (30 per 30 days)mirtazapine 15 mg tablet MO 3 QL (30 per 30 days)mirtazapine 30 mg odt MO 3 QL (30 per 30 days)mirtazapine 30 mg tablet MO 3 QL (30 per 30 days)mirtazapine 45 mg odt MO 3 QL (30 per 30 days)mirtazapine 45 mg tablet MO 3 QL (30 per 30 days)mirtazapine 7.5 mg tablet MO 3MOBAN 10 MG TAB MO 4MOBAN 25 MG TAB MO 4MOBAN 5 MG TABLET MO 4MOBAN 50 MG TAB MO 4morphine 0.5 mg/ml ampul p-f MO 3morphine 1 mg/ml syringe MO 3morphine 1 mg/ml vial p-f MO 3morphine 1 mg/ml-d5w 100 ml MO 3

Page 49: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 49

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

morphine 1 mg/ml-d5w 250 ml MO 3morphine 10 mg/ml syringe MO 3morphine 10 mg/ml vial MO 3morphine 15 mg/ml syringe MO 3morphine 15 mg/ml vial MO 3morphine 2 mg/ml syringe MO 3morphine 25 mg/ml syringe MO 3morphine 4 mg/ml syringe MO 3morphine 5 mg/ml vial MO 3morphine 8 mg/ml syringe MO 3morphine 8 mg/ml vial MO 3morphine sulf 10 mg suppos MO 3morphine sulf 10 mg/5 ml soln MO 3morphine sulf 100 mg/5 ml soln MO 3morphine sulf 20 mg suppos MO 3morphine sulf 20 mg/5 ml soln MO 3morphine sulf 30 mg suppos MO 3morphine sulf 5 mg suppos MO 3morphine sulf er 100 mg tablet MO 3morphine sulf er 15 mg tablet MO 3morphine sulf er 200 mg tablet MO 3morphine sulf er 30 mg tablet MO 3morphine sulf er 60 mg tablet MO 3morphine sulfate 1 mg/ml vial MO 3morphine sulfate 25 mg/ml vial MO 3morphine sulfate 25 mg/ml vl MO 3morphine sulfate 50 mg/ml vial MO 3morphine sulfate ir 15 mg tab MO 3morphine sulfate ir 30 mg tab MO 3mst 600 600 mg tab MO 2myophen caplet MO 2nabumetone 500 mg tablet MO 3nabumetone 750 mg tablet MO 3nalbuphine 10 mg/ml ampul MO 3nalbuphine 200 mg/10 ml vial MO 3NALFON 200 MG CAP MO 4NALFON 400 MG CAP MO 4naloxone 0.02 mg/ml vial MO 2naloxone 0.4 mg/ml syringe MO 2naloxone 0.4 mg/ml vial MO 2naloxone 1 mg/ml syringe MO 2

Page 50: Humana Walmart-Preferred Formulary - Q1Medicare

50 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

naltrexone 50 mg tablet MO 2NAMENDA 10 MG TAB MO 3 QL (60 per 30 days)NAMENDA 10 MG/5 ML ORAL SOLN MO 3 QL (360 per 30 days)NAMENDA 5 MG TAB MO 3 QL (60 per 30 days)NAMENDA TITRATION PAK 5 MG-10 MG TABS IN A DOSE PACK MO 3 QL (98 per 30 days)naproxen 125 mg/5 ml suspen MO 2naproxen 250 mg tablet MO 2naproxen 375 mg tablet MO 1naproxen 500 mg tablet MO 1naproxen ec 375 mg tablet MO 2naproxen ec 500 mg tablet MO 2naproxen sodium 275 mg tab MO 2naproxen sodium 550 mg tab MO 2naratriptan hcl 1 mg tablet MO 3 QL (9 per 30 days)naratriptan hcl 2.5 mg tablet MO 3 QL (9 per 30 days)NARDIL 15 MG TAB MO 4NAVANE 20 MG CAP MO 4nefazodone hcl 100 mg tablet MO 2nefazodone hcl 150 mg tablet MO 2nefazodone hcl 200 mg tablet MO 2nefazodone hcl 250 mg tablet MO 2nefazodone hcl 50 mg tablet MO 2NEURONTIN 250 MG/5 ML ORAL SOLN MO 4nortriptyline 10 mg/5 ml sol MO 2nortriptyline hcl 10 mg cap MO 1nortriptyline hcl 25 mg cap MO 1nortriptyline hcl 50 mg cap MO 2nortriptyline hcl 75 mg cap MO 2ORAP 1 MG TAB MO 4ORAP 2 MG TAB MO 4oxaprozin 600 mg tablet MO 2oxcarbazepine 150 mg tablet MO 3oxcarbazepine 300 mg tablet MO 3oxcarbazepine 300 mg/5 ml susp MO 3oxcarbazepine 600 mg tablet MO 3oxycodon-acetaminophen 2.5-325 MO 3 QL (360 per 30 days)oxycodon-acetaminophen 7.5-325 MO 3 QL (360 per 30 days)oxycodon-acetaminophen 7.5-500 MO 3 QL (240 per 30 days)oxycodone conc 20 mg/ml soln MO 3oxycodone hcl 10 mg tablet MO 3oxycodone hcl 15 mg tablet MO 3

Page 51: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 51

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

oxycodone hcl 20 mg tablet MO 3oxycodone hcl 30 mg tablet MO 3oxycodone hcl 5 mg capsule MO 3oxycodone hcl 5 mg tablet MO 3oxycodone hcl 5 mg/5 ml sol MO 3oxycodone-acetaminophen 10-325 MO 3 QL (360 per 30 days)oxycodone-acetaminophen 10-650 MO 3 QL (180 per 30 days)oxycodone-acetaminophen 5-325 MO 3 QL (360 per 30 days)oxycodone-acetaminophen 5-500 MO 3 QL (240 per 30 days)oxycodone-asa 4.5-0.38-325 tab MO 3oxycodone-aspirin 4.83-325 mg MO 3oxycodone-ibuprofen 5-400 tab MO 3 QL (240 per 30 days)paroxetine cr 12.5 mg tablet MO 3 QL (60 per 30 days)paroxetine cr 25 mg tablet MO 3 QL (90 per 30 days)paroxetine cr 37.5 mg tablet MO 3 QL (60 per 30 days)paroxetine hcl 10 mg tablet MO 1 QL (30 per 30 days)paroxetine hcl 10 mg/5 ml susp MO 2paroxetine hcl 20 mg tablet MO 1 QL (30 per 30 days)paroxetine hcl 30 mg tablet MO 2 QL (60 per 30 days)paroxetine hcl 40 mg tablet MO 2 QL (60 per 30 days)PEGANONE 250 MG TAB MO 4perphen-amitrip 2 mg-10 mg tab MO 2perphen-amitrip 2 mg-25 mg tab MO 2perphen-amitrip 4 mg-10 mg tab MO 2perphen-amitrip 4 mg-25 mg tab MO 2perphen-amitrip 4 mg-50 mg tab MO 2perphenazine 16 mg tablet MO 2perphenazine 2 mg tablet MO 2perphenazine 4 mg tablet MO 2perphenazine 8 mg tablet MO 2phenelzine sulfate 15 mg tab MO 3PHENYTEK 200 MG CAP MO 3PHENYTEK 300 MG CAP MO 3phenytoin 100 mg/4 ml susp MO 2phenytoin 125 mg/5 ml susp MO 2phenytoin 50 mg/ml syringe MO 3phenytoin 50 mg/ml vial MO 3phenytoin sod ext 100 mg cap MO 2phenytoin sod ext 200 mg cap MO 2phenytoin sod ext 300 mg cap MO 2piroxicam 10 mg capsule MO 2

Page 52: Humana Walmart-Preferred Formulary - Q1Medicare

52 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

piroxicam 20 mg capsule MO 2pramipexole 0.125 mg tablet MO 2pramipexole 0.25 mg tablet MO 2pramipexole 0.5 mg tablet MO 2pramipexole 0.75 mg tablet MO 2pramipexole 1 mg tablet MO 2pramipexole 1.5 mg tablet MO 2PRECEDEX 200 MCG/2 ML IV MO 4PRIALT 100 MCG/ML INTRATHECAL SP 4PRIALT 25 MCG/ML INTRATHECAL SP 4primalev 2.5-300 mg tablet MO 3primidone 250 mg tablet MO 3primidone 50 mg tablet MO 3PRISTIQ 100 MG 24 HR TAB MO 4 QL (30 per 30 days)PRISTIQ 50 MG 24 HR TAB MO 4 QL (30 per 30 days)protriptyline hcl 10 mg tablet MO 2protriptyline hcl 5 mg tablet MO 2qflex tablet MO 2rhinoflex 50 mg-500 mg tab MO 2rhinoflex-650 50 mg-650 mg tab MO 2RILUTEK 50 MG TAB MO 3RISPERDAL 1 MG/ML ORAL SOLN MO 4RISPERDAL CONSTA 12.5 MG/2 ML IM SYRINGE MO 4 QL (2 per 28 days)RISPERDAL CONSTA 25 MG/2 ML IM SYRINGE MO 4 QL (2 per 28 days)RISPERDAL CONSTA 37.5 MG/2 ML IM SYRINGE MO 4 QL (4 per 28 days)RISPERDAL CONSTA 50 MG/2 ML IM SYRINGE MO 4 QL (4 per 28 days)risperidone 0.25 mg odt MO 3 QL (60 per 30 days)risperidone 0.25 mg tablet MO 2 QL (60 per 30 days)risperidone 0.5 mg odt MO 3 QL (120 per 30 days)risperidone 0.5 mg tablet MO 2 QL (120 per 30 days)risperidone 1 mg odt MO 3 QL (60 per 30 days)risperidone 1 mg tablet MO 2 QL (60 per 30 days)risperidone 1 mg/ml solution MO 3risperidone 2 mg odt MO 3 QL (60 per 30 days)risperidone 2 mg tablet MO 2 QL (60 per 30 days)risperidone 3 mg odt MO 3 QL (60 per 30 days)risperidone 3 mg tablet MO 2 QL (60 per 30 days)risperidone 4 mg odt MO 3 QL (60 per 30 days)risperidone 4 mg tablet MO 2 QL (60 per 30 days)risperidone m-tab 0.5 mg tab, rapid dissolve MO 3 QL (120 per 30 days)risperidone m-tab 1 mg tab, rapid dissolve MO 3 QL (60 per 30 days)

Page 53: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 53

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

risperidone m-tab 2 mg tab, rapid dissolve MO 3 QL (60 per 30 days)risperidone m-tab 3 mg tab, rapid dissolve MO 3 QL (60 per 30 days)risperidone m-tab 4 mg tab, rapid dissolve MO 3 QL (60 per 30 days)ROMAZICON 0.1 MG/ML IV MO 4ropinirole hcl 0.25 mg tablet MO 2ropinirole hcl 0.5 mg tablet MO 2ropinirole hcl 1 mg tablet MO 2ropinirole hcl 2 mg tablet MO 2ropinirole hcl 3 mg tablet MO 2ropinirole hcl 4 mg tablet MO 2ropinirole hcl 5 mg tablet MO 2roxicet 5 mg-325 mg tab MO 3 QL (360 per 30 days)ROXICET 5 MG-500 MG TAB MO 3 QL (240 per 30 days)SABRIL 500 MG ORAL POWDER IN PACKET MO 4 PA,QL (180 per 30 days)SABRIL 500 MG TAB MO 4 PA,QL (180 per 30 days)salsalate 500 mg tablet MO 2salsalate 750 mg tablet MO 2SAPHRIS 10 MG SUBLINGUAL TAB MO 4 PA,QL (60 per 30 days)SAPHRIS 5 MG SUBLINGUAL TAB MO 4 PA,QL (60 per 30 days)SAVELLA 100 MG TAB MO 3 QL (60 per 30 days)SAVELLA 12.5 MG (5)-25 MG(8)-50MG(42) TABS IN A DOSE PACK MO 3 QL (60 per 30 days)SAVELLA 12.5 MG TAB MO 3 QL (60 per 30 days)SAVELLA 25 MG TAB MO 3 QL (60 per 30 days)SAVELLA 50 MG TAB MO 3 QL (60 per 30 days)selegiline hcl 5 mg capsule MO 2selegiline hcl 5 mg tablet MO 2SEROQUEL 100 MG TAB MO 3 QL (90 per 30 days)SEROQUEL 200 MG TAB MO 3 QL (120 per 30 days)SEROQUEL 25 MG TAB MO 3 QL (120 per 30 days)SEROQUEL 300 MG TAB MO 3 QL (90 per 30 days)SEROQUEL 400 MG TAB MO 3 QL (90 per 30 days)SEROQUEL 50 MG TAB MO 3 QL (120 per 30 days)SEROQUEL XR 150 MG 24 HR TAB MO 3 QL (90 per 30 days)SEROQUEL XR 200 MG 24 HR TAB MO 3 QL (30 per 30 days)SEROQUEL XR 300 MG 24 HR TAB MO 3 QL (60 per 30 days)SEROQUEL XR 400 MG 24 HR TAB MO 3 QL (60 per 30 days)SEROQUEL XR 50 MG 24 HR TAB MO 3 QL (120 per 30 days)sertraline 20 mg/ml oral conc MO 2sertraline hcl 100 mg tablet MO 2 QL (60 per 30 days)sertraline hcl 25 mg tablet MO 2 QL (60 per 30 days)sertraline hcl 50 mg tablet MO 2 QL (60 per 30 days)

Page 54: Humana Walmart-Preferred Formulary - Q1Medicare

54 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

somnote 500 mg cap MO 2STALEVO 100 25 MG-100 MG-200 MG TAB MO 3STALEVO 125 31.25 MG-125 MG-200 MG TAB MO 3STALEVO 150 37.5 MG-150 MG-200 MG TAB MO 3STALEVO 200 50 MG-200 MG-200 MG TAB MO 3STALEVO 50 12.5 MG-50 MG-200 MG TAB MO 3STALEVO 75 18.75 MG-75 MG-200 MG TAB MO 3STRATTERA 10 MG CAP MO 4 QL (60 per 30 days)STRATTERA 100 MG CAP MO 4 QL (30 per 30 days)STRATTERA 18 MG CAP MO 4 QL (60 per 30 days)STRATTERA 25 MG CAP MO 4 QL (60 per 30 days)STRATTERA 40 MG CAP MO 4 QL (60 per 30 days)STRATTERA 60 MG CAP MO 4 QL (60 per 30 days)STRATTERA 80 MG CAP MO 4 QL (30 per 30 days)sufentanil 250 mcg/5 ml ampul MO 3sulindac 150 mg tablet MO 2sulindac 200 mg tablet MO 2sumatriptan 20 mg nasal spray MO 3 QL (12 per 30 days)sumatriptan 4 mg/0.5 ml kit MO 3 QL (6 per 30 days)sumatriptan 4 mg/0.5 ml refill MO 3 QL (6 per 30 days)sumatriptan 4 mg/0.5 ml syrng MO 3 QL (6 per 30 days)sumatriptan 4 mg/0.5 ml vial MO 3 QL (6 per 30 days)sumatriptan 5 mg nasal spray MO 3 QL (12 per 30 days)sumatriptan 6 mg/0.5 ml inject MO 3 QL (6 per 30 days)sumatriptan 6 mg/0.5 ml refill MO 3 QL (6 per 30 days)sumatriptan 6 mg/0.5 ml syrng MO 3 QL (6 per 30 days)sumatriptan 6 mg/0.5 ml vial MO 3 QL (6 per 30 days)sumatriptan succ 100 mg tablet MO 2 QL (9 per 30 days)sumatriptan succ 25 mg tablet MO 2 QL (9 per 30 days)sumatriptan succ 50 mg tablet MO 2 QL (9 per 30 days)SURMONTIL 100 MG CAP MO 4SURMONTIL 25 MG CAP MO 4SURMONTIL 50 MG CAP MO 4TASMAR 100 MG TAB MO 4 PATASMAR 200 MG TABLET MO 4 PA,QL (90 per 30 days)TEGRETOL XR 100 MG 12 HR TAB MO 4THIOCYL 50 MG/ML AMPUL MO 4thioridazine 10 mg tablet MO 2 PAthioridazine 100 mg tablet MO 2 PAthioridazine 25 mg tablet MO 2 PAthioridazine 50 mg tablet MO 2 PA

Page 55: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 55

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

thiothixene 1 mg capsule MO 2thiothixene 10 mg capsule MO 2thiothixene 2 mg capsule MO 1thiothixene 5 mg capsule MO 2tolmetin sodium 200 mg tab MO 3tolmetin sodium 400 mg cap MO 3tolmetin sodium 600 mg tab MO 3topiragen 100 mg tab MO 2 QL (120 per 30 days)topiragen 200 mg tab MO 2 QL (120 per 30 days)topiragen 25 mg tab MO 2 QL (90 per 30 days)topiragen 50 mg tab MO 2 QL (120 per 30 days)topiramate 100 mg tablet MO 2 QL (120 per 30 days)topiramate 15 mg sprinkle cap MO 2topiramate 200 mg tablet MO 2 QL (120 per 30 days)topiramate 25 mg sprinkle cap MO 2topiramate 25 mg tablet MO 2 QL (90 per 30 days)topiramate 50 mg tablet MO 2 QL (120 per 30 days)tramadol hcl 50 mg tablet MO 1 QL (240 per 30 days)tramadol-acetaminophn 37.5-325 MO 3 QL (240 per 30 days)tranylcypromine sulf 10 mg tab MO 3trazodone 100 mg tablet MO 1trazodone 150 mg tablet MO 1trazodone 300 mg tablet MO 2trazodone 50 mg tablet MO 1trifluoperazine 1 mg tablet MO 2trifluoperazine 10 mg tablet MO 2trifluoperazine 2 mg tablet MO 2trifluoperazine 5 mg tablet MO 2trihexyphenidyl 2 mg tablet MO 1trihexyphenidyl 2 mg/5 ml elx MO 2trihexyphenidyl 5 mg tablet MO 2ULTIVA 1 MG SOLUTION MO 4ULTIVA 2 MG SOLUTION MO 4ULTIVA 5 MG SOLUTION MO 4valproate sod 500 mg/5 ml vl MO 2valproic acid 250 mg capsule MO 2valproic acid 250 mg/5 ml syr MO 2venlafaxine hcl 100 mg tablet MO 3venlafaxine hcl 25 mg tablet MO 3venlafaxine hcl 37.5 mg tablet MO 3venlafaxine hcl 50 mg tablet MO 3

Page 56: Humana Walmart-Preferred Formulary - Q1Medicare

56 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

venlafaxine hcl 75 mg tablet MO 3venlafaxine hcl er 150 mg cap MO 2 QL (60 per 30 days)VENLAFAXINE HCL ER 150 MG TAB MO 4 QL (30 per 30 days)VENLAFAXINE HCL ER 225 MG TAB MO 4 QL (30 per 30 days)venlafaxine hcl er 37.5 mg cap MO 2 QL (30 per 30 days)VENLAFAXINE HCL ER 37.5 MG TAB MO 4 QL (30 per 30 days)venlafaxine hcl er 75 mg cap MO 2 QL (90 per 30 days)VENLAFAXINE HCL ER 75 MG TAB MO 4 QL (60 per 30 days)VIIBRYD 10 MG TAB MO 4 PA,QL (30 per 30 days)VIIBRYD 20 MG TAB MO 4 PA,QL (30 per 30 days)VIIBRYD 40 MG TAB MO 4 PA,QL (30 per 30 days)VIMPAT 10 MG/ML ORAL SOLN MO 4 PA,QL (1395 per 30 days)VIMPAT 100 MG TAB MO 4 PA,QL (90 per 30 days)VIMPAT 150 MG TAB MO 4 PA,QL (90 per 30 days)VIMPAT 200 MG TAB MO 4 PA,QL (60 per 30 days)VIMPAT 200 MG/20 ML IV MO 4 PAVIMPAT 50 MG TAB MO 4 PA,QL (90 per 30 days)vistra 650 tablet MO 2XENAZINE 12.5 MG TAB SP 4 PA,QL (240 per 30 days)XENAZINE 25 MG TAB SP 4 PA,QL (120 per 30 days)XYREM 500 MG/ML ORAL SOLN SP 4zaleplon 10 mg capsule MO 2 QL (60 per 30 days)zaleplon 5 mg capsule MO 2 QL (30 per 30 days)zgesic 66 mg-600 mg tab MO 2zolpidem tartrate 10 mg tablet MO 2 QL (30 per 30 days)zolpidem tartrate 5 mg tablet MO 2 QL (30 per 30 days)zonisamide 100 mg capsule MO 2zonisamide 25 mg capsule MO 2zonisamide 50 mg capsule MO 2zorprin cr 800 mg tablet MO 2ZYPREXA 10 MG IM MO 4 PA,QL (60 per 30 days)ZYPREXA 10 MG TAB MO 4 PA,QL (30 per 30 days)ZYPREXA 15 MG TAB MO 4 PA,QL (60 per 30 days)ZYPREXA 2.5 MG TAB MO 4 PA,QL (30 per 30 days)ZYPREXA 20 MG TAB MO 4 PA,QL (60 per 30 days)ZYPREXA 5 MG TAB MO 4 PA,QL (30 per 30 days)ZYPREXA 7.5 MG TAB MO 4 PA,QL (30 per 30 days)ZYPREXA RELPREVV 210 MG IM SUSP MO 4ZYPREXA RELPREVV 300 MG IM SUSP MO 4ZYPREXA RELPREVV 405 MG IM SUSP MO 4ZYPREXA ZYDIS 10 MG TAB, RAPID DISSOLVE MO 4 PA,QL (30 per 30 days)

Page 57: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 57

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ZYPREXA ZYDIS 15 MG TAB, RAPID DISSOLVE MO 4 PA,QL (60 per 30 days)ZYPREXA ZYDIS 20 MG TAB, RAPID DISSOLVE MO 4 PA,QL (60 per 30 days)ZYPREXA ZYDIS 5 MG TAB, RAPID DISSOLVE MO 4 PA,QL (30 per 30 days)DEVICESACCUSURE INSULIN SYRN 0.5 ML MO 2ACCUSURE INSULIN SYRN 1 ML MO 2AIMSCO INSULIN SYRINGE 1 ML 28 X 1/2" MO 2AIMSCO INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2AUTOJECT 2 INJECTION DEVICE SUB-Q INSULIN PEN MO 2AUTOJECT 2 SUB-Q INSULIN PEN MO 2AUTOPEN 1 TO 16 UNITS SUB-Q INSULIN PEN MO 2AUTOPEN 1 TO 21 UNITS SUB-Q INSULIN PEN MO 2AUTOPEN 2 TO 32 UNITS SUB-Q INSULIN PEN MO 2AUTOPEN 2 TO 42 UNITS SUB-Q INSULIN PEN MO 2BD ECLIPSE LUER-LOK 1 ML 30 X 1/2" SYRINGE MO 2BD INSULIN PEN NEEDLE UF ORIG 29 X 1/2" MO 2BD INSULIN SYR 1 ML 25GX5/8" MO 2BD INSULIN SYRINGE 1 ML 25 X 1" MO 2BD INSULIN SYRINGE 1 ML 25 X 5/8" MO 2BD INSULIN SYRINGE 1 ML 26 X 1/2" MO 2BD INSULIN SYRINGE 1 ML 28 X 1/2" MO 2BD INSULIN SYRINGE HALF UNIT 0.3 ML 31 X 5/16" MO 2BD INSULIN SYRINGE MICRO-FINE 0.3 ML 28 MO 2BD INSULIN SYRINGE MICRO-FINE 0.3 ML 28 X 1/2" MO 2BD INSULIN SYRINGE MICRO-FINE 1 ML 27 X 5/8" MO 2BD INSULIN SYRINGE MICRO-FINE 1 ML 28 X 1/2" MO 2BD INSULIN SYRINGE MICRO-FINE 1/2 ML 28 X 1/2" MO 2BD INSULIN SYRINGE SAFETY-LOK 1 ML 29 X 1/2" MO 2BD INSULIN SYRINGE SLIP TIP 1 ML MO 2BD INSULIN SYRINGE ULT-FINE II 0.3 ML 31 X 5/16" MO 2BD INSULIN SYRINGE ULT-FINE II 1 ML 31 X 5/16" MO 2BD INSULIN SYRINGE ULT-FINE II 1/2 ML 31 X 5/16" MO 2BD INSULIN SYRINGE ULTRA-FINE 0.3 ML 30 X 1/2" MO 2BD INSULIN SYRINGE ULTRA-FINE 1 ML 29 X 1/2" MO 2BD INSULIN SYRINGE ULTRA-FINE 1 ML 30 X 1/2" MO 2BD INSULIN SYRINGE ULTRA-FINE 1/2 ML 30 X 1/2" MO 2BD INTEGRA INSULIN SYRINGE 1 ML 29 X 1/2" MO 2BD LO-DOSE MICRO-FINE IV 0.3 ML 28 X 1/2" SYRINGE MO 2BD LO-DOSE MICRO-FINE IV 1/2 ML 28 X 1/2" SYRINGE MO 2BD LO-DOSE ULTRA-FINE 0.3 ML 29 X 1/2" SYRINGE MO 2BD LO-DOSE ULTRA-FINE 1/2 ML 29 X 1/2" SYRINGE MO 2

Page 58: Humana Walmart-Preferred Formulary - Q1Medicare

58 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

BD LUER-LOK SYRINGE 1 ML MO 2BD SAFETYGLIDE INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2BD SAFETYGLIDE INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2BD SAFETYGLIDE INSULIN SYRINGE 1 ML 29 X 1/2" MO 2BD SAFETYGLIDE INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2BD SAFETYGLIDE SYRINGE 1 ML 27 X 5/8" MO 2CAREONE ULTIGUARD 0.3 ML 29 X 1/2" SYRINGE MO 2CAREONE ULTIGUARD 0.3 ML 30 X 5/16" SYRINGE MO 2CAREONE ULTIGUARD 1 ML 29 X 1/2" SYRINGE MO 2CAREONE ULTIGUARD 1 ML 30 X 5/16" SYRINGE MO 2CAREONE ULTIGUARD 1/2 ML 29 X 1/2" SYRINGE MO 2CAREONE ULTIGUARD 1/2 ML 30 X 5/16" SYRINGE MO 2CVS SYRINGE 3/10 ML MO 2DISCOVISC 40 MG-17 MG/ML INTRAOCULAR SYRINGE MO 4DUOVISC VISCO ELASTIC 3 %-4 % (0.35 ML) 1 %(0.4 ML) INTRAOCULARKIT MO

4

DUOVISC VISCO ELASTIC 3 %-4 % (0.5 ML) 1 %(0.55 ML) INTRAOCULARKIT MO

4

EASY COMFORT INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2EASY COMFORT INSULIN SYRINGE 1 ML 30 X 5/16" MO 2EASY COMFORT INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2EASY TOUCH 0.3 ML 30 X 5/16" SYRINGE MO 2EASY TOUCH 0.3 ML 31 X 5/16" SYRINGE MO 2EASY TOUCH 1 ML 28 X 1/2" SYRINGE MO 2EASY TOUCH 1 ML 29 X 1/2" SYRINGE MO 2EASY TOUCH 1 ML 30 X 1/2" SYRINGE MO 2EASY TOUCH 1 ML 30 X 5/16" SYRINGE MO 2EASY TOUCH 1 ML 31 X 5/16" SYRINGE MO 2EASY TOUCH 1/2 ML 28 X 1/2" SYRINGE MO 2EASY TOUCH 1/2 ML 29 X 1/2" SYRINGE MO 2EASY TOUCH 1/2 ML 30 X 5/16" SYRINGE MO 2EASY TOUCH 1/2 ML 31 X 5/16" SYRINGE MO 2euflexxa 10 mg/ml intra-articular syringe SP 4EXEL INSULIN 0.3 ML 29 X 1/2" SYRINGE MO 2EXEL INSULIN 1 ML 27 X 1/2" SYRINGE MO 2EXEL INSULIN 1 ML 30 X 5/16" SYRINGE MO 2EXEL INSULIN 1/2 ML 28 X 1/2" SYRINGE MO 2EXEL INSULIN 1/2 ML 30 X 5/16" SYRINGE MO 2FIFTY50 RESERVOIR 1.8 ML MISC MO 2FIFTY50 RESERVOIR 3 ML MISC MO 4GENTLE DRAW LANCING DEVICE MO 2

Page 59: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 59

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

GLUCOPRO 0.3 ML 29 X 1/2" SYRINGE MO 2GLUCOPRO 0.3 ML 30 X 1/2" SYRINGE MO 2GLUCOPRO 0.3 ML 30 X 5/16" SYRINGE MO 2GLUCOPRO 0.3 ML 31 X 5/16" SYRINGE MO 2GLUCOPRO 1 ML 29 X 1/2" SYRINGE MO 2GLUCOPRO 1 ML 30 X 1/2" SYRINGE MO 2GLUCOPRO 1 ML 30 X 5/16" SYRINGE MO 2GLUCOPRO 1 ML 31 X 5/16" SYRINGE MO 2GLUCOPRO 1/2 ML 29 X 1/2" SYRINGE MO 2GLUCOPRO 1/2 ML 30 X 1/2" SYRINGE MO 2GLUCOPRO 1/2 ML 30 X 5/16" SYRINGE MO 2GLUCOPRO 1/2 ML 31 X 5/16" SYRINGE MO 2GLUCOPRO SYRINGE MO 2HUMAPEN LUXURA HD SUB-Q INSULIN PEN MO 4HUMAPEN MEMOIR SUB-Q INSULIN PEN MO 4HYALGAN 10 MG/ML INTRA-ARTICULAR SP 4HYALGAN 10 MG/ML INTRA-ARTICULAR SYRINGE SP 4INNOVO SUB-Q INSULIN PEN MO 2INSULIN 1 ML SYRINGE MO 2INSULIN 1/2 ML SYRINGE MO 2INSULIN 3/10 ML SYRINGE MO 2INSULIN CARTRIDGE 3 ML MO 4INSULIN SYR 1/2 ML BULK PACK MO 2INSULIN SYRIN 0.3 ML 31GX5/16" MO 2INSULIN SYRIN 0.5 ML 31GX5/16" MO 2INSULIN SYRINGE 0.3 ML MO 2INSULIN SYRINGE 0.5 ML MO 2INSULIN SYRINGE 1 ML MO 2INSULIN SYRINGE 1 ML 28 X 1/2" MO 2INSULIN SYRINGE 1 ML 29 X 1/2" MO 2INSULIN SYRINGE 1 ML 30 X 5/16" MO 2INSULIN SYRINGE 1 ML 31GX5/16" MO 2INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2INSULIN SYRINGE MICROFINE 0.3 ML 28 X 1/2" MO 2INSULIN SYRINGE MICROFINE 1 ML 27 X 5/8" MO 2INSULIN SYRINGE MICROFINE 1/2 ML 28 X 1/2" MO 2INSULIN SYRINGE U100 0.5 ML MO 2INSULIN SYRINGE U100 1 ML MO 2INSULIN SYRINGE ULTRAFINE 1/2 ML 29 X 1/2" MO 2

Page 60: Humana Walmart-Preferred Formulary - Q1Medicare

60 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

INSULIN SYRINGE/NEEDLE 0.5CC/27G 1/2 ML 27 X 1/2" MO 2INSUMED SYR 0.3 ML 31GX5/16" MO 2INSUMED SYR 0.5 ML 31GX5/16" MO 2INSUMED SYRINGE 1 ML 30GX1/2" MO 2INSUMED SYRINGE 1 ML 30GX5/16" MO 2KMART VALU PLUS SYR 1/2 ML MO 2KMART VALU PLUS SYRINGE 1 ML MO 2KROGER PEN NEEDLES 31G MO 2LITE TOUCH INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2LITE TOUCH INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2LITE TOUCH INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2LITE TOUCH INSULIN SYRINGE 1 ML 28 MO 2LITE TOUCH INSULIN SYRINGE 1 ML 29 MO 2LITE TOUCH INSULIN SYRINGE 1 ML 30 X 7/16" MO 2LITE TOUCH INSULIN SYRINGE 1 ML 31 X 5/16" MO 2LITE TOUCH INSULIN SYRINGE 1/2 ML 28 MO 2LITE TOUCH INSULIN SYRINGE 1/2 ML 29 MO 2LITE TOUCH INSULIN SYRINGE 1/2 ML 30 MO 2LITE TOUCH INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2MAGELLAN INSULIN SAFETY SYRINGE 0.3 ML 29 X 1/2" MO 2MAGELLAN INSULIN SAFETY SYRINGE 0.5 ML 29 X 1/2" MO 2MAGELLAN INSULIN SAFETY SYRINGE 1 ML 29 X 1/2" MO 2MAGELLAN INSULIN SAFETY SYRINGE 1 ML 30 X 5/16" MO 2MAGELLAN SYRINGE 0.3 ML 30 X 5/16" MO 2MAGELLAN SYRINGE 0.5 ML 30 X 5/16" MO 2MAGELLAN SYRINGE 1 ML 27 X 1/2" MO 2MEDI-JECTOR VISION SUB-Q INSULIN PEN MO 2MINI ULTRA-THIN II 31 X 3/16" NEEDLE MO 2MINIMED SYRINGE RESERVOIR 3 ML MO 4MONOJECT INSULIN SAFETY SYRINGE 0.3 ML 29 X 1/2" MO 2MONOJECT INSULIN SAFETY SYRINGE 0.3 ML 30 X 5/16" MO 2MONOJECT INSULIN SAFETY SYRINGE 1/2 ML 29 X 1/2" MO 2MONOJECT INSULIN SAFETY SYRINGE 1/2 ML 30 X 5/16" MO 2MONOJECT INSULIN SAFETY SYRINGE 29 X 1/2" MO 2MONOJECT INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2MONOJECT INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2MONOJECT INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2MONOJECT INSULIN SYRINGE 1 ML MO 2MONOJECT INSULIN SYRINGE 1 ML 25 X 5/8" MO 2MONOJECT INSULIN SYRINGE 1 ML 27 X 1/2" MO 2MONOJECT INSULIN SYRINGE 1 ML 28 X 1/2" MO 2

Page 61: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 61

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

MONOJECT INSULIN SYRINGE 1 ML 29 X 1/2" MO 2MONOJECT INSULIN SYRINGE 1 ML 30 X 5/16" MO 2MONOJECT INSULIN SYRINGE 1 ML 31 X 5/16" MO 2MONOJECT INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2MONOJECT INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2MONOJECT INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2MONOJECT INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2MONOJECT SYRINGE 1/2 ML 28 MO 2MONOJECT ULTRA COMFORT INSULIN 1/2 ML 28 SYRINGE MO 2NEEDLE-PRO EDGE 0.3 ML 29GX1/2 MO 2NEEDLE-PRO EDGE 0.3 ML 30GX1/2 MO 2NEEDLE-PRO EDGE 0.5 ML 28GX1/2 MO 2NEEDLE-PRO EDGE 0.5 ML 29GX1/2 MO 2NEEDLE-PRO EDGE 0.5 ML 30GX1/2 MO 2NEEDLE-PRO EDGE 1 ML 26GX1/2" MO 2NEEDLE-PRO EDGE 1 ML 27GX1/2" MO 2NEEDLE-PRO EDGE 1 ML 28GX1/2" MO 2NEEDLE-PRO EDGE 1 ML 29GX1/2" MO 2NEEDLE-PRO EDGE 1 ML 30GX1/2" MO 2NOVOFINE 30 30 X 1/3" NEEDLE MO 2NOVOFINE 32 32 X 1/4" NEEDLE MO 2NOVOFINE AUTOCOVER 30 X 1/3" NEEDLE MO 2NOVOPEN 3 PENMATE SUB-Q INSULIN PEN MO 2NOVOPEN 3 SUB-Q INSULIN PEN MO 2NOVOPEN JR SUB-Q INSULIN PEN MO 2NOVOTWIST 30 X 1/3" NEEDLE MO 2NOVOTWIST 32 X 1/5" NEEDLE MO 2ORSINI INSULIN SYRINGE 1 ML 30 X 5/16" MO 2ORSINI INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2ORSINI INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2ORTHOVISC 30 MG/2 ML INTRA-ARTICULAR SYRINGE SP 4PARADIGM RESERVOIR 1.8 ML MO 4PARADIGM RESERVOIR 3 ML MO 4PEN NEEDLE 29 GAUGE MO 2PEN NEEDLE 29 X 1/2" MO 2PEN NEEDLE 30 X 5/16" MO 2PEN NEEDLE 31 X 1/4" MO 2PEN NEEDLE 31 X 3/16" MO 2PEN NEEDLE 31 X 5/16" MO 2PRECISION 1 ML 29 X 1/2" SYRINGE MO 2PRECISION 1/2 ML 30 X 3/8" SYRINGE MO 2

Page 62: Humana Walmart-Preferred Formulary - Q1Medicare

62 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

PRECISION SURE-DOSE 0.3 ML 30 X 3/8" SYRINGE MO 2PRECISION SURE-DOSE 1/2 ML 28 X 1/2" SYRINGE MO 2PRECISION SURE-DOSE INSULIN 1 ML 28 X 1/2" SYRINGE MO 2PRECISION SURE-DOSE INSULIN 1/2 ML 29 X 1/2" SYRINGE MO 2PRECISION SUREDOSE PLUS 0.3 ML 29 X 1/2" SYRINGE MO 2PREFERRED PLUS SYRINGE 0.5 ML MO 2PREFERRED PLUS SYRINGE 1 ML MO 2PRODIGY AUTOCODE METER KIT MO 2PRODIGY CONTROL SOLUTION,HIGH MO 2PRODIGY INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2PRODIGY INSULIN SYRINGE 1 ML 28 X 1/2" MO 2PRODIGY INSULIN SYRINGE 1 ML 29 X 1/2" MO 2PRODIGY INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2PRODIGY PEN NEEDLE 29 X 1/2" MO 2PRODIGY PEN NEEDLE 31 X 3/16" MO 2PRODIGY PEN NEEDLE 31 X 5/16" MO 2PRODIGY POCKET METER KIT MO 2provisc 10 mg/ml intraocular syringe MO 4PUB INS SYRIN 0.3 ML 30GX1/2" MO 2PUB INS SYRINGE 1 ML 30GX1/2" MO 2PUB INSUL SYR 0.5 ML 30GX1/2" MO 2RELION INS SYR 0.3 ML 29GX1/2" MO 2RELION INS SYR 0.3 ML 30GX5/16 MO 2RELION INS SYR 1 ML 29GX1/2" MO 2RELION INS SYR 1 ML 30GX5/16" MO 2RELION NEEDLES 31 X 1/4" MO 2RELION SYR 0.5 ML 30GX5/16" MO 2SAFESNAP INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2SAFESNAP INSULIN SYRINGE 0.5 ML 29 X 1/2" MO 2SAFESNAP INSULIN SYRINGE 0.5 ML 30 X 5/16" MO 2SAFESNAP INSULIN SYRINGE 1 ML 28 X 1/2" MO 2SAFESNAP INSULIN SYRINGE 1 ML 29 X 1/2" MO 2supartz 10 mg/ml intra-articular syringe SP 4SURE COMFORT INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 0.3 ML 30 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2SURE COMFORT INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2SURE COMFORT INSULIN SYRINGE 1 ML 28 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 1 ML 29 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 1 ML 30 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 1 ML 30 X 5/16" MO 2

Page 63: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 63

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

SURE COMFORT INSULIN SYRINGE 1 ML 31 X 5/16" MO 2SURE COMFORT INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 1/2 ML 30 X 1/2" MO 2SURE COMFORT INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2SURE COMFORT INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2SURE COMFORT INSULIN SYRINGE U-100 1/2 ML 29 X 1/2" MO 2SURE-JECT INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2SURE-JECT INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2SURE-JECT INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2SURE-JECT INSULIN SYRINGE 1 ML 28 X 1/2" MO 2SURE-JECT INSULIN SYRINGE 1 ML 29 X 1/2" MO 2SURE-JECT INSULIN SYRINGE 1 ML 30 X 5/16" MO 2SURE-JECT INSULIN SYRINGE 1 ML 31 X 5/16" MO 2SURE-JECT INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2SURE-JECT INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2SURE-JECT INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2SURE-JECT INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2SURE-LANCE MISC MO 2SYNVISC 16MG/2 ML INTRA-ARTICULAR SYRINGE SP 4SYNVISC-ONE 48 MG/6 ML INTRA-ARTICULAR SYRINGE SP 4TERUMO INS SYRINGE U100-1 ML MO 2TERUMO INSULIN SYRINGE 0.3 ML 30 X 3/8" MO 2TERUMO INSULIN SYRINGE 0.5CC/27G 1/2 ML 27 X 1/2" MO 2TERUMO INSULIN SYRINGE 1 ML 27 X 1/2" MO 2TERUMO INSULIN SYRINGE 1 ML 28 X 1/2" MO 2TERUMO INSULIN SYRINGE 1 ML 29 X 1/2" MO 2TERUMO INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2TERUMO INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2TERUMO INSULIN SYRINGE 1/2 ML 30 X 3/8" MO 2TERUMO SURGUARD SYR 28G-1 ML MO 2TERUMO SURGUARD SYR 28G-1/2 ML MO 2TERUMO SURGUARD SYR 29G-0.3 ML MO 2TERUMO SURGUARD SYR 29G-1/2 ML MO 2TERUMO SURGUARD SYRN 29G-1 ML MO 2THINPRO INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2THINPRO INSULIN SYRINGE 0.3 ML 30 X 3/8" MO 2THINPRO INSULIN SYRINGE 0.3 ML 31 X 3/8" MO 2THINPRO INSULIN SYRINGE 0.5 ML 31 X 3/8" MO 2THINPRO INSULIN SYRINGE 1 ML 28 X 1/2" MO 2THINPRO INSULIN SYRINGE 1 ML 29 X 1/2" MO 2THINPRO INSULIN SYRINGE 1 ML 30 X 3/8" MO 2

Page 64: Humana Walmart-Preferred Formulary - Q1Medicare

64 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

THINPRO INSULIN SYRINGE 1 ML 31 X 3/8" MO 2THINPRO INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2THINPRO INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2THINPRO INSULIN SYRINGE 1/2 ML 30 X 3/8" MO 2THINSET RESERVOIR 1.8 ML MO 4THINSET RESERVOIR 3 ML MO 4TOPCARE ULTRA COMFORT 0.3 ML 29 X 1/2" SYRINGE MO 2TOPCARE ULTRA COMFORT 0.3 ML 30 X 5/16" SYRINGE MO 2TOPCARE ULTRA COMFORT 0.3 ML 31 X 5/16" SYRINGE MO 2TOPCARE ULTRA COMFORT 1 ML 29 X 1/2" SYRINGE MO 2TOPCARE ULTRA COMFORT 1 ML 30 X 5/16" SYRINGE MO 2TOPCARE ULTRA COMFORT 1 ML 31 X 5/16" SYRINGE MO 2TOPCARE ULTRA COMFORT 1/2 ML 29 X 1/2" SYRINGE MO 2TOPCARE ULTRA COMFORT 1/2 ML 30 X 5/16" SYRINGE MO 2TOPCARE ULTRA COMFORT 1/2 ML 31 X 5/16" SYRINGE MO 2TRUERESULT BLOOD GLUCOSE SYSTM KIT MO 2TRUETEST HIGH GLUCOSE CONTROL SOLN MO 2TRUETEST NORMAL GLUCOSE CONTROL SOLN MO 2ULTICARE 0.3 ML 30 X 1/2" SYRINGE MO 2ULTICARE 1 ML 30 X 1/2" SYRINGE MO 2ULTICARE 1.5 ML 22 X 1 1/2" SYRINGE MO 2ULTICARE 1/2 ML 30 X 1/2" SYRINGE MO 2ULTICARE INS SYR 1 ML 28GX1/2" MO 2ULTICARE SYRIN 0.5 ML 28GX1/2" MO 2ULTICARE U100 0.5 ML 29GX1/2" MO 2ULTIGUARD 0.3 ML 29 X 1/2" SYRINGE MO 2ULTIGUARD 0.3 ML 30 X 1/2" SYRINGE MO 2ULTIGUARD 0.3 ML 30 X 5/16" SYRINGE MO 2ULTIGUARD 0.3 ML 31 X 5/16" SYRINGE MO 2ULTIGUARD 1 ML 29 X 1/2" SYRINGE MO 2ULTIGUARD 1 ML 30 X 1/2" SYRINGE MO 2ULTIGUARD 1 ML 30 X 5/16" SYRINGE MO 2ULTIGUARD 1 ML 31 X 5/16" SYRINGE MO 2ULTIGUARD 1/2 ML 29 X 1/2" SYRINGE MO 2ULTIGUARD 1/2 ML 30 X 1/2" SYRINGE MO 2ULTIGUARD 1/2 ML 30 X 5/16" SYRINGE MO 2ULTIGUARD 1/2 ML 31 X 5/16" SYRINGE MO 2ULTILET INSULIN SYRINGE 0.3 ML 29 MO 2ULTILET INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2ULTILET INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2ULTILET INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2

Page 65: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 65

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ULTILET INSULIN SYRINGE 1 ML 29 MO 2ULTILET INSULIN SYRINGE 1 ML 29 X 1/2" MO 2ULTILET INSULIN SYRINGE 1 ML 30 X 5/16" MO 2ULTILET INSULIN SYRINGE 1 ML 31 X 5/16" MO 2ULTILET INSULIN SYRINGE 1/2 ML 29 MO 2ULTILET INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2ULTILET INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2ULTILET INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2ULTRA COMFORT INSULIN SYRINGE MO 2ULTRA COMFORT INSULIN SYRINGE 0.3 ML 29 MO 2ULTRA COMFORT INSULIN SYRINGE 0.3 ML 29 X 1/2" MO 2ULTRA COMFORT INSULIN SYRINGE 0.3 ML 30 MO 2ULTRA COMFORT INSULIN SYRINGE 0.3 ML 30 X 5/16" MO 2ULTRA COMFORT INSULIN SYRINGE 0.3 ML 31 X 5/16" MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 28 MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 28 X 1/2" MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 29 MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 29 X 1/2" MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 30 X 5/16" MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 30 X 7/16" MO 2ULTRA COMFORT INSULIN SYRINGE 1 ML 31 X 5/16" MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 28 MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 28 X 1/2" MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 29 MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 29 X 1/2" MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 30 MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 30 X 5/16" MO 2ULTRA COMFORT INSULIN SYRINGE 1/2 ML 31 X 5/16" MO 2ULTRACOMFORT 1 ML 29 X 1/2" SYRINGE MO 2ULTRACOMFORT 1 ML 30 X 1/2" SYRINGE MO 2ULTRACOMFORT 1 ML 31 X 5/16" SYRINGE MO 2ULTRACOMFORT 1/2 ML 29 X 1/2" SYRINGE MO 2ULTRACOMFORT 1/2 ML 30 X 1/2" SYRINGE MO 2ULTRACOMFORT 1/2 ML 31 X 5/16" SYRINGE MO 2ULTRACOMFORT W/ CONTAINER 1 ML 29 X 1/2" SYRINGE MO 2ULTRACOMFORT W/ CONTAINER 1 ML 30 X 1/2" SYRINGE MO 2ULTRACOMFORT W/ CONTAINER 1 ML 31 X 5/16" SYRINGE MO 2ULTRACOMFORT W/ CONTAINER 1/2 ML 29 X 1/2" SYRINGE MO 2ULTRACOMFORT W/ CONTAINER 1/2 ML 30 X 1/2" SYRINGE MO 2ULTRACOMFORT W/ CONTAINER 1/2 ML 31 X 5/16" SYRINGE MO 2

Page 66: Humana Walmart-Preferred Formulary - Q1Medicare

66 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

VANISHPOINT SYRINGE 1 ML 29 X 1/2" MO 2VISCOAT 4 %-3 % (40 MG-30 MG/ML) INTRAOCULAR SYRINGE MO 4DIAGNOSTIC AGENTSACTHAR H.P. 80 UNIT/ML INJECTION GEL SP 4 PAACTHREL 100 MCG IV SOLUTION MO 4APLISOL 5 UNIT/0.1 ML INTRADERMAL MO 4ASSURE PLATINUM STRIPS MO 2CANDIN FDA STANDARD ALLERGEN PREP INTRADERMAL MO 4CARESENS N TEST STRIPS MO 3CORTROSYN 0.25 MG SOLUTION FOR INJECTION MO 4cosyntropin 0.25 mg vial MO 2cosyntropin 0.25 mg/ml MO 2EASY TRAK GLUCOSE TEST STRIPS MO 2enlon 10 mg/ml injection MO 2FORA G71A STRIPS MO 2HISTATROL 1:10,000 VIAL MO 4LIBERTY TEST STRIPS MO 4MEMBRANEBLUE 0.15 % INTRAOCULAR SYRINGE MO 4OPTIUM EZ STRIPS MO 2RIGHTEST GS550 TEST STRIPS MO 3SMART CARESENS N TEST STRIPS MO 3THYROGEN 1.1 MG IM MO 4TUBERSOL 5 UNIT/0.1 ML INTRADERMAL MO 4VISIONBLUE 0.06 % INTRAOCULAR SYRINGE MO 4ELECTROLYTIC, CALORIC, AND WATER BALANCEAH-CHEW II CHEWABLE TABLET MO 4AHIST 12 MG TABLET MO 4allanvan-s suspension MO 4amiloride hcl 5 mg tablet MO 2amiloride hcl-hctz 5-50 mg tab MO 1AMINOACETIC ACID 1.5 % IRRIGATION SOLN MO 4AMINOSYN 10 % IV MO 4 B vs DAMINOSYN 3.5 % IV MO 4 B vs DAMINOSYN 5% IV SOLUTION MO 4 B vs DAMINOSYN 7 % IV MO 4 B vs DAMINOSYN 7 % WITH ELECTROLYTES IV MO 4 B vs DAMINOSYN 8.5 % IV MO 4 B vs DAMINOSYN 8.5 % WITH ELECTROLYTES IV MO 4 B vs DAMINOSYN II 10 % IV MO 4 B vs DAMINOSYN II 15% IV MO 4 B vs DAMINOSYN II 3.5% M-D5W IV MO 4 B vs D

Page 67: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 67

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

AMINOSYN II 4.25% IN D10W MO 4 B vs DAMINOSYN II 4.25% M-D10W IV MO 4 B vs DAMINOSYN II 4.25%-LYTE-CA-DW MO 4 B vs DAMINOSYN II 5% IN D25W IV MO 4 B vs DAMINOSYN II 7 % IV MO 4 B vs DAMINOSYN II 8.5 % IV MO 4 B vs DAMINOSYN II 8.5 % WITH ELECTROLYTES IV MO 4 B vs DAMINOSYN M 3.5 % IV MO 4 B vs DAMINOSYN-HBC 7% IV MO 4 B vs DAMINOSYN-HF 8% IV SOLUTION MO 4 B vs DAMINOSYN-PF 10 % IV MO 4 B vs DAMINOSYN-PF 7 % (SULFITE-FREE) IV MO 4 B vs DAMINOSYN-RF 5.2 % IV MO 4 B vs Dammonium chloride 5 meq/ml MO 2AMMONUL 10 %-10 % IV MO 4arbinoxa 4 mg tab MO 2arbinoxa 4 mg/5 ml oral liquid MO 2AXONA 20 GRAM/40 GRAM ORAL POWDER PACKET MO 4BRANCHAMIN 4% IV SOLUTION MO 4bromax 11 mg tablet MO 4brompheniramine-phenylephrine MO 4BROVEX 12 MG/5 ML ORAL SUSP MO 4BROVEX PB TABLET MO 4bumetanide 0.25 mg/ml vial MO 2bumetanide 0.5 mg tablet MO 1bumetanide 1 mg tablet MO 1bumetanide 2 mg tablet MO 2BUPHENYL 500 MG TAB MO 4BUPHENYL ORAL POWDER MO 4calcium acetate 667 mg capsule MO 3calcium chloride 10% syrng MO 2calcium chloride 10% vial MO 2calcium gluconate 10% vial MO 2 B vs DCARBAGLU 200 MG TAB SP 4 PAcarbinoxamine 4 mg/5 ml liquid MO 2carbinoxamine maleate 4 mg tab MO 2cetirizine hcl 1 mg/ml syrup MO 2 QL (300 per 30 days)chlorothiazide 250 mg tablet MO 2chlorothiazide 500 mg tablet MO 2chlorothiazide sod 500 mg vial MO 2chlorphen-pse drops MO 4

Page 68: Humana Walmart-Preferred Formulary - Q1Medicare

68 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

chlorthalidone 25 mg tablet MO 2chlorthalidone 50 mg tablet MO 2clemastine 0.67 mg/5 ml syrup MO 2clemastine fum 2.68 mg tab MO 2CLINIMIX 2.75%/D5 SULFITE FREE IV MO 4 B vs DCLINIMIX 4.25%/D10 SULFITE FREE IV MO 4 B vs DCLINIMIX 4.25%/D20 SULFITE FREE IV MO 4 B vs DCLINIMIX 4.25%/D25 SULFITE FREE IV MO 4 B vs DCLINIMIX 4.25%/D5 SULFITE FREE IV MO 4 B vs DCLINIMIX 5%/D15 SULFITE FREE IV MO 4 B vs DCLINIMIX 5%/D20 SULFITE FREE IV MO 4 B vs DCLINIMIX 5%/D25 SULFITE FREE IV MO 4 B vs DCLINIMIX E 2.75%/D10 SULFITE FREE IV MO 4 B vs DCLINIMIX E 2.75%/D5 SULFITE FREE IV MO 4 B vs DCLINIMIX E 4.25%/D10 SULFITE FREE IV MO 4 B vs DCLINIMIX E 4.25%/D25 SULFITE FREE IV MO 4 B vs DCLINIMIX E 4.25%/D5 SULFITE FREE IV MO 4 B vs DCLINIMIX E 5%/D15 SULFITE FREE IV MO 4 B vs DCLINIMIX E 5%/D20 SULFITE FREE IV MO 4 B vs DCLINIMIX E 5%/D25 SULFITE FREE IV MO 4 B vs Dconstulose 10 gram/15 ml oral soln MO 2cpm-pe-msc syrup MO 2cpm-pse drops MO 4cytra k crystals 3,300 mg-1,002 mg oral packet MO 4cytra-3 550 mg-500 mg-334 mg/5 ml oral soln MO 2cytra-k 1,100 mg-334 mg/5 ml oral soln MO 2d10%-1/2ns soln/excel cont MO 2d5%-1/2ns-kcl 10 meq/l iv sol MO 2d5%-1/2ns-kcl 30 meq/l iv sol MO 2d5%-1/2ns-kcl 40 meq/l iv sol MO 2d5%-1/4ns-kcl 10 meq/l iv sol MO 2d5%-1/4ns-kcl 30 meq/l iv sol MO 2d5%-1/4ns-kcl 40 meq/l iv sol MO 2d5w-kcl 30 meq/l iv solution MO 2dex10%-electrolyte-48 soln MO 2dextrose 10% ampul MO 2dextrose 10%-1/4ns iv soln MO 2dextrose 10%-ns iv solution MO 2dextrose 10%-water iv solution MO 2dextrose 2.5%-1/2ns iv soln MO 2dextrose 2.5%-water iv soln MO 2

Page 69: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 69

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

dextrose 20%-water iv soln MO 2dextrose 25%-water syringe MO 2dextrose 30%-water iv soln MO 2dextrose 40%-water iv soln MO 2dextrose 5%-1/2ns iv solution MO 2dextrose 5%-1/3ns iv solution MO 2dextrose 5%-1/4ns iv solution MO 2dextrose 5%-electrolyte 48 MO 2dextrose 5%-lr iv solution MO 2dextrose 5%-ns iv solution MO 2dextrose 5%-ringers iv soln MO 2dextrose 5%-water iv soln MO 2dextrose 5%-water vial MO 2dextrose 50%-water abboject MO 2dextrose 50%-water vial MO 2dextrose 70%-water iv soln MO 2DICEL SUSPENSION MO 4DIURIL 250 MG/5 ML ORAL SUSP MO 3duradryl syrup MO 4DYRENIUM 100 MG CAP MO 4DYRENIUM 50 MG CAP MO 4ed chlorped d pediatric drops MO 4effer-k 25 meq effervescent tab MO 2eliphos 667 mg tab MO 2entre-b suspension MO 4enulose 10 gram/15 ml oral soln MO 2epiklor 20 meq oral packet MO 2epiklor 25 meq oral packet MO 2EXTRANEAL PERITONEAL DIALYSIS CA+ (3.5 MEQ/L)&LOW MAG (0.5) MO 4fexofenadine hcl 180 mg tablet MO 3 QL (30 per 30 days)fexofenadine hcl 30 mg tablet MO 3 QL (60 per 30 days)fexofenadine hcl 60 mg tablet MO 3 QL (60 per 30 days)fexofenadine-pse er 180-240 tb MO 3 QL (30 per 30 days)fexofenadine-pse er 60-120 tab MO 3 QL (60 per 30 days)FREAMINE HBC 6.9 % IV MO 4 B vs DFREAMINE III 10 % IV MO 4 B vs DFREAMINE III 3 % WITH ELECTROLYTES IV MO 4 B vs DFREAMINE III 8.5 % IV MO 4 B vs Dfurosemide 10 mg/ml solution MO 2furosemide 10 mg/ml syringe MO 2furosemide 10 mg/ml vial MO 2

Page 70: Humana Walmart-Preferred Formulary - Q1Medicare

70 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

furosemide 20 mg tablet MO 1furosemide 40 mg tablet MO 1furosemide 40 mg/5 ml soln MO 2furosemide 80 mg tablet MO 1generlac 10 gram/15 ml oral soln MO 2HEPATAMINE 8% IV MO 4 B vs DHEPATASOL 8 % IV MO 4 B vs DHISTEX SR CAPLET MO 4hydrochlorothiazide 12.5 mg cp MO 1hydrochlorothiazide 12.5 mg tb MO 2hydrochlorothiazide 25 mg tab MO 1hydrochlorothiazide 50 mg tab MO 1HYPERLYTE-CR 25 MEQ-20 MEQ-5 MEQ/20 ML IV MO 4indapamide 1.25 mg tablet MO 1indapamide 2.5 mg tablet MO 1INPERSOL WITH 1.5% DEXTROSE MO 4inpersol with 4.25% dextrose MO 4INTRALIPID 10% IV FAT EMUL MO 4 B vs DINTRALIPID 20 % IV MO 4 B vs DINTRALIPID 30 % IV MO 4 B vs DIONOSOL-B IN D5W IV MO 4IONOSOL-MB IN D5W IV MO 4ISOLYTE-H IN D5W IV MO 4ISOLYTE-M IN D5W IV MO 4ISOLYTE-P IN D5W IV MO 4ISOLYTE-S IN D5W IV MO 4ISOLYTE-S IV MO 4ISOLYTE-S PH 7.4 IV MO 4k-effervescent 25 meq tab MO 2K-PHOS MF 155 MG-350 MG TAB MO 4K-PHOS NO 2 305 MG-700 MG TAB MO 4K-PHOS ORIGINAL 500 MG SOLUBLE TAB MO 4K-PHOS-NEUTRAL 250 MG TAB MO 4k-prime 25 meq tablet eff MO 2kalexate oral powder MO 4KAON-CL ER 10 MEQ TABLET MO 2kcl 10 meq in d5w-1/3 ns MO 2kcl 20 meq in d5w solution MO 2kcl 20 meq in d5w-1/2 ns MO 2kcl 20 meq in d5w-1/4 ns MO 2kcl 20 meq in d5w-lact ringer MO 2

Page 71: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 71

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

kcl 20 meq in d5w-ns MO 2kcl 20 meq-ns 1,000 ml iv soln MO 2kcl 40 meq in d5w solution MO 2kcl 40 meq in d5w-lact ringer MO 2kcl 40 meq in d5w-nacl 0.9% MO 2kcl 40 meq-ns 1,000 ml iv soln MO 2kionex 15 g/60 ml oral susp MO 3kionex oral powder MO 3KLOR-CON 10 10 MEQ TAB MO 2klor-con 20 meq oral packet MO 2KLOR-CON 25 MEQ ORAL PACKET MO 2KLOR-CON 8 MEQ TAB MO 2klor-con m10 10 meq tab MO 2klor-con m15 15 meq tab MO 2klor-con m20 20 meq tab MO 2klor-con/ef 25 meq effervescent tab MO 2l-cysteine 50 mg/ml vial MO 2lactated ringers injection MO 2lactated ringers irrigation MO 2lactulose 10 gm/15 ml solution MO 1levocetirizine 5 mg tablet MO 3 QL (30 per 30 days)LIPOSYN II 10 % IV MO 4 B vs DLIPOSYN II 20 % IV MO 4 B vs DLIPOSYN III 10 % IV MO 4 B vs DLIPOSYN III 20 % IV MO 4 B vs DLIPOSYN III 30 % IV MO 4 B vs DMAGNEBIND 400 400 MG-200 MG-1 MG TAB MO 4mannitol 10% iv solution MO 2mannitol 15% iv solution MO 2mannitol 20% iv solution MO 2mannitol 25% vial MO 2mannitol 5% iv solution MO 2methyclothiazide 5 mg tablet MO 2metolazone 10 mg tablet MO 2metolazone 2.5 mg tablet MO 2metolazone 5 mg tablet MO 2MICRO-K 10 MEQ CAP MO 4MICRO-K 8 MEQ CAP MO 4monoject prefill advanced 0.9 % sodium chloride syringe MO 2monoject prefill saline flush syringe MO 2myci chlor-tan 8 mg caplet MO 2

Page 72: Humana Walmart-Preferred Formulary - Q1Medicare

72 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

nalex a 12 suspension MO 4NEPHRAMINE 5.4 % IV MO 4 B vs DNEUT 4 % IV MO 4NOREL SR TABLET MO 4NORMOSOL-M IN D5W IV MO 4NORMOSOL-R IN D5W IV MO 4NORMOSOL-R IV MO 4NORMOSOL-R PH 7.4 IV MO 4NUTRILYTE 25 MEQ-40.6 MEQ-5 MEQ/20 ML IV MO 4nutrilyte ii 35 meq-20 meq-5 meq/20 ml iv MO 4ny-tannic tablet MO 2ORACIT 490 MG-640 MG/5 ML ORAL SOLN MO 4OSMITROL 10 % IV MO 4OSMITROL 15 % IV MO 4OSMITROL 20 % IV MO 4OSMITROL 5 % IV MO 4palgic 4 mg tab MO 2palgic 4 mg/5 ml oral liquid MO 2pe-cpm-msn liquid MO 2phenadoz 12.5 mg rectal suppository MO 2phenadoz 25 mg rectal suppository MO 2PHOSLYRA 667 MG (169 MG CALCIUM)/5 ML ORAL SOLN MO 4phospha 250 neutral 250 mg tab MO 2PHYSIOLYTE 140 MEQ-5 MEQ-3 MEQ-98 MEQ/L IRRIGATION SOLN MO 2PHYSIOSOL IRRIGATION 140 MEQ-5 MEQ-3 MEQ-98 MEQ/L SOLN MO 2PLASMA-LYTE 148 IV MO 4PLASMA-LYTE A IV MO 4PLASMA-LYTE-56 IN D5W IV MO 4potassium 25 meq tablet eff MO 2potassium acet 2 meq/ml vial MO 2potassium acet 4 meq/ml vial MO 2potassium cit-citric acid sln MO 2potassium citrate er 10 meq tb MO 3potassium citrate er 5 meq tab MO 3potassium cl 10 meq/100 ml sol MO 2potassium cl 10 meq/50 ml sol MO 2potassium cl 10% (20 meq/15 ml MO 1potassium cl 2 meq/ml syrng MO 2potassium cl 2 meq/ml vial MO 2potassium cl 20 meq-0.45% nacl MO 2potassium cl 20 meq/100 ml sol MO 2

Page 73: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 73

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

potassium cl 20 meq/50 ml sol MO 2potassium cl 20% (40 meq/15 ml MO 2potassium cl 25 meq tab eff MO 2potassium cl 30 meq/100 ml sol MO 2potassium cl 40 meq/100 ml sol MO 2potassium cl er 10 meq capsule MO 2potassium cl er 10 meq tablet MO 2potassium cl er 20 meq tablet MO 2potassium cl er 8 meq capsule MO 2potassium cl er 8 meq tablet MO 2potassium ph 3mm/ml vial MO 2PREMASOL 10 % IV MO 2 B vs DPREMASOL 6 % IV MO 2 B vs DPRISMASOL BGK CA (2.5 MEQ/L)-MG(1.5MEQ/L) MO 4PRISMASOL BGK K (2 MEQ/L)-CA (3.5)-MG (1) MO 4PRISMASOL BGK K (2 MEQ/L)-MG(1MEQ/L) MO 4PRISMASOL BGK K (4 MEQ/L)-CA (2.5)-MG (1.5) MO 4probenecid 500 mg tablet MO 2probenecid-colchicine tabs MO 2PROCALAMINE 3% IV MO 4 B vs Dpromethegan 12.5 mg rectal suppository MO 3promethegan 25 mg rectal suppository MO 3promethegan 50 mg rectal suppository MO 3PROTID ER 8 MG-40 MG-500 MG TAB MO 4PYRIL D 5 MG-16 MG/5 ML ORAL SUSP MO 4pyril-chlor-phen tablet MO 4r-tanna tablet MO 4RADIOGARDASE 0.5 G CAPSULE MO 4RENACIDIN 6.602 G-0.198 G/100 ML IRRIGATION SOLN MO 4RENAMIN 6.5% IV SOLUTION MO 4 B vs DRENVELA 0.8 GRAM ORAL PWPK MO 3 QL (540 per 30 days)RENVELA 2.4 GRAM ORAL PWPK MO 3 QL (180 per 30 days)RENVELA 800 MG TAB MO 3 QL (540 per 30 days)RESECTISOL 5 % URETHRAL MO 4ringer’s iv solution MO 2ringers irrigation solution MO 2ru-tuss tablet MO 4RYNATAN PEDIATRIC CHEWABLE TAB MO 4saline 0.45% soln-excel con MO 2saline flush syringe MO 2SAMSCA 15 MG TAB SP 4 QL (60 per 30 days)

Page 74: Humana Walmart-Preferred Formulary - Q1Medicare

74 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

SAMSCA 30 MG TAB SP 4 QL (60 per 30 days)SEMPREX-D 8 MG-60 MG CAP MO 4sinuhist tablet MO 4sodium acetate 2 meq/ml vial MO 2sodium acetate 4 meq/ml vial MO 2sodium bicarb 4.2% abbjct MO 2sodium bicarb 4.2% vial MO 2sodium bicarb 7.5% abboject MO 2sodium bicarb 7.5% vial MO 2sodium bicarb 8.4% abboject MO 2sodium bicarb 8.4% vial MO 2sodium chloride 0.45% irrig MO 2sodium chloride 0.45% soln MO 2sodium chloride 0.9% irrig. MO 2sodium chloride 0.9% soln. MO 2sodium chloride 0.9% solution MO 2sodium chloride 0.9% syringe MO 2sodium chloride 10% vial MO 2sodium chloride 3% iv soln MO 2sodium chloride 3% vial MO 2sodium chloride 4 meq/ml vl MO 2sodium chloride 5% iv soln MO 2sodium cl 2.5 meq/ml vial MO 2SODIUM EDECRIN 50 MG IV SOLUTION MO 3sodium lactate 1/6molar inj MO 2sodium lactate 5 meq/ml vial MO 2sodium phosphate 3mm/ml vial MO 2sodium polystyrene sulf pwd MO 3sorbitol-mannitol irrig MO 2SPS 30 GRAM/120 ML ENEMA MO 4sterile water for irrigation MO 2SUDAL 12 TANNATE CHEWABLE TAB MO 4syrex sodium chloride 0.9% syringe MO 2tanahist d drops MO 4taron-crystals 3,300 mg-1,002 mg oral packet MO 2THAM 36 MG/ML (0.3 M) IV MO 4torsemide 10 mg tablet MO 2torsemide 100 mg tablet MO 2torsemide 20 mg tablet MO 2torsemide 20 mg/2 ml vial MO 2torsemide 5 mg tablet MO 2

Page 75: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 75

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

torsemide 50 mg/5 ml vial MO 2TPN ELECTROLYTES 35 MEQ-20 MEQ-5 MEQ/20 ML IV MO 4TPN ELECTROLYTES II 18 MEQ-18 MEQ-5 MEQ/20 ML IV MO 4TRAVASOL 10 % IV MO 4 B vs Dtriamterene-hctz 37.5-25 mg cp MO 1triamterene-hctz 37.5-25 mg tb MO 1triamterene-hctz 50-25 mg cap MO 2triamterene-hctz 75-50 mg tab MO 1tricitrates 550 mg-500 mg-334 mg/5 ml oral soln MO 2tricitrates oral solution MO 2trigofen drops MO 4trital sr tablet MO 4TROPHAMINE 10 % IV MO 4 B vs DTROPHAMINE 6% IV MO 4 B vs DULTRABAG/DIANEAL PD-2/2.5% DEX CA+ (3.5 MEQ/L)&LOW MAG (0.5) MO

4

ULTRABAG/DIANEAL PD-2/4.25%DEX CA+ (3.5 MEQ/L)&LOW MAG (0.5) MO

4

vaso dose pack tablet MO 4vis-phos n 250 mg tablet MO 2VOLUVEN 6 % IV MO 4ENZYMESADAGEN 250 UNIT/ML IM SP 4ALDURAZYME 2.9 MG/5 ML IV SP 4AMPHADASE 150 UNITS/ML VIAL MO 4CEREDASE 80 UNIT/ML IV SP 4 PACEREZYME 200 UNIT IV SOLUTION SP 4 PACEREZYME 400 UNIT IV SOLUTION SP 4 PAELAPRASE 6 MG/3 ML IV SP 4 PAELITEK 1.5 MG IV SOLUTION MO 4ELITEK 7.5 MG IV SOLUTION MO 4FABRAZYME 35 MG IV SOLUTION SP 4 PAFABRAZYME 5 MG IV SOLUTION SP 4 PAHYLENEX 150 UNIT/ML INJECTION MO 4LUMIZYME 50 MG IV SOLUTION SP 4 PAMYOZYME 50 MG IV SOLUTION SP 4 PANAGLAZYME 5 MG/5 ML IV SP 4PULMOZYME 1 MG/ML SOLN FOR INHALATION SP 4 B vs D,QL (150 per 30 days)VITRASE 200 UNIT/ML INJECTION MO 4VITRASE 6,200 UNITS VIAL MO 4VPRIV 400 UNIT SOLUTION SP 4 PA

Page 76: Humana Walmart-Preferred Formulary - Q1Medicare

76 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

EYE, EAR, NOSE AND THROAT (EENT) PREPS.acetasol hc 1 %-2 % ear drops MO 3acetazolamide 125 mg tablet MO 2acetazolamide 250 mg tablet MO 2acetazolamide er 500 mg cap MO 2acetazolamide sod 500 mg vial MO 2acetic acid 2% ear solution MO 2acetic acid-aluminum drops MO 2acetic acid-hc ear drops MO 3ACUVAIL 0.45 % EYE DROPPERETTE MO 4ak-con 0.1 % eye drops MO 2ak-poly-bac 500 unit-10,000 unit/g eye ointment MO 2ak-tob 0.3 % eye drops MO 2akorn balanced salt intraocular MO 2AKTEN (PF) 3.5 % EYE GEL MO 4allersol 0.1% eye drops MO 2altafluor 0.25 %-0.4 % eye drops MO 2altafrin 10 % eye drops MO 2altafrin 2.5 % eye drops MO 2antipyrine-benzocaine ear drop MO 2APHTHASOL 5% PASTE MO 4apraclonidine hcl 0.5% drops MO 2atropine 1% eye drops MO 2atropine 1% eye ointment MO 2ATROPINE-CARE 1 % EYE DROPS MO 2aurodex 5.4 %-1.4 % ear drops MO 2auroguard 5.4 %-1.4 % ear drops MO 2AZASITE 1 % EYE DROPS MO 3azelastine hcl 0.05% drops MO 3AZOPT 1 % EYE DROPS MO 3bacitracin 500 unit/gm ointmnt MO 2bacitracin-polymyxin eye oint MO 2balanced salt intraocular MO 2benzotic ear drops MO 2BESIVANCE 0.6 % EYE DROPS MO 3BETADINE OPHTHALMIC PREP 5 % SOLN MO 4betaxolol hcl 0.5% eye drop MO 3BETIMOL 0.25 % EYE DROPS MO 4BETIMOL 0.5 % EYE DROPS MO 4BLEPHAMIDE 10 %-0.2 % EYE DROPS MO 4BLEPHAMIDE S.O.P. 10 %-0.2 % EYE OINTMENT MO 4

Page 77: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 77

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

borofair 2 % ear drops MO 2brimonidine 0.2% eye drop MO 3brimonidine tartrate 0.15% drp MO 3BSS INTRAOCULAR MO 4BSS PLUS INTRAOCULAR MO 4carteolol hcl 1% eye drops MO 2CELLUGEL 2 % INTRAOCULAR SYRINGE MO 4chlorhexidine 0.12% rinse MO 1chloroxylenol-pramoxine hcl MO 2ciprofloxacin 0.3% eye drop MO 2cocaine 10% solution MO 2cocaine 4% solution MO 2cortomycin ear solution MO 2cortomycin ear suspension MO 2cortomycin eye ointment MO 2CRESYLATE 25 % EAR DROPS MO 4CYCLOGYL 0.5 % EYE DROPS MO 4CYCLOGYL 2 % EYE DROPS MO 4CYCLOMYDRIL 0.2 %-1 % EYE DROPS MO 4cyclopentolate 1% eye drops MO 2cylate 1% eye drops MO 2dexamethasone 0.1% eye drop MO 2dexasol 0.1 % eye drops MO 2diclofenac 0.1% eye drops MO 2dorzolamide hcl 2% eye drops MO 3 QL (10 per 30 days)dorzolamide-timolol eye drops MO 3 QL (10 per 30 days)doxycycline hyclate 20 mg tab MO 2DUREZOL 0.05 % EYE DROPS MO 4ELESTAT 0.05 % EYE DROPS MO 4epinastine hcl 0.05% eye drops MO 3erythromycin eye ointment MO 1flunisolide 0.025% spray MO 3 QL (50 per 30 days)flunisolide 29 mcg-0.025% spr MO 3 QL (50 per 30 days)fluorescein-benoxinate eye drp MO 2fluorescein-proparacaine drops MO 2fluorometholone 0.1% drops MO 2flurate 0.25 %-0.4 % eye drops MO 2flurbiprofen 0.03% eye drop MO 2flurox 0.25 %-0.4 % eye drops MO 2fluticasone prop 50 mcg spray MO 2 QL (16 per 30 days)FML FORTE 0.25 % EYE DROPS MO 4

Page 78: Humana Walmart-Preferred Formulary - Q1Medicare

78 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

FML S.O.P. 0.1 % EYE OINTMENT MO 4FRESHKOTE 2 %-0.9 %-1.8 % EYE DROPS MO 4GARAMYCIN 0.3 % (3 MG/G) EYE OINTMENT MO 3GARAMYCIN 0.3 % EYE DROPS MO 3gentak 0.3 % (3 mg/g) eye ointment MO 3gentak 3 mg/ml eye drops MO 3gentamicin 3 mg/gm eye oint MO 2gentamicin 3 mg/ml eye drops MO 1gentasol 3 mg/ml eye drops MO 2homatropaire 5 % eye drops MO 2homatropine hbr 5% eye drop MO 4ILOTYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT MO 3INTROL 75 % ORAL SOLN MO 4ipratropium 0.03% spray MO 2 QL (30 per 30 days)ipratropium 0.06% spray MO 2 QL (45 per 30 days)ISOPTO HYOSCINE 0.25 % EYE DROPS MO 4ISTALOL 0.5 % EYE DROPS MO 4ketorolac 0.4% ophth solution MO 2ketorolac 0.5% ophth solution MO 2LACRISERT 5 MG EYE INSERTS MO 4latanoprost 0.005% eye drops MO 2 QL (3 per 25 days)levobunolol 0.25% eye drops MO 2levobunolol 0.5% eye drops MO 1levofloxacin 0.5% eye drops MO 3lidocaine 2% viscous soln MO 2lidocaine hcl 2% jelly MO 2lidocaine hcl 4% solution MO 2lidocaine viscous 2 % mucosal soln MO 2LOTEMAX 0.5 % EYE DROPS MO 4LOTEMAX 0.5 % EYE OINTMENT MO 4LUMIGAN 0.01 % EYE DROPS MO 3 QL (3 per 25 days)LUMIGAN 0.03 % EYE DROPS MO 3 QL (3 per 25 days)MAXITROL 3.5 MG-10,000 UNIT/G-0.1 % EYE OINTMENT MO 3MAXITROL 3.5 MG/ML-10,000 UNIT/ML-0.1% EYE DROPS MO 3methadex eye drops MO 2methazolamide 25 mg tablet MO 2methazolamide 50 mg tablet MO 2metipranolol 0.3% eye drops MO 2MIOCHOL-E 1:100 (20 MG/2 ML) INTRAOCULAR KIT MO 4MIOSTAT 0.01 % INTRAOCULAR MO 4MOXEZA 0.5 % EYE DROPS MO 4

Page 79: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 79

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

MUROCOLL-2 EYE DROPS MO 4mydral 0.5% eye drops MO 2mydral 1% eye drops MO 2NASONEX 50 MCG/ACTUATION SPRAY MO 3 QL (34 per 30 days)neo-bacit-poly-hc eye ointment MO 2neo-polycin 3.5 mg-400 unit-10,000 unit/g eye ointment MO 2neofrin 10 % eye drops MO 2neofrin 2.5 % eye drops MO 2neomyc-bacit-polymix eye ointm MO 2neomyc-polym-dexamet eye ointm MO 1neomyc-polym-dexameth eye drop MO 1neomyc-polym-gramicid eye drop MO 2neomycin-poly-hc eye drops MO 2neomycin-polymixin-hc ear susp MO 2neomycin-polymyxin-hc ear soln MO 2neosporin 1.75 mg-10k unit-0.025 mg/ml eye drops MO 2NEVANAC 0.1 % EYE DROPS MO 4ocucoat 2 % intraocular syringe MO 4ofloxacin 0.3% ear drops MO 2ofloxacin 0.3% eye drops MO 2omedia otic 20% ear drops MO 4ORASEP 600 MG-30 MG-30MG-300MG/30 ML MUCOSAL SOLN MO 4ORASEP MUCOSAL SPRAY MO 4otic edge otic solution MO 2oticin 0.1 %-1 % ear drops MO 2otogesic ear drops MO 2parcaine 0.5 % eye drops MO 2PAREMYD 1 %-0.25 % EYE DROPS MO 4PATADAY 0.2 % EYE DROPS MO 3PATANOL 0.1 % EYE DROPS MO 4periogard 0.12 % mouthwash MO 2phenylephrine 10% eye drops MO 2phenylephrine 2.5% eye drop MO 2PHOSPHOLINE IODIDE 0.125 % EYE DROPS MO 4pilocarpine 0.5% eye drops MO 3pilocarpine 1% eye drops MO 1pilocarpine 2% eye drops MO 1pilocarpine 3% eye drops MO 3pilocarpine 4% eye drops MO 3pilocarpine 6% eye drops MO 3PILOPINE HS 4 % EYE GEL MO 4

Page 80: Humana Walmart-Preferred Formulary - Q1Medicare

80 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

pinnacaine 20 % ear drops MO 4poly-dex eye drops MO 2poly-dex eye ointment MO 2polycin-b eye ointment MO 2polymyxin b-tmp eye drops MO 1POLYTRIM 0.1 %-10,000 UNIT/ML EYE DROPS MO 2PRED MILD 0.12 % EYE DROPS MO 4PRED-G 0.3 %-1 % EYE DROPS MO 4PRED-G S.O.P. 0.3 %-0.6 % EYE OINTMENT MO 4prednisol 1% eye drops MO 2prednisolone ac 1% eye drop MO 2prednisolone sod 1% eye drop MO 2proparacaine 0.5% eye drops MO 2re benzotic 20% otic drops MO 4RESTASIS 0.05 % EYE DROPPERETTE MO 3romycin 5 mg/gram (0.5 %) eye ointment MO 2sulf-pred 10-0.23% eye drops MO 2sulfac 10% eye drops MO 2sulfacetamide 10% eye drops MO 1sulfamide 10 % eye drops MO 2TERRAMYCIN WITH POLYMYXIN B 5 MG-10,000 UNIT/GRAM EYEOINTMENT MO

4

tetcaine 0.5 % eye drops MO 2tetracaine 0.5% eye drops MO 2tetracaine hcl 0.5% eye soln MO 2TETRAVISC 0.5 % VISCOUS EYE DROPPERETTE MO 4TETRAVISC 0.5 % VISCOUS EYE DROPS MO 4TETRAVISC FORTE 0.5 % DROPPERETTE, HYPERVISCOUS MO 4TETRAVISC FORTE 0.5 % DROPS, HYPERVISCOUS MO 4timolol 0.25% eye drops MO 1timolol 0.25% gfs gel-solution MO 3timolol 0.5% eye drops MO 1timolol 0.5% gfs gel-solution MO 3TIMOPTIC OCUDOSE 0.25 % EYE DROPPERETTE MO 4TIMOPTIC OCUDOSE 0.5 % EYE DROPPERETTE MO 4TOBRADEX 0.3 %-0.1 % EYE OINTMENT MO 4TOBRADEX ST 0.3 %-0.05 % EYE DROPS MO 4tobramycin 0.3% eye drops MO 1tobramycin-dexameth ophth susp MO 3tobrasol 0.3 % eye drops MO 2TOBREX 0.3 % EYE OINTMENT MO 4

Page 81: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 81

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

TRAVATAN Z 0.004 % EYE DROPS MO 3 QL (3 per 25 days)treagan otic 5.4 %-1.4 % ear drops MO 2trifluridine 1% eye drops MO 3tropicacyl 0.5 % eye drops MO 2tropicacyl 1 % eye drops MO 2tropicamide 0.5% eye drops MO 2tropicamide 1% eye drops MO 2TYZINE 0.05 % NASAL DROPS MO 3TYZINE 0.1 % NASAL DROPS MO 3TYZINE 0.1 % NASAL SPRAY MO 3VERAMYST 27.5 MCG/ACTUATION NASAL SPRAY MO 3 QL (10 per 30 days)VIGAMOX 0.5 % EYE DROPS MO 4ZINOTIC ES (WITH GLYCERIN) 0.1 %-1 %-1 %-1 % EAR DROPS MO 4ZIRGAN 0.15 % EYE GEL MO 4 QL (5 per 30 days)ZYLET 0.3 %-0.5 % EYE DROPS MO 4ZYMAXID 0.5 % EYE DROPS MO 3 QL (3 per 25 days)GASTROINTESTINAL DRUGSAMITIZA 24 MCG CAP MO 4AMITIZA 8 MCG CAP MO 4APRISO 0.375 GRAM 24 HR CAP MO 4 QL (120 per 30 days)balsalazide disodium 750 mg cp MO 3CANASA 1,000 MG RECTAL SUPPOSITORY MO 3 QL (30 per 30 days)CHENODAL 250 MG TAB SP 4cimetidine 150 mg/ml vial MO 2cimetidine 200 mg tablet MO 2cimetidine 300 mg tablet MO 2cimetidine 300 mg/5 ml soln MO 2cimetidine 400 mg tablet MO 2cimetidine 800 mg tablet MO 1compro 25 mg rectal suppository MO 2CREON 12,000-38,000-60,000 UNIT CAP MO 3CREON 24,000-76,000-120,000 UNIT CAP MO 3CREON 3,000-9,500-15,000 UNIT CAP MO 3CREON 6,000-19,000-30,000 UNIT CAP MO 3dimenhydrinate 50 mg/ml vial MO 2diphenoxylate-atropine liq MO 2 PAdiphenoxylate-atropine tablet MO 2 PAdronabinol 10 mg capsule MO 3 B vs D,QL (120 per 30 days)dronabinol 2.5 mg capsule MO 3 B vs D,QL (120 per 30 days)dronabinol 5 mg capsule MO 3 B vs D,QL (120 per 30 days)EMEND 115 MG IV SOLUTION MO 4 PA,QL (2 per 28 days)

Page 82: Humana Walmart-Preferred Formulary - Q1Medicare

82 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

EMEND 125 MG (1)-80 MG (1)-80 MG(1) CAPS IN DOSE PACK MO 4 B vs D,QL (6 per 28 days)EMEND 125 MG CAP MO 4 B vs D,QL (2 per 28 days)EMEND 150 MG IV SOLUTION SP 4 PA,QL (2 per 28 days)EMEND 40 MG CAP MO 4 B vs D,QL (2 per 28 days)EMEND 80 MG CAP MO 4 B vs D,QL (4 per 28 days)famotidine 10 mg/ml vial MO 2famotidine 20 mg piggyback MO 2famotidine 20 mg tablet MO 1famotidine 20 mg/2 ml vial MO 2famotidine 40 mg tablet MO 2famotidine 40 mg/5 ml susp MO 2gavilyte-c 240 g-22.72 g-6.72 g-5.84 g oral solution MO 2gavilyte-g 236 g-22.74 g-6.74 g-5.86 g oral solution MO 2gavilyte-n 420 g oral solution MO 2GOLYTELY 227.1 G-21.5 G-6.36 G-5.53 G PACKET MO 3GOLYTELY 236 G-22.74 G-6.74 G-5.86 G ORAL SOLUTION MO 3granisetron hcl 0.1 mg/ml vial MO 3granisetron hcl 1 mg tablet MO 3 B vs D,QL (28 per 28 days)granisetron hcl 1 mg/ml vial MO 3granisetron hcl 4 mg/4 ml vial MO 3 QL (4 per 28 days)granisol 1 mg/5 ml oral soln MO 3 B vs D,QL (150 per 28 days)HALFLYTELY-BISACODYL BOWEL KIT MO 3HALFLYTELY-BISACODYL W-FLAVOR PACK 5 MG-210 GRAM ORAL KIT MO 3lansoprazole dr 15 mg capsule MO 3 QL (30 per 30 days)lansoprazole dr 30 mg capsule MO 3 QL (30 per 30 days)lansoprazole odt 15 mg tablet MO 3 QL (30 per 30 days)lansoprazole odt 30 mg tablet MO 3 QL (30 per 30 days)LIALDA 1.2 G TAB MO 4 QL (120 per 30 days)loperamide 2 mg capsule MO 2LOTRONEX 0.5 MG TAB MO 3 QL (60 per 30 days)LOTRONEX 1 MG TAB MO 3 QL (60 per 30 days)mesalamine 4 gm/60 ml enema MO 2 QL (1800 per 30 days)mesalamine 4 gm/60 ml kit MO 3 QL (1800 per 30 days)metoclopramide 10 mg tablet MO 1metoclopramide 5 mg tablet MO 2metoclopramide 5 mg/5 ml soln MO 1metoclopramide 5 mg/ml syr MO 2metoclopramide 5 mg/ml vial MO 2misoprostol 100 mcg tablet MO 2misoprostol 200 mcg tablet MO 2MOVIPREP 100 G-7.5 G-2.691 G-4.7 G ORAL POWDER PACKET MO 3

Page 83: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 83

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

nizatidine 15 mg/ml solution MO 2NULYTELY WITH FLAVOR PACKS 420 G ORAL SOLUTION MO 3NUTRESTORE 5 GRAM ORAL POWDER PACKET MO 4omeprazole dr 10 mg capsule MO 2 QL (30 per 30 days)omeprazole dr 20 mg capsule MO 2 QL (60 per 30 days)omeprazole dr 40 mg capsule MO 2 QL (30 per 30 days)ondansetron 32 mg/50 ml bag MO 2ondansetron 4 mg/5 ml solution MO 3 B vs D,QL (450 per 30 days)ondansetron 40 mg/20 ml vial MO 3ondansetron hcl 24 mg tablet MO 3 B vs D,QL (30 per 30 days)ondansetron hcl 32 mg/50 ml bg MO 2ondansetron hcl 4 mg tablet MO 3 B vs D,QL (90 per 30 days)ondansetron hcl 4 mg/2 ml syr MO 3ondansetron hcl 4 mg/2 ml vial MO 3ondansetron hcl 8 mg tablet MO 3 B vs D,QL (90 per 30 days)ondansetron odt 4 mg tablet MO 2 B vs D,QL (90 per 30 days)ondansetron odt 8 mg tablet MO 2 B vs D,QL (90 per 30 days)OSMOPREP 1.5 GRAM (1.102-0.398) TAB MO 3PANCREAZE 10,500-25,000-43,750 UNIT CAP MO 4PANCREAZE 16,800-40,000-70,000 UNIT CAP MO 4PANCREAZE 21,000-37,000-61,000 UNIT CAP MO 4PANCREAZE 4,200-10,000-17,500 UNIT CAP MO 4pancrelipase 5000 5,000-17,000-27,000 unit cap MO 4pantoprazole sod dr 20 mg tab MO 2 QL (30 per 30 days)pantoprazole sod dr 40 mg tab MO 2 QL (30 per 30 days)paregoric liquid MO 2peg 3350 electrolyte soln MO 2peg-3350 and electrolytes soln MO 2peg-3350 with flavor packs 420 g oral solution MO 2peg-3350 with flavor packs sol MO 2polyethylene glycol 3350 powd MO 2prochlorperazine 10 mg tab MO 1 B vs Dprochlorperazine 25 mg supp MO 2prochlorperazine 5 mg tablet MO 2 B vs Dprochlorperazine 5 mg/ml vial MO 2PROTONIX 40 MG IV SOLUTION MO 4ranitidine 1,000 mg/40 ml vial MO 2ranitidine 15 mg/ml syrup MO 2ranitidine 150 mg capsule MO 3ranitidine 150 mg tablet MO 1ranitidine 300 mg capsule MO 2

Page 84: Humana Walmart-Preferred Formulary - Q1Medicare

84 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ranitidine 300 mg tablet MO 1ranitidine hcl 25 mg/ml vial MO 2RELISTOR 12 MG/0.6 ML SUB-Q MO 4 PA,QL (36 per 30 days)RELISTOR 12 MG/0.6 ML SUB-Q KIT MO 4 PA,QL (36 per 30 days)sucralfate 1 gm tablet MO 2sucralfate 1 gm/10 ml susp MO 2trilyte with flavor packets 420 g oral solution MO 3trimethobenzamide 300 mg cap MO 3 B vs Dursodiol 250 mg tablet MO 3ursodiol 300 mg capsule MO 3ursodiol 500 mg tablet MO 3ZENPEP 10,000-34,000-55,000 UNIT CAP MO 3ZENPEP 15,000-51,000-82,000 UNIT CAP MO 3ZENPEP 20,000-68,000-109,000 UNIT CAP MO 3ZENPEP 5,000-17,000-27,000 UNIT CAP MO 3GOLD COMPOUNDSMYOCHRYSINE 50 MG/ML INJECTION MO 4RIDAURA 3 MG CAP MO 4HEAVY METAL ANTAGONISTSBAL IN OIL 100 MG/ML IM MO 4CALCIUM DISODIUM VERSENATE 200 MG/ML INJECTION MO 2CHEMET 100 MG CAP MO 4CUPRIMINE 250 MG CAP MO 4deferoxamine 2 gram vial MO 3 B vs Ddeferoxamine 500 mg vial MO 3 B vs DENDRATE 150 MG/ML AMPUL MO 4EXJADE 125 MG TAB SP 3 PAEXJADE 250 MG TAB SP 3 PAEXJADE 500 MG TAB SP 3 PASYPRINE 250 MG CAP MO 4HORMONES AND SYNTHETIC SUBSTITUTESa-hydrocort 100 mg solution for injection MO 2a-methapred 125 mg/2 ml solution for injection MO 2a-methapred 40 mg solution for injection MO 2a-methapred 40 mg/ml solution for injection MO 2acarbose 100 mg tablet MO 3acarbose 25 mg tablet MO 3acarbose 50 mg tablet MO 3ACTOPLUS MET 15 MG-500 MG TAB MO 4 QL (90 per 30 days)ACTOPLUS MET 15 MG-850 MG TAB MO 4 QL (90 per 30 days)ACTOPLUS MET XR 15 MG-1,000 MG 24 HR TAB MO 4 QL (30 per 30 days)

Page 85: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 85

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ACTOPLUS MET XR 30 MG-1,000 MG 24 HR TAB MO 4 QL (30 per 30 days)ACTOS 15 MG TAB MO 3 ST,QL (30 per 30 days)ACTOS 30 MG TAB MO 3 ST,QL (30 per 30 days)ACTOS 45 MG TAB MO 3 ST,QL (30 per 30 days)ADVAIR DISKUS 100 MCG-50 MCG/DOSE FOR INHALATION MO 3 QL (60 per 30 days)ADVAIR DISKUS 250 MCG-50 MCG/DOSE FOR INHALATION MO 3 QL (60 per 30 days)ADVAIR DISKUS 500 MCG-50 MCG/DOSE FOR INHALATION MO 3 QL (60 per 30 days)ADVAIR HFA 115 MCG-21 MCG/ACTUATION AEROSOL INHALER MO 3 QL (12 per 30 days)ADVAIR HFA 230 MCG-21 MCG/ACTUATION AEROSOL INHALER MO 3 QL (12 per 30 days)ADVAIR HFA 45 MCG-21 MCG/ACTUATION AEROSOL INHALER MO 3 QL (12 per 30 days)altavera (28) 0.15 mg-30 mcg tab MO 2ANADROL-50 50 MG TAB MO 4ANDROGEL 1 % (25 MG/2.5 GRAM) TRANSDERMAL PACKET MO 3 QL (300 per 30 days)ANDROGEL 1 % (50 MG/5 GRAM) TRANSDERMAL PACKET MO 3 QL (300 per 30 days)ANDROGEL 1.25 G/ACTUATION (1%) TRANSDERMAL GEL PUMP MO 3 QL (300 per 30 days)ANDROGEL 20.25 MG/1.25 GRAM (1.62 %) TRANSDERMAL GEL PUMP MO 3 QL (176 per 30 days)androxy 10 mg tab MO 4apri 0.15 mg-30 mcg tab MO 2aranelle (28) 0.5/1/0.5 mg-35 mcg tab MO 2ARISTOSPAN INTRA-ARTICULAR 20 MG/ML SUSP FOR INJECTION MO 4ARISTOSPAN INTRALESIONAL 5 MG/ML SUSP FOR INJECTION MO 4ASMANEX TWISTHALER 110 MCG (30 DOSES) BREATH ACTIVATED MO 3 QL (7 per 30 days)ASMANEX TWISTHALER 110 MCG (7 DOSES) BREATH ACTIVATED MO 3 QL (1 per 30 days)ASMANEX TWISTHALER 220 MCG (120 DOSES) BREATH ACTIVATED MO 3 QL (53 per 30 days)ASMANEX TWISTHALER 220 MCG (14 DOSES) BREATH ACTIVATED MO 3 QL (6 per 30 days)ASMANEX TWISTHALER 220 MCG (30 DOSES) BREATH ACTIVATED MO 3 QL (13 per 30 days)ASMANEX TWISTHALER 220 MCG (60 DOSES) BREATH ACTIVATED MO 3 QL (26 per 30 days)AVANDARYL 4 MG-1 MG TAB MO 4 QL (60 per 30 days)AVANDARYL 4 MG-2 MG TAB MO 4 QL (60 per 30 days)AVANDARYL 4 MG-4 MG TAB MO 4 QL (60 per 30 days)AVANDARYL 8 MG-2 MG TAB MO 4 QL (30 per 30 days)AVANDARYL 8 MG-4 MG TAB MO 4 QL (30 per 30 days)aviane 0.1 mg-20 mcg tab MO 2AZMACORT INHALER MO 4azurette 0.15 mg-0.02 mg x21/0.01 mgx5 tab MO 2baycadron 0.5 mg/5 ml elixir MO 2betamethasone ac-sp 6 mg/ml vl MO 2budesonide 0.25 mg/2 ml susp MO 2 B vs Dbudesonide 0.5 mg/2 ml susp MO 2 B vs Dbudesonide ec 3 mg capsule MO 4BYETTA 10 MCG/0.04 ML PER DOSE SUB-Q PEN INJECTOR MO 4 PA,QL (3 per 30 days)

Page 86: Humana Walmart-Preferred Formulary - Q1Medicare

86 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

BYETTA 5 MCG/0.02 ML PER DOSE SUB-Q PEN INJECTOR MO 4 PA,QL (3 per 30 days)calcitonin-salmon 200 units sp MO 3 QL (4 per 28 days)camila 0.35 mg tab MO 2caziant 0.1/0.125/0.15 mg-25 mcg tab MO 2CELESTONE SOLUSPAN 6 MG/ML SUSP FOR INJECTION MO 4cortisone 25 mg tablet MO 2cryselle (28) 0.3 mg-30 mcg tab MO 2cyclafem 1/35 (28) 1 mg-35 mcg tab MO 2cyclafem 7/7/7 (28) 0.5/0.75/1 mg-35 mcg tab MO 2CYTOMEL 25 MCG TAB MO 4CYTOMEL 5 MCG TAB MO 4CYTOMEL 50 MCG TAB MO 4danazol 100 mg capsule MO 3danazol 200 mg capsule MO 3danazol 50 mg capsule MO 3DEPO-ESTRADIOL 5 MG/ML IM OIL MO 2desmopressin 0.1 mg/ml sol MO 3desmopressin 0.1 mg/ml spray MO 3desmopressin ac 4 mcg/ml amp MO 3desmopressin acetate 0.1 mg tb MO 2desmopressin acetate 0.2 mg tb MO 2dexamethasone 0.5 mg tablet MO 1dexamethasone 0.5 mg/5 ml elx MO 2dexamethasone 0.5 mg/5 ml liq MO 2dexamethasone 0.75 mg tablet MO 1dexamethasone 1 mg tablet MO 2dexamethasone 1.5 mg tablet MO 2dexamethasone 10 mg/ml vial MO 2dexamethasone 2 mg tablet MO 2dexamethasone 4 mg tablet MO 1dexamethasone 4 mg/ml vial MO 2dexamethasone 6 mg tablet MO 2dexamethasone intensol 1 mg/ml oral drops MO 3EGRIFTA 1 MG SUB-Q SOLN SP 4 PA,QL (60 per 30 days)emoquette 0.15 mg-30 mcg tab MO 2enpresse 50-30 (6)/75-40(5)/125-30(10) tab MO 2ENTOCORT EC 3 MG CAP MO 4errin 0.35 mg tab MO 2estradiol 0.05 mg/day patch MO 2 QL (4 per 28 days)estradiol 0.1 mg/day patch MO 2 QL (4 per 28 days)estradiol 0.5 mg tablet MO 1

Page 87: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 87

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

estradiol 1 mg tablet MO 1estradiol 2 mg tablet MO 1estradiol tds 0.025 mg/day MO 2 QL (4 per 28 days)estradiol tds 0.0375 mg/day MO 2 QL (4 per 28 days)estradiol tds 0.06 mg/day MO 2 QL (4 per 28 days)estradiol tds 0.075 mg/day MO 2 QL (4 per 28 days)estradiol valerate 10 mg/ml vl MO 2estradiol valerate 20 mg/ml vl MO 2estradiol valerate 40 mg/ml vl MO 2estradiol-noreth 1-0.5 mg tab MO 3EVAMIST 1.53 MG/SPRAY (1.7 %) TRANSDERMAL SPRAY MO 4EVISTA 60 MG TAB MO 3 QL (30 per 30 days)FEMCON FE 0.4 MG-35 MCG (21)/75 MG (7) CHEWABLE TAB MO 4FLOVENT DISKUS 100 MCG/ACTUATION FOR INHALATION MO 3 QL (60 per 30 days)FLOVENT DISKUS 250 MCG/ACTUATION FOR INHALATION MO 3 QL (60 per 30 days)FLOVENT DISKUS 50 MCG/ACTUATION FOR INHALATION MO 3 QL (60 per 30 days)FLOVENT HFA 110 MCG/ACTUATION AEROSOL INHALER MO 3 QL (24 per 30 days)FLOVENT HFA 220 MCG/ACTUATION AEROSOL INHALER MO 3 QL (24 per 30 days)FLOVENT HFA 44 MCG/ACTUATION AEROSOL INHALER MO 3 QL (1 per 30 days)fludrocortisone 0.1 mg tablet MO 2FORTEO 20 MCG/DOSE (600 MCG/2.4 ML) SUB-Q PEN INJECTOR MO 4 ST,QL (2 per 28 days)FORTICAL 200 UNIT/ACTUATION NASAL SPRAY MO 4 QL (4 per 28 days)gianvi 3 mg-20 mcg (24) tab MO 2gildess fe 1 mg-20 mcg tab MO 2gildess fe 1.5 mg-30 mcg tab MO 2glimepiride 1 mg tablet MO 1glimepiride 2 mg tablet MO 1glimepiride 4 mg tablet MO 1glipizide 10 mg tablet MO 1glipizide 5 mg tablet MO 1glipizide er 10 mg tablet MO 2glipizide er 2.5 mg tablet MO 2glipizide er 5 mg tablet MO 2glipizide-metformin 2.5-250 mg MO 3glipizide-metformin 2.5-500 mg MO 3glipizide-metformin 5-500 mg MO 3GLUCAGEN 1 MG SOLUTION FOR INJECTION MO 4GLUCAGEN HYPOKIT 1 MG INJECTION MO 4GLUCAGON EMERGENCY 1 MG INJECTION KIT MO 2glyburid-metformin 1.25-250 mg MO 2glyburide 1.25 mg tablet MO 2

Page 88: Humana Walmart-Preferred Formulary - Q1Medicare

88 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

glyburide 2.5 mg tablet MO 1glyburide 5 mg tablet MO 1glyburide micro 1.5 mg tab MO 2glyburide micro 3 mg tablet MO 1glyburide micro 6 mg tablet MO 1glyburide-metformin 2.5-500 mg MO 2glyburide-metformin 5-500 mg MO 2GLYSET 100 MG TAB MO 4GLYSET 25 MG TAB MO 4GLYSET 50 MG TAB MO 4heather 0.35 mg tab MO 2HUMALOG 100 UNIT/ML SUB-Q MO 3 QL (240 per 30 days)HUMALOG 100 UNIT/ML SUBQ CARTRIDGE MO 3 QL (240 per 30 days)HUMALOG 100 UNITS/ML PEN MO 3HUMALOG KWIKPEN 100 UNIT/ML SUB-Q PEN MO 3HUMALOG MIX 50-50 100 UNIT/ML (50-50) SUSP, SUB-Q INJ MO 3HUMALOG MIX 50-50 KWIKPEN 100 UNIT/ML (50-50) SUB-Q PEN MO 3HUMALOG MIX 50-50 PEN MO 3HUMALOG MIX 75-25 100 UNIT/ML (75-25) SUSP, SUB-Q INJ MO 3HUMALOG MIX 75-25 KWIKPEN 100 UNIT/ML (75-25) SUB-Q PEN MO 3HUMALOG MIX 75-25 PEN MO 3HUMULIN 50-50 VIAL MO 3HUMULIN 70/30 100 UNIT/ML (70-30) SUSP, SUB-Q INJ MO 3HUMULIN 70/30 PEN 100 UNIT/ML (70-30) SUBQ MO 3HUMULIN N 100 UNIT/ML SUSP, SUB-Q INJ MO 3HUMULIN N PEN 100 UNIT/ML (3 ML) SUBQ MO 3HUMULIN R 100 UNIT/ML INJECTION MO 3HUMULIN R U-500 "CONCENTRATED" INSULIN 500 UNIT/ML INJECTION MO

3

hydrocortisone 10 mg tablet MO 2hydrocortisone 20 mg tablet MO 2hydrocortisone 5 mg tablet MO 2INCRELEX 10 MG/ML SUB-Q SP 4 PAintrovale 0.15 mg-30 mcg tabs,3 month dose pack MO 3 QL (91 per 90 days)JANUMET 50 MG-1,000 MG TAB MO 3 ST,QL (60 per 30 days)JANUMET 50 MG-500 MG TAB MO 3 ST,QL (60 per 30 days)JANUVIA 100 MG TAB MO 3 ST,QL (30 per 30 days)JANUVIA 25 MG TAB MO 3 ST,QL (30 per 30 days)JANUVIA 50 MG TAB MO 3 ST,QL (30 per 30 days)jevantique 1 mg-5 mcg tab MO 3jinteli 1 mg-5 mcg tab MO 3

Page 89: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 89

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

junel 1.5/30 (21) 1.5 mg-30 mcg tab MO 2junel 1/20 (21) 1 mg-20 mcg tab MO 2junel fe 1.5/30 (28) 1.5 mg-30 mcg tab MO 2junel fe 1/20 (28) 1 mg-20 mcg tab MO 2kariva 0.15 mg-0.02 mg x21/0.01 mgx5 tab MO 2kelnor 1/35 (28) 1 mg-35 mcg tab MO 2KOMBIGLYZE XR 2.5 MG-1,000 MG 24 HR TAB MO 4 ST,QL (60 per 30 days)KOMBIGLYZE XR 5 MG-1,000 MG 24 HR TAB MO 4 ST,QL (30 per 30 days)KOMBIGLYZE XR 5 MG-500 MG 24 HR TAB MO 4 ST,QL (30 per 30 days)LANTUS 100 UNIT/ML SUB-Q MO 3LANTUS 100 UNITS/ML CARTRIDGE MO 3LANTUS SOLOSTAR 100 UNIT/ML (3 ML) SUB-Q INSULIN PEN MO 3lessina 0.1 mg-20 mcg tab MO 2LEVEMIR 100 UNIT/ML SUB-Q MO 3LEVEMIR FLEXPEN 100 UNIT/ML (3 ML) SUB-Q INSULIN PEN MO 3levora-28 0.15 mg-30 mcg tab MO 2LEVOTHROID 100 MCG TAB MO 2LEVOTHROID 112 MCG TAB MO 2LEVOTHROID 125 MCG TAB MO 2LEVOTHROID 137 MCG TAB MO 2LEVOTHROID 150 MCG TAB MO 2LEVOTHROID 175 MCG TAB MO 2LEVOTHROID 200 MCG TAB MO 2LEVOTHROID 25 MCG TAB MO 2LEVOTHROID 300 MCG TAB MO 2LEVOTHROID 50 MCG TAB MO 2LEVOTHROID 75 MCG TAB MO 2LEVOTHROID 88 MCG TAB MO 2levothyroxine 100 mcg tablet MO 1levothyroxine 112 mcg tablet MO 1levothyroxine 125 mcg tablet MO 1levothyroxine 137 mcg tablet MO 2levothyroxine 150 mcg tablet MO 1levothyroxine 175 mcg tablet MO 1levothyroxine 200 mcg tablet MO 1levothyroxine 200 mcg vial MO 2levothyroxine 25 mcg tablet MO 1levothyroxine 300 mcg tablet MO 2levothyroxine 50 mcg tablet MO 1levothyroxine 500 mcg vial MO 2levothyroxine 75 mcg tablet MO 1

Page 90: Humana Walmart-Preferred Formulary - Q1Medicare

90 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

levothyroxine 88 mcg tablet MO 1LEVOXYL 100 MCG TAB MO 3LEVOXYL 112 MCG TAB MO 3LEVOXYL 125 MCG TAB MO 3LEVOXYL 137 MCG TAB MO 3LEVOXYL 150 MCG TAB MO 3LEVOXYL 175 MCG TAB MO 3LEVOXYL 200 MCG TAB MO 3LEVOXYL 25 MCG TAB MO 3LEVOXYL 50 MCG TAB MO 3LEVOXYL 75 MCG TAB MO 3LEVOXYL 88 MCG TAB MO 3liothyronine sod 10 mcg/ml vl MO 3liothyronine sod 25 mcg tab MO 2liothyronine sod 5 mcg tab MO 2liothyronine sod 50 mcg tab MO 2loryna 3 mg-20 mcg (24) tab MO 2LOSEASONIQUE 0.10 MG-20 MCG (84)/10 MCG(7) TABS,3 MONTH DOSEPACK MO

4 QL (91 per 90 days)

low-ogestrel (28) 0.3 mg-30 mcg tab MO 2lutera (28) 0.1 mg-20 mcg tab MO 2medroxyprogesterone 10 mg tab MO 1medroxyprogesterone 150 mg/ml MO 2 QL (1 per 90 days)medroxyprogesterone 2.5 mg tab MO 1medroxyprogesterone 5 mg tab MO 1meprolone unipak 4 mg tab MO 2metformin hcl 1,000 mg tablet MO 1metformin hcl 500 mg tablet MO 1metformin hcl 850 mg tablet MO 1metformin hcl er 500 mg tablet MO 1 QL (120 per 30 days)metformin hcl er 750 mg tablet MO 2 QL (60 per 30 days)methimazole 10 mg tablet MO 2methimazole 5 mg tablet MO 2methylprednisolone 125 mg vial MO 2methylprednisolone 16 mg tab MO 2methylprednisolone 32 mg tab MO 2methylprednisolone 4 mg dosepk MO 1methylprednisolone 4 mg tablet MO 1methylprednisolone 40 mg vial MO 2methylprednisolone 40 mg/ml vl MO 2methylprednisolone 500 mg vial MO 2

Page 91: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 91

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

methylprednisolone 8 mg tab MO 2methylprednisolone 80 mg/ml vl MO 2methylprednisolone ss 1 gm vl MO 2microgestin 1.5/30 (21) 1.5 mg-30 mcg tab MO 2microgestin 1/20 (21) 1 mg-20 mcg tab MO 2microgestin fe 1.5/30 (28) 1.5 mg-30 mcg tab MO 2microgestin fe 1/20 (28) 1 mg-20 mcg tab MO 2mimvey 1 mg-0.5 mg tab MO 2NATAZIA 3 MG/2 MG-2 MG/2 MG-3 MG/1 MG TAB MO 4nateglinide 120 mg tablet MO 2nateglinide 60 mg tablet MO 2necon 0.5/35 (28) 0.5 mg-35 mcg tab MO 2necon 1/35 (28) 1 mg-35 mcg tab MO 2necon 1/50 (28) 1 mg-50 mcg tab MO 4necon 10/11 (28) 0.5mg-35mcg(10)/1mg-35mcg(11) tab MO 2norethindrone 0.35 mg tablet MO 2norethindrone 5 mg tablet MO 3norg-ethin estr 0.3-0.03 mg tb MO 2norgestimate-eth estradiol tab MO 2NORINYL 1+50 (28) 1 MG-50 MCG TAB MO 4nortrel 0.5/35 (28) 0.5 mg-35 mcg tab MO 2nortrel 1/35 (21) 1 mg-35 mcg tab MO 2nortrel 1/35 (28) 1 mg-35 mcg tab MO 2nortrel 7/7/7 (28) 0.5/0.75/1 mg-35 mcg tab MO 2NOVOLIN 70-30 INNOLET MO 3NOVOLIN 70-30 U100 CARTRIDGE MO 3NOVOLIN 70/30 100 UNIT/ML (70-30) SUSP, SUB-Q INJ MO 3NOVOLIN N 100 UNIT/ML CARTRIDG MO 3NOVOLIN N 100 UNIT/ML INNOLET MO 3NOVOLIN N 100 UNIT/ML SUSP, SUB-Q INJ MO 3NOVOLIN R 100 UNIT/ML CARTRIDG MO 3NOVOLIN R 100 UNIT/ML INJECTION MO 3NOVOLIN R 100 UNIT/ML INNOLET MO 3NOVOLOG 100 UNIT/ML SUB-Q MO 3NOVOLOG FLEXPEN 100 UNIT/ML SUB-Q MO 3NOVOLOG MIX 70-30 100 UNIT/ML (70-30) SUB-Q MO 3NOVOLOG MIX 70-30 FLEXPEN 100 UNIT/ML (70-30) SUB-Q MO 3NOVOLOG PENFILL 100 UNIT/ML SUBQ CARTRIDGE MO 3ogestrel (28) 0.5 mg-50 mcg tab MO 2OMNITROPE 10 MG/1.5 ML SUBQ CARTRIDGE SP 4 PA,QL (12 per 28 days)OMNITROPE 5 MG/1.5 ML (3.3 MG/ML) SUBQ CARTRIDGE SP 4 PA,QL (24 per 28 days)

Page 92: Humana Walmart-Preferred Formulary - Q1Medicare

92 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

OMNITROPE 5.8 MG SUB-Q SOLN SP 4 PA,QL (8 per 28 days)ONGLYZA 2.5 MG TAB MO 4 ST,QL (30 per 30 days)ONGLYZA 5 MG TAB MO 4 ST,QL (30 per 30 days)ORAPRED ODT 10 MG TAB, RAPID DISSOLVE MO 4ORAPRED ODT 15 MG TAB, RAPID DISSOLVE MO 4ORAPRED ODT 30 MG TAB, RAPID DISSOLVE MO 4orsythia 0.1 mg-20 mcg tab MO 2oxandrolone 10 mg tablet MO 4 QL (60 per 30 days)oxandrolone 2.5 mg tablet MO 3 QL (120 per 30 days)PITRESSIN 20 UNIT/ML INJECTION MO 2portia 0.15 mg-30 mcg tab MO 2PRANDIN 0.5 MG TAB MO 4PRANDIN 1 MG TAB MO 4PRANDIN 2 MG TAB MO 4prednisolone 15 mg/5 ml soln MO 2prednisolone 15 mg/5 ml syrup MO 2prednisolone 5 mg/5 ml soln MO 2prednisolone 5 mg/5 ml syrup MO 2prednisone 1 mg tablet MO 2prednisone 10 mg tablet MO 1prednisone 2.5 mg tablet MO 1prednisone 20 mg tablet MO 1prednisone 5 mg tablet MO 1prednisone 5 mg/5 ml solution MO 2prednisone 50 mg tablet MO 2prednisone intensol 5 mg/ml oral concentrate MO 3PREMARIN 0.625 MG/GRAM VAGINAL CREAM MO 3previfem 0.25 mg-35 mcg tab MO 2progesterone in oil 50 mg/ml im MO 2progesterone oil 50 mg/ml vl MO 2propylthiouracil 50 mg tablet MO 2quasense 0.15 mg-30 mcg tabs,3 month dose pack MO 3 QL (91 per 90 days)QVAR 40 MCG/ACTUATION AEROSOL INHALER MO 3 QL (37 per 30 days)QVAR 80 MCG/ACTUATION AEROSOL INHALER MO 3 QL (22 per 30 days)reclipsen (28) 0.15 mg-30 mcg tab MO 2SAIZEN 5 MG SUB-Q SOLN SP 4 PA,QL (28 per 30 days)SAIZEN 8.8 MG SUB-Q SOLN SP 4 PASAIZEN CLICK.EASY 8.8 MG/1.5 ML (FINAL CONC.) SUBQ CARTRIDGE SP 4 PASEROSTIM 4 MG SUB-Q SOLN SP 4 PA,QL (28 per 30 days)SEROSTIM 5 MG SUB-Q SOLN SP 4 PA,QL (28 per 30 days)SEROSTIM 6 MG SUB-Q SOLN SP 4 PA,QL (28 per 30 days)

Page 93: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 93

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

SEROSTIM 8.8 MG VIAL SP 4 PASOLU-CORTEF (PF) 1,000 MG/8 ML SOLUTION FOR INJECTION MO 4SOLU-CORTEF (PF) 100 MG/2 ML SOLUTION FOR INJECTION MO 4SOLU-CORTEF (PF) 250 MG/2 ML SOLUTION FOR INJECTION MO 4SOLU-CORTEF (PF) 500 MG/4 ML SOLUTION FOR INJECTION MO 4SOLU-CORTEF 100 MG SOLUTION FOR INJECTION MO 4SOLU-CORTEF 250 MG ACT-O-VL MO 4SOLU-CORTEF 500 MG ACT-O-VL MO 4SOLU-MEDROL (PF) 1,000 MG/8 ML IV SOLUTION MO 4SOLU-MEDROL (PF) 125 MG/2 ML SOLUTION FOR INJECTION MO 4SOLU-MEDROL (PF) 40 MG/ML SOLUTION FOR INJECTION MO 4SOLU-MEDROL (PF) 500 MG/4 ML IV SOLUTION MO 4SOLU-MEDROL 1,000 MG IV SOLUTION MO 4SOLU-MEDROL 125 MG/2 ML SOLUTION FOR INJECTION MO 4SOLU-MEDROL 2 GRAM IV SOLUTION MO 4SOLU-MEDROL 500 MG IV SOLUTION MO 4SOMAVERT 10 MG SUB-Q SOLN SP 4 PA,QL (30 per 30 days)SOMAVERT 15 MG SUB-Q SOLN SP 4 PA,QL (30 per 30 days)SOMAVERT 20 MG SUB-Q SOLN SP 4 PA,QL (30 per 30 days)sprintec (28) 0.25 mg-35 mcg tab MO 1sronyx 0.1 mg-20 mcg tab MO 2STIMATE 150 MCG/SPRAY (0.1 ML) NASAL SPRAY MO 4syeda 3 mg-0.03 mg tab MO 3SYMBICORT 160 MCG-4.5 MCG/ACTUATION HFA AEROSOL INHALER MO 3 QL (11 per 30 days)SYMBICORT 80 MCG-4.5 MCG/ACTUATION HFA AEROSOL INHALER MO 3 QL (11 per 30 days)SYMLIN 600 MCG/ML SUB-Q MO 4 PA,QL (25 per 30 days)SYMLINPEN 120 2,700 MCG/2.7 ML SUB-Q PEN INJECTOR MO 4 PA,QL (11 per 30 days)SYMLINPEN 60 1,500 MCG/1.5 ML SUB-Q PEN INJECTOR MO 4 PA,QL (11 per 30 days)SYNAREL 2 MG/ML NASAL SPRAY SP 4SYNTHROID 100 MCG TAB MO 3SYNTHROID 112 MCG TAB MO 3SYNTHROID 125 MCG TAB MO 3SYNTHROID 137 MCG TAB MO 3SYNTHROID 150 MCG TAB MO 3SYNTHROID 175 MCG TAB MO 3SYNTHROID 200 MCG TAB MO 3SYNTHROID 25 MCG TAB MO 3SYNTHROID 300 MCG TAB MO 3SYNTHROID 50 MCG TAB MO 3SYNTHROID 75 MCG TAB MO 3SYNTHROID 88 MCG TAB MO 3

Page 94: Humana Walmart-Preferred Formulary - Q1Medicare

94 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

testosterone cyp 100 mg/ml MO 2testosterone cyp 200 mg/ml MO 3testosterone enan 200 mg/ml MO 3THYROLAR-1 12.5 MCG-50 MCG TAB MO 2THYROLAR-1/2 6.25 MCG-25 MCG TAB MO 2THYROLAR-1/4 3.1 MCG-12.5 MCG TAB MO 2THYROLAR-2 25 MCG-100 MCG TAB MO 2THYROLAR-3 37.5 MCG-150 MCG TAB MO 2tilia fe 1-20 (5)/1-30(7)/1mg-35mcg(9) tab MO 4tolazamide 250 mg tablet MO 2tolazamide 500 mg tablet MO 2tolbutamide 500 mg tablet MO 2tri-legest fe 1-20 (5)/1-30(7)/1mg-35mcg(9) tab MO 4tri-previfem (28) 0.18/0.215/0.25 mg-35 mcg(28) tab MO 2tri-sprintec (28) 0.18/0.215/0.25 mg-35 mcg(28) tab MO 2triamcinolone acet 10mg/ml sus MO 2triamcinolone acet 40mg/ml sus MO 2trinessa (28) 0.18/0.215/0.25 mg-35 mcg(28) tab MO 2trivora (28) 50-30 (6)/75-40(5)/125-30(10) tab MO 2UNITHROID 100 MCG TAB MO 2UNITHROID 112 MCG TAB MO 2UNITHROID 125 MCG TAB MO 2UNITHROID 137 MCG TABLET MO 2UNITHROID 150 MCG TAB MO 2UNITHROID 175 MCG TAB MO 2UNITHROID 200 MCG TAB MO 2UNITHROID 25 MCG TAB MO 2UNITHROID 300 MCG TAB MO 2UNITHROID 50 MCG TAB MO 2UNITHROID 75 MCG TAB MO 2UNITHROID 88 MCG TAB MO 2vasopressin 10 unit/0.5 ml vl MO 2velivet 0.1/0.125/0.15 mg-25 mcg tab MO 2VERIPRED 20 20 MG/5 ML ORAL SOLN MO 4VICTOZA 0.6 MG/0.1 ML (18 MG/3 ML) SUB-Q PEN INJECTOR MO 4 PA,QL (9 per 30 days)zarah 3 mg-0.03 mg tab MO 3zema-pak 10 day 1.5 mg tablet MO 2zema-pak 13 day 1.5 mg tablet MO 2zema-pak 6 day 1.5 mg tablet MO 2zeosa 0.4 mg-35 mcg (21)/75 mg (7) chewable tab MO 3

Page 95: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 95

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

zovia 1/35e (28) 1 mg-35 mcg tab MO 2zovia 1/50e (28) 1 mg-50 mcg tab MO 2LOCAL ANESTHETICS (PARENTERAL)bupivacaine 0.25% ampul MO 2bupivacaine 0.25% vial MO 2bupivacaine 0.5% ampul MO 2bupivacaine 0.75% vial MO 2bupivacaine-dextr 0.75% amp MO 2bupivacaine-epi 0.25%-0.0005 MO 2bupivacaine-epi 0.5%-0.0005 MO 2bupivacaine-epi 0.75%-0.0005 MO 2CARBOCAINE (PF) 10 MG/ML (1 %) INJECTION MO 4CARBOCAINE (PF) 15 MG/ML (1.5 %) INJECTION MO 4CARBOCAINE (PF) 20 MG/ML (2 %) INJECTION MO 4CARBOCAINE 1 % INJECTION MO 4CARBOCAINE 2 % INJECTION MO 4chloroprocaine 2% vial MO 2chloroprocaine 3% vial MO 2lidocaine 0.5%-epi 1:200,000 MO 2lidocaine 1%-epi 1:100,000 MO 2lidocaine 1.5%-epi 1:200,000 MO 2lidocaine 2% - epi 1:100,000 MO 2lidocaine 2% - epi 1:50,000 MO 2lidocaine 2%-epi 1:100,000 MO 2lidocaine 2%-epi 1:200,000 MO 2lidocaine 5% in d7.5w ampul MO 2lidocaine hcl 0.5% vial MO 2lidocaine hcl 1% ampul MO 2lidocaine hcl 1% vial MO 2lidocaine hcl 1.5% ampul MO 2lidocaine hcl 2% ampul MO 2lidocaine hcl 2% vial MO 2lidocaine hcl 4% ampul MO 2MARCAINE (PF) 0.25 % (2.5 MG/ML) INJECTION MO 4MARCAINE (PF) 0.5 % (5 MG/ML) INJECTION MO 4MARCAINE (PF) 0.75 % (7.5 MG/ML) INJECTION MO 4MARCAINE 0.25 % (2.5 MG/ML) INJECTION MO 4MARCAINE SPINAL 7.5 MG/ML (0.75 %) INJECTION MO 4MARCAINE-EPINEPHRINE (PF) 0.25 %-1:200,000 INJECTION MO 4MARCAINE-EPINEPHRINE (PF) 0.5 %-1:200,000 INJECTION MO 4MARCAINE-EPINEPHRINE 0.25 %-1:200,000 INJECTION MO 4

Page 96: Humana Walmart-Preferred Formulary - Q1Medicare

96 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

MARCAINE-EPINEPHRINE 0.5 %-1:200,000 INJECTION MO 4mepivacaine hcl 3% cartridge MO 2NAROPIN (PF) 5 MG/ML (0.5 %) INJECTION MO 4NAROPIN 10 MG/ML INJECTION MO 4NAROPIN 2 MG/ML (0.2 %) INJECTION MO 4NAROPIN 5 MG/ML INJECTION MO 4NAROPIN 7.5 MG/ML INJECTION MO 4polocaine (pf) 10 mg/ml (1 %) injection MO 2polocaine (pf) 15 mg/ml (1.5 %) injection MO 2polocaine (pf) 20 mg/ml (2 %) injection MO 2polocaine 1 % injection MO 2polocaine 2 % injection MO 2PONTOCAINE 20 MG SOLUTION FOR INJECTION MO 4SENSORCAINE 0.25 % (2.5 MG/ML) INJECTION MO 4sensorcaine-mpf spinal 7.5 mg/ml (0.75 %) injection MO 2sensorcaine-mpf/epinephrine 0.25 %-1:200,000 injection MO 2SENSORCAINE-MPF/EPINEPHRINE 0.75 %-1:200,000 INJECTION MO 4sensorcaine/epinephrine 0.25 %-1:200,000 injection MO 2sensorcaine/epinephrine 0.5 %-1:200,000 injection MO 2MISCELLANEOUS THERAPEUTIC AGENTSACTIMMUNE 2 MILLION UNIT/0.5 ML SUB-Q SP 4 PAACTONEL 150 MG TAB MO 4 QL (2 per 30 days)ACTONEL 30 MG TAB MO 4 QL (30 per 30 days)ACTONEL 35 MG TAB MO 4 QL (4 per 28 days)ACTONEL 5 MG TAB MO 4 QL (30 per 30 days)ACTONEL WITH CALCIUM TABLET MO 4 QL (28 per 28 days)alendronate sodium 10 mg tab MO 2 QL (30 per 30 days)alendronate sodium 35 mg tab MO 1 QL (4 per 28 days)alendronate sodium 40 mg tab MO 2 QL (30 per 30 days)alendronate sodium 5 mg tablet MO 2 QL (30 per 30 days)alendronate sodium 70 mg tab MO 1 QL (4 per 28 days)allopurinol 100 mg tablet MO 1allopurinol 300 mg tablet MO 1allopurinol sodium 500 mg vial MO 2amifostine 500 mg vial MO 3 B vs DAMPYRA 10 MG 12 HR TAB SP 4 PA,QL (60 per 30 days)ANTIZOL 1.5 GM/1.5 ML VIAL MO 4ARCALYST 220 MG SUB-Q SOLN SP 4 PAaspergillus allergen extract MO 2AVODART 0.5 MG CAP MO 3 QL (30 per 30 days)AVONEX 30 MCG IM KIT SP 4 PA,QL (4 per 28 days)

Page 97: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 97

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

AVONEX ADMINISTRATION PACK 30 MCG/0.5 ML IM KIT SP 4 PA,QL (4 per 28 days)azathioprine 50 mg tablet MO 2 B vs Dazathioprine sod 100 mg vial MO 2 B vs DBETASERON 0.3 MG SUB-Q KIT SP 4 PA,QL (15 per 30 days)BONIVA 150 MG TAB MO 4 QL (1 per 28 days)BONIVA 3 MG/3 ML IV SYRINGE MO 4 PA,QL (3 per 90 days)calcium folinate 10 mg/ml injection MO 2candida albicans extract MO 2CARNITOR 200 MG/ML IV MO 3 B vs DCARNITOR SUGAR-FREE 100 MG/ML ORAL SOLN MO 4 B vs Dcavarest 1.1% dental gel MO 2cavirinse oral rinse MO 2CELLCEPT 200 MG/ML ORAL SUSP MO 4 B vs DCELLCEPT 250 MG CAP MO 4 B vs DCELLCEPT 500 MG TAB MO 4 B vs DCELLCEPT INTRAVENOUS 500 MG IV SOLUTION MO 4 B vs DCOLCRYS 0.6 MG TAB MO 3control rx cream MO 2COPAXONE 20 MG SUB-Q KIT SP 4 PA,QL (30 per 30 days)cyanide antidote 300 mg/10 ml-12.5 gram/50 ml iv kit MO 2cyclosporine 100 mg capsule MO 3 B vs Dcyclosporine 100 mg/ml soln MO 3 B vs Dcyclosporine 25 mg capsule MO 3 B vs Dcyclosporine 50 mg softgel MO 3 B vs Dcyclosporine 50 mg/ml vial MO 3 B vs Dcyclosporine modified 100 mg MO 2 B vs Dcyclosporine modified 25 mg MO 3 B vs DCYSTADANE ORAL POWDER MO 4CYSTAGON 150 MG CAP MO 4CYSTAGON 50 MG CAP MO 4DEMSER 250 MG CAP MO 4denta 5000 plus 1.1 % cream MO 2dentagel 1.1 % MO 2dexrazoxane 250 mg vial MO 2 B vs Ddexrazoxane 500 mg vial MO 2 B vs Ddisulfiram 250 mg tablet MO 3ENBREL 25 MG (1 ML) SUB-Q KIT SP 4 PA,QL (8 per 28 days)ENBREL 25 MG/0.5 ML (0.51 ML) SUB-Q SYRINGE SP 4 PA,QL (8 per 28 days)ENBREL 50 MG/ML (0.98 ML) SUB-Q SYRINGE SP 4 PA,QL (8 per 28 days)ENBREL SURECLICK 50 MG/ML (0.98 ML) SUB-Q PEN INJECTOR SP 4 PA,QL (8 per 28 days)epiflur 0.25 mg fluoride (0.55 mg) chewable tab MO 2

Page 98: Humana Walmart-Preferred Formulary - Q1Medicare

98 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

epiflur 0.5 mg fluoride (1.1 mg) chewable tab MO 2epiflur 1 mg fluoride (2.2 mg) chewable tab MO 2ETHYOL 500 MG IV SOLUTION MO 4 B vs Detidronate disodium 200 mg tab MO 3etidronate disodium 400 mg tab MO 3EXTAVIA 0.3 MG SUB-Q KIT SP 4 PA,QL (15 per 30 days)finasteride 5 mg tablet MO 3 QL (30 per 30 days)FIRAZYR 30 MG/3 ML SUB-Q SYRINGE MO 4 PA,QL (9 per 30 days)FLUORABON 0.25 MG FLUORIDE(0.55)/0.6 ML ORAL DROPS MO 4fluoride 1 mg chew tablet MO 2fluoridex defense 1.1% gel MO 2fluoridex whitening 1.1% gel MO 2fluoritab 0.5 mg fluoride (1.1 mg) chewable MO 2FLURA-DROPS 0.25 MG FLUORIDE (0.55)/DROP ORAL MO 4fomepizole 1.5 gm/1.5 ml vial MO 2FUSILEV 50 MG IV SOLUTION SP 4 PAgel-kam 0.63% dental rinse MO 2gengraf 100 mg cap MO 3 B vs Dgengraf 100 mg/ml oral soln MO 3 B vs Dgengraf 25 mg cap MO 3 B vs DHONEY BEE VENOM PROTEIN VL MO 4HONEY BEE VENOM TREATMNT KT MO 4HUMIRA 20 MG/0.4 ML SUB-Q KIT SP 4 PA,QL (6 per 28 days)HUMIRA 40 MG/0.8 ML SUB-Q KIT SP 4 PA,QL (6 per 28 days)HUMIRA CROHN’S DISEASE STARTER PACK 40 MG/0.8 ML SUBQ PEN KIT SP

4 PA,QL (6 per 28 days)

HUMIRA PEN 40 MG/0.8 ML SUBQ KIT SP 4 PA,QL (6 per 28 days)HUMIRA PSORIASIS STARTER PACK 40 MG/0.8 ML SUBQ PEN KIT SP 4 PA,QL (6 per 28 days)JALYN 0.5 MG-0.4 MG 24 HR CAP MO 3 QL (30 per 30 days)KUVAN 100 MG SOLUBLE TAB SP 4 PAleflunomide 10 mg tablet MO 2 QL (30 per 30 days)leflunomide 20 mg tablet MO 2 QL (30 per 30 days)leucovorin cal 500 mg/50 ml vl MO 2 B vs Dleucovorin calcium 10 mg tab MO 2leucovorin calcium 100 mg vl MO 2 B vs Dleucovorin calcium 15 mg tab MO 2leucovorin calcium 200 mg vl MO 2 B vs Dleucovorin calcium 25 mg tab MO 2leucovorin calcium 350 mg vl MO 2 B vs Dleucovorin calcium 5 mg tab MO 2leucovorin calcium 50 mg vl MO 2 B vs D

Page 99: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 99

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

leucovorin calcium 500 mg vl MO 2 B vs Dlevocarnitine 100 mg/ml soln MO 3 B vs Dlevocarnitine 200 mg/ml vial MO 3 B vs Dlevocarnitine 330 mg tablet MO 3 B vs Dlozi-flur 1 mg fluoride (2.2 mg) lozenges MO 2ludent fluoride 0.25 mg fluoride (0.55 mg) chewable tab MO 2ludent fluoride 0.5 mg fluoride (1.1 mg) chewable tab MO 2ludent fluoride 1 mg fluoride (2.2 mg) chewable tab MO 2mesna 100 mg/ml vial MO 4 B vs DMESNEX 100 MG/ML IV MO 4 B vs DMESNEX 400 MG TAB MO 4methylene blue 1% ampul MO 2mycophenolate 250 mg capsule MO 2 B vs Dmycophenolate 500 mg tablet MO 2 B vs DMYFORTIC 180 MG TAB MO 3 B vs DMYFORTIC 360 MG TAB MO 3 B vs DMYOBLOC 10,000 UNIT/2 ML IM SP 4 PAMYOBLOC 2,500 UNIT/0.5 ML IM SP 4 PAMYOBLOC 5,000 UNIT/ML IM SP 4 PAneutragard advanced 1.1% gel MO 2neutragard gel MO 2neutral sodium fluoride MO 2NEXAVIR 25.5 MG/ML INJECTION MO 4NULOJIX 250 MG IV SOLUTION SP 4 PA,QL (20 per 30 days)octreotide 1,000 mcg/ml vial MO 3 PAoctreotide acet 100 mcg/ml syr SP 3 PAoctreotide acet 100 mcg/ml vl MO 3 PAoctreotide acet 200 mcg/ml vl MO 3 PAoctreotide acet 50 mcg/ml syr SP 3 PAoctreotide acet 50 mcg/ml vial MO 3 PAoctreotide acet 500 mcg/ml amp MO 3 PAoctreotide acet 500 mcg/ml syr SP 3 PAORFADIN 10 MG CAP MO 4ORFADIN 2 MG CAP MO 4ORFADIN 5 MG CAP MO 4ORTHOCLONE OKT3 1 MG/ML IV SP 4 B vs Dpamidronate 30 mg/10 ml vial MO 3 B vs D,QL (30 per 21 days)pamidronate 60 mg/10 ml vial MO 3 B vs D,QL (10 per 21 days)pamidronate 90 mg/10 ml vial MO 3 B vs D,QL (10 per 21 days)pamidronate disod 30 mg vial SP 3 B vs D,QL (3 per 21 days)pamidronate disod 90 mg vial SP 3 B vs D,QL (1 per 21 days)

Page 100: Humana Walmart-Preferred Formulary - Q1Medicare

100 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

PANHEMATIN 313 MG IV SOLUTION MO 4PROGRAF 5 MG/ML IV MO 4 B vs DPROLIA 60 MG/ML SUB-Q SYRINGE SP 4 PA,QL (60 per 180 days)RAPAMUNE 0.5 MG TAB MO 4 B vs DRAPAMUNE 1 MG TAB MO 4 B vs DRAPAMUNE 1 MG/ML ORAL SOLN MO 4 B vs DRAPAMUNE 2 MG TAB MO 4 B vs DREBIF 22 MCG/0.5 ML SUB-Q SYRINGE SP 4 PA,QL (12 per 30 days)REBIF 44 MCG/0.5 ML SUB-Q SYRINGE SP 4 PA,QL (12 per 30 days)REBIF TITRATION PACK 8.8 MCG/0.2 ML-22 MCG/0.5 ML SUB-Q SYRINGE SP

4 PA,QL (12 per 30 days)

RECLAST 5 MG/100 ML IV SP 4 PA,QL (100 per 365 days)REMICADE 100 MG IV SOLUTION SP 4 PArenaf fluoride 0.25 mg tb chew MO 2renaf fluoride 0.5 mg tab chew MO 2renaf fluoride 1 mg tab chew MO 2SANDOSTATIN 1,000 MCG/ML INJECTION MO 4 PASANDOSTATIN 100 MCG/ML INJECTION MO 4 PASANDOSTATIN 200 MCG/ML INJECTION MO 4 PASANDOSTATIN 50 MCG/ML INJECTION MO 4 PASANDOSTATIN 500 MCG/ML INJECTION MO 4 PASANDOSTATIN LAR DEPOT 10 MG IM KIT SP 4 PASANDOSTATIN LAR DEPOT 20 MG IM KIT SP 4 PASANDOSTATIN LAR DEPOT 30 MG IM KIT SP 4 PASENSIPAR 30 MG TAB MO 3 QL (60 per 30 days)SENSIPAR 60 MG TAB MO 4 QL (60 per 30 days)SENSIPAR 90 MG TAB MO 4 QL (120 per 30 days)sf 1.1 % dental gel MO 2sf 5000 plus 1.1 % dental cream MO 2SIMULECT 10 MG IV SOLUTION MO 4 B vs DSIMULECT 20 MG IV SOLUTION MO 4 B vs Dsodiphluor 0.5 mg/ml drops MO 2sodium fluoride 0.25 (0.55) mg MO 2sodium fluoride 0.5 mg(1.1 mg) MO 2sodium fluoride 0.5 mg/ml drop MO 2sodium fluoride 1 mg (2.2 mg) MO 2sodium nitrite 30 mg/ml vial MO 2sodium thiosulfate 10% vial MO 2sodium thiosulfate 25% vial MO 2SOMATULINE DEPOT 120 MG/0.5 ML SUB-Q SYRINGE SP 4 PA,QL (1 per 28 days)SOMATULINE DEPOT 60 MG/0.2 ML SUB-Q SYRINGE SP 4 PA,QL (1 per 28 days)

Page 101: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 101

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

SOMATULINE DEPOT 90 MG/0.3 ML SUB-Q SYRINGE SP 4 PA,QL (1 per 28 days)stannous fluor 0.63% rinse MO 2tacrolimus 0.5 mg capsule MO 2 B vs Dtacrolimus 1 mg capsule MO 2 B vs Dtacrolimus 5 mg capsule MO 2 B vs DTHALOMID 100 MG CAP SP 3 PA,QL (30 per 30 days)THALOMID 150 MG CAP SP 4 PA,QL (60 per 30 days)THALOMID 200 MG CAP SP 4 PA,QL (30 per 30 days)THALOMID 50 MG CAP SP 3 PA,QL (30 per 30 days)THYMOGLOBULIN 25 MG IV SOLUTION MO 3 B vs DXGEVA 120 MG/1.7 ML (70 MG/ML) SUB-Q SP 4 PA,QL (1 per 28 days)XIGRIS 20 MG IV SOLUTION MO 4XIGRIS 5 MG IV SOLUTION MO 4ZAVESCA 100 MG CAP SP 4 QL (90 per 30 days)ZENAPAX 5 MG/ML VIAL MO 4ZOMETA 4 MG/100 ML IV MO 4 B vs D,QL (300 per 21 days)ZOMETA 4 MG/5 ML IV SP 4 B vs D,QL (15 per 21 days)ZORTRESS 0.25 MG TAB MO 4 B vs D,QL (60 per 30 days)ZORTRESS 0.5 MG TAB MO 4 B vs D,QL (60 per 30 days)ZORTRESS 0.75 MG TAB MO 4 B vs D,QL (60 per 30 days)OXYTOCICSCERVIDIL 10 MG VAGINAL INSERTS MO 4ERGOTRATE 0.2 MG TABLET MO 4ERGOTRATE 0.2 MG/ML AMPULE MO 4HEMABATE 250 MCG/ML IM MO 4METHERGINE 0.2 MG TAB MO 4METHERGINE 0.2 MG/ML (1 ML) INJECTION MO 4methylergonovine 0.2 mg tablet MO 3methylergonovine 0.2 mg/ml amp MO 3oxytocin 10 units/ml vial MO 2PITOCIN 10 UNIT/ML INJECTION MO 4PREPIDIL 0.5 MG/3 G VAGINAL GEL MO 4PROSTIN E2 20 MG VAGINAL SUPPOSITORY MO 4PHARMACEUTICAL AIDSFORMA-RAY 20 % SOLN MO 2STERILE BANDAGE ROLL 2.25"X3YD MO 2STERILE GAUZE PAD 2" X 2" BANDAGE MO 2STERILE GAUZE PAD 3" X 3" BANDAGE MO 2STERILE GAUZE PAD 4" X 4" BANDAGE MO 2STERILE PADS 2" X 2" BANDAGE MO 2STERILE PADS 3" X 3" BANDAGE MO 2

Page 102: Humana Walmart-Preferred Formulary - Q1Medicare

102 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

STERILE PADS 4" X 4" BANDAGE MO 2STERILE PADS BANDAGE MO 2STERILE STRETCH GAUZE BANDAGE 2" X 2 YARD MO 2STERILE STRETCH GAUZE BANDAGE 3" X 147" MO 2VEHICLE/N MILD TOPICAL SOLN MO 4VEHICLE/N TOPICAL SOLN MO 4RESPIRATORY TRACT AGENTSacetylcysteine 10% vial MO 2 B vs Dacetylcysteine 20% vial MO 2 B vs DARALAST 1,000 MG VIAL SP 4 PAARALAST NP 1,000 MG IV SUSP SP 4 PAARALAST NP 500 MG IV SUSP SP 4 PAcrolom 4% eye drops MO 2cromolyn 20 mg/2 ml neb soln MO 2 B vs Dcromolyn 4% eye drops MO 2CUROSURF 120 MG/1.5 ML INTRATRACHEAL SUSP MO 4CUROSURF 240 MG/3 ML INTRATRACHEAL SUSP MO 4GLASSIA 1 GRAM/50 ML (2 %) IV SP 4 PAINFASURF 35 MG/ML INTRATRACHEAL SUSP MO 4INTAL INHALER MO 4PROLASTIN 1,000 MG IV SUSP SP 4 PAPROLASTIN 500 MG IV SUSP SP 4 PAPROLASTIN C 1,000 MG IV SUSP SP 4 PASINGULAIR 10 MG TAB MO 4 ST,QL (30 per 30 days)SINGULAIR 4 MG CHEWABLE TAB MO 4 ST,QL (30 per 30 days)SINGULAIR 4 MG ORAL GRANULES IN PACKET MO 4 ST,QL (30 per 30 days)SINGULAIR 5 MG CHEWABLE TAB MO 4 ST,QL (30 per 30 days)SURVANTA 25 MG/ML INTRATRACHEAL SUSP MO 4XOLAIR 150 MG SUB-Q SOLN SP 4 PA,QL (750 per 28 days)zafirlukast 10 mg tablet MO 3 QL (60 per 30 days)zafirlukast 20 mg tablet MO 3 QL (60 per 30 days)ZEMAIRA 1,000 MG IV SUSP SP 4 PASERUMS, TOXOIDS, AND VACCINESACTHIB 10 MCG/0.5 ML IM MO 4ADACEL (ADOLESCENT & ADULT) 2 LF-(5-3-5MCG)-5 LF/0.5 ML IM SUSP MO

4

ADACEL (ADOLESCENT & ADULT) 2 LF-(5-3-5MCG)-5 LF/0.5ML IMSYRINGE MO

4

ALBENZA 200 MG TAB MO 4antivenin micrurus fulvius MO 2antivenin(latrodectus) vial MO 2

Page 103: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 103

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

ATTENUVAX VACCINE W-DILUENT MO 4BCG VACCINE (TICE STRAIN) VIAL MO 4 B vs DBILTRICIDE 600 MG TAB MO 4BOOSTRIX 2.5 LF UNIT-8 MCG-5 LF/0.5 ML IM SUSP MO 4BOOSTRIX 2.5 LF UNIT-8 MCG-5 LF/0.5 ML IM SYRINGE MO 4carimune nf nanofiltered 12 g iv solution SP 4 PAcarimune nf nanofiltered 3 gram iv solution SP 4 PAcarimune nf nanofiltered 6 gram iv solution SP 4 PACERVARIX VACCINE 20 MCG-20 MCG/0.5 ML IM SUSP MO 3CERVARIX VACCINE 20 MCG-20 MCG/0.5 ML IM SYRINGE MO 3COMVAX 5 MCG-7.5 MCG-125 MCG/0.5 ML IM MO 4CROFAB SOLUTION FOR INJECTION MO 4CYTOGAM 50 MG/ML IV SP 4DAPTACEL (PEDIATRIC) (PF) 15 LF UNIT-10 MCG-5 LF/0.5 ML IM SUSP MO 4DECAVAC 5 LF UNIT-2 LF UNIT/0.5 ML IM SUSP MO 4DECAVAC 5 LF UNIT-2 LF UNIT/0.5 ML IM SYRINGE MO 4DIGIBIND 38 MG VIAL MO 4DIGIFAB 40 MG IV SOLUTION MO 4diphtheria-tetanus tox-ped MO 4ENGERIX-B (PF) 10 MCG/0.5 ML IM SUSP MO 4 B vs DENGERIX-B (PF) 10 MCG/0.5 ML IM SYRINGE MO 4 B vs DENGERIX-B (PF) 20 MCG/ML IM SUSP MO 4 B vs DENGERIX-B (PF) 20 MCG/ML IM SYRINGE MO 4 B vs Dflebogamma 5% vial SP 4 PAFLEBOGAMMA DIF 10 % IV SP 4 PAflebogamma dif 5 % iv SP 4 PAFLUARIX 2009-10 SYRINGE MO 4FLULAVAL 2009-10 VIAL MO 4FLUMIST NASAL 2009-10 VACCINE MO 4FLUVIRIN 2009-2010 SYRINGE MO 4FLUVIRIN 2009-2010 VIAL MO 4FLUZONE 2009-10 SYRINGE MO 4FLUZONE 2009-10 VIAL MO 4FLUZONE HIGH-DOSE 2009-10 SYR MO 4FLUZONE PEDI 2009-10 SYRINGE MO 4GAMASTAN S/D 15 %-18 % RANGE IM SP 4 PAGAMASTAN S/D SYRINGE SP 4 PAgammagard liquid 10 % iv SP 4 PAGAMMAGARD S-D (IGA<1UG/ML) 10 GRAM IV SOLUTION SP 4 PAGAMMAGARD S-D (IGA<1UG/ML) 5 GRAM IV SOLUTION SP 4 PAGAMMAGARD S-D 0.5 GM VL W-ST SP 4 PA

Page 104: Humana Walmart-Preferred Formulary - Q1Medicare

104 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

GAMMAGARD S/D 10 GRAM IV SOLUTION SP 4 PAGAMMAGARD S/D 2.5 G IV SOLUTION SP 4 PAGAMMAGARD S/D 5 GRAM IV SOLUTION SP 4 PAGAMMAKED 1 GRAM/10 ML (10 %) INJECTION SP 4 PAGAMMAKED 10 GRAM/100 ML (10 %) INJECTION SP 4 PAGAMMAKED 2.5 GRAM/25 ML (10 %) INJECTION SP 4 PAGAMMAKED 20 GRAM/200 ML (10 %) INJECTION SP 4 PAGAMMAKED 5 GRAM/50 ML (10 %) INJECTION SP 4 PAgammaplex 5 % iv SP 4 PAGAMUNEX 10 % IV SP 4 PAGAMUNEX-C 1 GRAM/10 ML (10 %) INJECTION SP 4 PAGAMUNEX-C 10 GRAM/100 ML (10 %) INJECTION SP 4 PAGAMUNEX-C 2.5 GRAM/25 ML (10 %) INJECTION SP 4 PAGAMUNEX-C 20 GRAM/200 ML (10 %) INJECTION SP 4 PAGAMUNEX-C 5 GRAM/50 ML (10 %) INJECTION SP 4 PAGARDASIL 20MCG-40MCG-40MCG-20MCG/0.5ML IM SUSP MO 4 QL (3 per 365 days)GARDASIL 20MCG-40MCG-40MCG-20MCG/0.5ML IM SYRINGE MO 4 QL (3 per 365 days)HAVRIX (PF) 1,440 ELISA UNIT/ML IM SUSP MO 4HAVRIX (PF) 1,440 ELISA UNIT/ML IM SYRINGE MO 4HAVRIX (PF) 720 ELISA UNIT/0.5 ML IM SUSP MO 4HAVRIX (PF) 720 ELISA UNIT/0.5 ML IM SYRINGE MO 4HEPAGAM B >312 UNIT/ML (5 ML) INJECTION MO 4HEPAGAM B >312 UNIT/ML INJECTION MO 4HIBERIX 10 MCG/0.5 ML IM MO 4HIZENTRA 1 GRAM/5 ML (20 %) SUB-Q SP 4 PAHIZENTRA 2 GRAM/10 ML (20 %) SUB-Q SP 4 PAHIZENTRA 4 GRAM/20 ML (20 %) SUB-Q SP 4 PAHYPERRAB S/D (PF) 150 UNIT/ML IM MO 4HYPERRAB S/D SYRINGE MO 4HYPERRHO S/D 300 MCG IM SYRINGE MO 4hyperrho s/d 50 mcg im syringe MO 4HYPERTET S/D (PF) 250 UNIT IM SYRINGE MO 4IMOGAM RABIES-HT (PF) 150 UNIT/ML IM MO 4IMOVAX RABIES VACCINE 2.5 UNIT IM SOLUTION MO 3INFANRIX (PF) 25 LF UNIT-58 MCG-10 LF/0.5ML IM SUSP MO 4INFANRIX (PF) 25 LF UNIT-58MCG-10 LF/0.5ML IM SYRINGE MO 4INFLUENZA A (H1N1) 2009 SPRAY MO 4INFLUENZA A (H1N1) 2009 SYR MO 4INFLUENZA A (H1N1) 2009 VIAL MO 4IPOL 40 UNIT-8 UNIT-32 UNIT/0.5 ML SUSP FOR INJECTION MO 4IPOL 40 UNIT-8 UNIT-32 UNIT/0.5 ML SYRINGE MO 4

Page 105: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 105

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

IXIARO (PF) 6 MCG/0.5 ML IM SYRINGE MO 4JE-VAX SUB-Q SOLN MO 4KINRIX 25 LF-58 MCG-10 LF/0.5 ML IM SUSP MO 4KINRIX 25 LF-58 MCG-10 LF/0.5 ML IM SYRINGE MO 4M-M-R II (PF) 1,000-12,500 TCID50/0.5 ML SUB-Q SUSP MO 4mebendazole 100 mg tab chew MO 2MENACTRA (PF) 4 MCG/0.5 ML IM MO 4MENACTRA 4 MCG/0.5 ML SYRINGE MO 4MENOMUNE - A/C/Y/W-135 (PF) 50 MCG SUB-Q SOLN MO 4MENOMUNE - A/C/Y/W-135 50 MCG SUB-Q SOLN MO 4MENVEO A-C-Y-W-135-DIP (PF) 10 MCG-5 MCG/0.5 ML IM KIT MO 4MERUVAX II VACCINE-DILUENT MO 4MICRHOGAM ULTRA-FILTERED 50 MCG IM SYRINGE MO 4MICRHOGAM ULTRA-FILTERED PLUS 50 MCG IM SYRINGE MO 4MUMPSVAX VACCINE-DILUENT MO 4NABI-HB >1,560 UNIT/5 ML IM MO 4NABI-HB >312 UNIT/ML IM MO 4OCTAGAM 5% VIAL SP 4 PAPEDIARIX (PF) 10MCG-25LF-25MCG-10LF-40-8-32 IM SYRINGE MO 4 B vs DPEDIARIX 0.5 ML VIAL MO 4 B vs DPEDVAX HIB (PF) 7.5 MCG/0.5 ML IM MO 4PENTACEL 15 LF UNIT-20 MCG-5 LF /0.5ML IM KIT MO 4PREVNAR 13 0.5 ML IM SYRINGE MO 4privigen 10 % iv SP 4 PAPROQUAD 10EXP3-4.3-3-3.99TCID50/0.5ML SUB-Q MO 4RABAVERT (PF) 2.5 UNIT IM KIT MO 3RECOMBIVAX HB (PF) 10 MCG/ML IM SUSP MO 4 B vs DRECOMBIVAX HB (PF) 10 MCG/ML IM SYRINGE MO 4 B vs DRECOMBIVAX HB (PF) 40 MCG/ML IM SUSP MO 4 B vs DRECOMBIVAX HB (PF) 5 MCG/0.5 ML IM SUSP MO 4 B vs DRHOGAM ULTRA-FILTERED 300 MCG IM SYRINGE MO 4RHOGAM ULTRA-FILTERED PLUS 300 MCG IM SYRINGE MO 4RHOPHYLAC 300 MCG/2 ML SYRINGE MO 4ROTARIX 10EXP6 CCID50/ML ORAL SUSP MO 4ROTATEQ VACCINE 2 ML ORAL SUSP MO 4STROMECTOL 3 MG TAB MO 4tetanus diphtheria toxoids MO 4tetanus toxoid adsorbed vial MO 4THERACYS 81 MG INTRAVESICAL SUSP MO 4 B vs DTICE BCG 50 MG INTRAVESICAL SUSP MO 4TRIHIBIT PRESERVATIVE FREE 6.7 LF-46.8 MCG-5 LF-10 MCG IM KIT MO 4

Page 106: Humana Walmart-Preferred Formulary - Q1Medicare

106 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

TRIPEDIA (PF) 6.7 LF UNIT-46.8 MCG-5/0.5 ML IM SUSP MO 4TWINRIX (PF) 720 ELISA UNIT-20 MCG/ML IM SUSP MO 4TWINRIX (PF) 720 ELISA UNIT-20 MCG/ML IM SYRINGE MO 4TYPHIM VI 25 MCG/0.5 ML IM MO 4TYPHIM VI 25 MCG/0.5 ML IM SYRINGE MO 4VAQTA (PF) 25 UNIT/0.5 ML IM SUSP MO 4VAQTA (PF) 50 UNIT/ML IM SUSP MO 4VAQTA 50 UNITS/ML SYRINGE MO 4VARIVAX (PF) 1,350 UNIT/0.5 ML SUB-Q SOLN MO 3VIVAGLOBIN 16 % (160 MG/ML) SUB-Q SP 4 PAWINRHO SDF 1,500 UNIT/1.3 ML INJECTION MO 2WINRHO SDF 15,000 UNIT/13 ML INJECTION MO 2WINRHO SDF 2,500 UNIT/2.2 ML INJECTION MO 2WINRHO SDF 5,000 UNIT/4.4 ML INJECTION MO 2YF-VAX 10 EXP4.74 UNIT/0.5 ML SUB-Q SUSP MO 4ZOSTAVAX 19,400 UNIT SUB-Q SOLN MO 4 QL (1 per 365 days)SKIN AND MUCOUS MEMBRANE AGENTS8-MOP 10 MG CAP MO 4acid jelly 0.921 %-0.7 %-0.025 % vaginal gel MO 2acticin 5% cream MO 2ACZONE 5 % TOPICAL GEL MO 4adapalene 0.1% cream MO 3adapalene 0.1% gel MO 3ALA-SCALP 2 % LOTION MO 2alclometasone dipr 0.05% oint MO 2alclometasone dipro 0.05% crm MO 2ALCOHOL PADS MO 2ALCOHOL PREP PADS MO 2ALCOHOL PREP SWABS MO 2ALCOHOL SWABS MO 2ALCOHOL WIPES MO 2aliclen 6 % shampoo MO 2ALTABAX 1 % OINTMENT MO 4aluvea 40% cream MO 2amcinonide 0.1% cream MO 2amcinonide 0.1% lotion MO 2amcinonide 0.1% ointment MO 2AMERICAINE ANESTHETIC 20 % TOPICAL LUBRICANT MO 4ammonium lactate 12% cream MO 2ammonium lactate 12% lotion MO 2ANACAINE 10 % OINTMENT MO 4

Page 107: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 107

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

apexicon 0.05 % ointment MO 3apexicon e 0.05 % topical cream MO 3AVC VAGINAL 15 % CREAM MO 2BACTROBAN 2 % TOPICAL CREAM MO 4BD ALCOHOL SWAB TOPICAL PADS MO 2bencort lotion MO 2benprox 2.75% gel MO 2benprox 5.25% gel MO 2benprox 5.25% wash MO 2bensal hp 3 %-6 % ointment MO 2BENZASHAVE 10% CREAM MO 4BENZASHAVE 5% CREAM MO 4benzoin tincture MO 2benzoyl perox 4% creamy wash MO 2benzoyl perox 8% creamy wash MO 2benzoyl peroxide 10% gel MO 2benzoyl peroxide 10% wash MO 2benzoyl peroxide 2.5% gel MO 2benzoyl peroxide 2.5% wash MO 2benzoyl peroxide 3% cleanser MO 2benzoyl peroxide 3% pad MO 2benzoyl peroxide 4% gel MO 2benzoyl peroxide 4% lotion MO 2benzoyl peroxide 4% wash kit MO 2benzoyl peroxide 4.5% cleanser MO 2benzoyl peroxide 4.5% pads MO 2benzoyl peroxide 5% gel MO 2benzoyl peroxide 5% wash MO 2benzoyl peroxide 6% cleanser MO 2benzoyl peroxide 6% pad MO 2benzoyl peroxide 6.5% cleanser MO 2benzoyl peroxide 6.5% pads MO 2benzoyl peroxide 8% gel MO 2benzoyl peroxide 8% lotion MO 2benzoyl peroxide 8% wash kit MO 2benzoyl peroxide 8.5% cleanser MO 2benzoyl peroxide 8.5% pads MO 2benzoyl peroxide 9% cleanser MO 2benzoyl peroxide 9% pad MO 2betamethasone dp 0.05% crm MO 2betamethasone dp 0.05% lot MO 2

Page 108: Humana Walmart-Preferred Formulary - Q1Medicare

108 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

betamethasone dp 0.05% oint MO 2betamethasone dp aug 0.05% crm MO 2betamethasone dp aug 0.05% gel MO 2betamethasone dp aug 0.05% lot MO 2betamethasone dp aug 0.05% oin MO 2betamethasone va 0.1% cream MO 2betamethasone va 0.1% lotion MO 2betamethasone valer 0.1% ointm MO 2bp 10-1 10 %-1 % topical cleanser MO 2bp 5.25 % topical susp MO 2bpo 4 % topical gel MO 2bpo 8 % topical gel MO 2calcipotriene 0.005% ointment MO 3calcipotriene 0.005% solution MO 3 QL (60 per 30 days)calcitrene 0.005 % ointment MO 3capsicum tincture MO 2CARAC 0.5 % TOPICAL CREAM MO 4cerisa 10 %-1 % topical cleanser MO 2cerovel 40% gel MO 2cerovel 40% lotion MO 2CETACAINE MEDICAL KIT E 2 %-2 %-14 % TOPICAL MO 4 B vs Dciclodan 8 % topical soln MO 3ciclopirox 0.77% cream MO 3ciclopirox 0.77% gel MO 3ciclopirox 0.77% topical susp MO 3ciclopirox 1% shampoo MO 3ciclopirox 8 % kit MO 3ciclopirox 8% solution MO 3CLINAC BPO 7 % TOPICAL GEL MO 4clinda-derm 1 % topical soln MO 2clindacin p 1 % topical swab MO 2clindamax 1 % lotion MO 2clindamax 1 % topical gel MO 2clindamycin 2% vaginal cream MO 2clindamycin ph 1% gel MO 2clindamycin ph 1% solution MO 2clindamycin phos 1% pledget MO 2clindamycin phosp 1% lotion MO 2clindamycin-benzoyl perox gel MO 2CLINDAREACH 1 % TOPICAL KIT MO 4clindets 1% pledgets MO 2

Page 109: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 109

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

clobetasol 0.05% cream MO 2clobetasol 0.05% gel MO 2clobetasol 0.05% ointment MO 2clobetasol 0.05% solution MO 2clobetasol emollient 0.05% crm MO 2clobetasol prop 0.05% foam MO 2clotrimazole 1% cream MO 2clotrimazole 1% solution MO 2clotrimazole 10 mg troche MO 2clotrimazole-betamethasone crm MO 2clotrimazole-betamethasone lot MO 2colocort 100 mg/60 ml enema MO 2CONSTANT CLENS SPRAY MO 4cormax 0.05 % topical soln MO 4cortalo 2% gel MO 4CORTIFOAM 10 % (80 MG) RECTAL MO 4CURITY ALCOHOL SWABS MO 2DEBACTEROL 30 %-50 % MUCOSAL SWAB MO 4DENAVIR 1 % TOPICAL CREAM MO 3desonide 0.05% cream MO 2desonide 0.05% lotion MO 2desonide 0.05% ointment MO 2desoximetasone 0.05% cream MO 3desoximetasone 0.05% gel MO 3desoximetasone 0.25% cream MO 3desoximetasone 0.25% ointment MO 3desquam-x 5 % topical cleanser MO 2diflorasone 0.05% cream MO 3diflorasone 0.05% ointment MO 3DOAK TAR DISTILLATE LIQUID MO 4DRITHO-SCALP 0.5 % TOPICAL CREAM MO 4DRITHOCREME HP 1 % TOPICAL MO 4DUAC CS CONVENIENCE KIT MO 4econazole nitrate 1% cream MO 2ELIDEL 1 % TOPICAL CREAM MO 4emgel 2 % topical MO 2EPIDUO 0.1 %-2.5 % TOPICAL GEL MO 4ery pads 2 % topical swab MO 2erythromycin 2% gel MO 2erythromycin 2% pledgets MO 2erythromycin 2% solution MO 2

Page 110: Humana Walmart-Preferred Formulary - Q1Medicare

110 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

erythromycin-benzoyl gel MO 3EURAX 10 % LOTION MO 4EURAX 10 % TOPICAL CREAM MO 4exoderm 25 %-1 % lotion MO 2fluocinolone 0.01% cream MO 2fluocinolone 0.01% solution MO 2fluocinolone 0.025% cream MO 2fluocinolone 0.025% oint MO 2fluocinonide 0.05% cream MO 1fluocinonide 0.05% gel MO 2fluocinonide 0.05% ointment MO 2fluocinonide 0.05% solution MO 2fluocinonide-e 0.05 % topical cream MO 2fluocinonide-emol 0.05% cream MO 2FLUOROPLEX 1 % TOPICAL CREAM MO 4fluorouracil 2% topical soln MO 3fluorouracil 5% cream MO 3fluorouracil 5% top solution MO 3fluticasone prop 0.005% oint MO 2fluticasone prop 0.05% cream MO 2gentamicin 0.1% cream MO 1gentamicin 0.1% ointment MO 1GLUCOPRO ALCOHOL TOPICAL PADS MO 2GORDOFILM 16.7 %-16.7 % TOPICAL SOLN MO 4GORDONS UREA 22 % OINTMENT MO 4GORDONS UREA 40 % OINTMENT MO 4GUAIACOL LIQUID PURIFIED MO 4halac 0.05 %-12 % topical pack, ointment & lotion MO 3halobetasol prop 0.05% cream MO 3halobetasol prop 0.05% ointmnt MO 3HALOG 0.1 % OINTMENT MO 4HALOG 0.1 % TOPICAL CREAM MO 4halonate 0.05 %-12 % topical pack, ointment & foam MO 4halonate pac 0.05 %-12 % topical pack, ointment & lotion MO 3HALOTIN 1% CREAM MO 4helistat 3" x 4" sponge MO 4hydrocortisone 0.1% soln MO 2hydrocortisone 1% absorbase MO 2hydrocortisone 1% cream MO 1hydrocortisone 1% lotion MO 2hydrocortisone 100 mg enema MO 2

Page 111: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 111

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

hydrocortisone 2.5% cream MO 2hydrocortisone 2.5% lotion MO 2hydrocortisone 2.5% ointment MO 2hydrocortisone acetate 2% gel MO 2hydrocortisone buty 0.1% cream MO 2hydrocortisone butyr 0.1% oint MO 2hydrocortisone val 0.2% cream MO 2hydrocortisone val 0.2% ointmt MO 2hypercare 20 % topical soln MO 2imiquimod 5% cream packet MO 3 QL (12 per 30 days)INOVA 4 %-5 % TOPICAL COMBO PACK MO 4INOVA 4-1 1 %-4 %-5 % TOPICAL COMBO PACK MO 4IV PREP WIPES MEDICATED MO 2KENALOG 0.147 MG/GRAM TOPICAL AEROSOL MO 4KEPIVANCE 6.25 MG SOLUTION SP 4KERAFOAM 30 % TOPICAL FOAM MO 4KERAFOAM 42 % TOPICAL FOAM MO 4keralac 50 % topical cream MO 2keratol plus 50% gel MO 3ketoconazole 2% cream MO 2ketoconazole 2% shampoo MO 2laclotion 12 % MO 4lavoclen-4 (new cleanser) 4 % topical kit MO 2lavoclen-4 4 % topical cleanser MO 2lavoclen-8 (new cleanser) 8 % topical kit MO 2lavoclen-8 8 % topical cleanser MO 2LEVULAN 20 % TOPICAL SOLN MO 4lidocaine 5% ointment MO 2 B vs Dlidocaine-hc 3-0.5% cream MO 3lidocaine-hc 3-0.5% cream kit MO 3lidocaine-hc 3-0.5% cream kit MO 3lidocaine-hc 3-0.5% lotion MO 3 B vs Dlidocaine-hc 3-1% cream kit MO 3lidocaine-prilocaine cream MO 2 B vs DLIDODERM 5 % (700 MG/PATCH) ADHESIVE PATCH MO 4 PA,QL (90 per 30 days)lindane 1% lotion MO 3lindane 1% shampoo MO 3lokara 0.05 % lotion MO 2LTA PRE-ATTACHED 4 % TOPICAL SOLN MO 4 B vs Dlugols 5 %-10 % topical soln MO 2malathion 0.5% lotion MO 2

Page 112: Humana Walmart-Preferred Formulary - Q1Medicare

112 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

MENTAX 1 % TOPICAL CREAM MO 4metronidazole 0.75% cream MO 2metronidazole 0.75% lotion MO 2metronidazole topical 0.75% gl MO 2metronidazole vaginal 0.75% gl MO 2METVIXIA 16.8 % (168 MG/GRAM) TOPICAL CREAM MO 4miconazole-3 200 mg vaginal suppository MO 2mometasone furoate 0.1% cream MO 2mometasone furoate 0.1% oint MO 2mometasone furoate 0.1% soln MO 2mupirocin 2% ointment MO 3neomy-polymyxin b 40 mg/ml amp MO 3nuzole 2 % topical cream MO 3nyamyc 100,000 unit/g topical powder MO 2nystatin 100,000 unit/gm cream MO 1nystatin 100,000 unit/gm powd MO 2nystatin 100,000 units/gm oint MO 1nystatin vaginal tablet MO 2nystatin-triamcinolone cream MO 1nystatin-triamcinolone ointm MO 1nystop 100,000 unit/g topical powder MO 2OLUX-OLUX-E COMPLETE PACK MO 4oralone 0.1 % dental paste MO 2oscion 3 % topical cleanser MO 2oscion 3 % topical pads MO 2oscion 6 % topical cleanser MO 2oscion 6 % topical pads MO 2oscion 9 % topical cleanser MO 2oscion 9 % topical pads MO 2OVACE PLUS 10% SHAMPOO MO 4OXALIS OINTMENT MO 4OXSORALEN 1 % LOTION MO 4OXSORALEN ULTRA 10 MG CAP MO 4PAIN EASE TOPICAL SPRAY MO 4PANRETIN 0.1 % TOPICAL GEL MO 4pedi-dri 100,000 unit/g topical powder MO 2permethrin 5% cream MO 2phenazopyridine 100 mg tab MO 1phenazopyridine 200 mg tab MO 1podocon 25 % topical liquid MO 3podofilox 0.5% topical soln MO 3

Page 113: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 113

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

PONTOCAINE 2 % TOPICAL SOLN MO 4pramox 1% gel MO 2prednicarbate 0.1% cream MO 2prednicarbate 0.1% ointment MO 2procto-pak 1 % rectal cream MO 2proctocream-hc 2.5 % rectal MO 2proctosol hc 2.5 % rectal cream MO 2proctozone-hc 2.5 % rectal cream MO 2PYROGALLIC ACID 25 %-2 % OINTMENT MO 4re 40 gel MO 2re benzoyl peroxide 3.5% cream MO 2re benzoyl peroxide 5.5% cream MO 2re benzoyl peroxide 8.5% cream MO 2re sa 6% cream MO 2re sa 6% lotion MO 2re urea 40 lotion MO 2re-u40 foam MO 2REGRANEX 0.01 % TOPICAL GEL MO 4relagard 0.9 %-0.025 % vaginal gel MO 2remeven 50 % topical cream MO 2RIMSO-50 50 % INTRAVESICAL MO 2salacyn 6 % lotion MO 2salicylic acid 6% cream MO 2salicylic acid 6% gel MO 2salicylic acid 6% lotion MO 2salicylic acid 6% shampoo MO 2salitop 6% cream MO 2salitop 6% lotion MO 2SANTYL 250 UNIT/G OINTMENT MO 4scalacort 2% lotion MO 2scalp treatment kit MO 2selenium sulfide 2.25% shampoo MO 2selenium sulfide 2.5% lotion MO 2selenos 2.25% shampoo MO 2silver nitrate 0.5% soln MO 2silver nitrate 10% ointment MO 2silver nitrate 10% solution MO 2silver nitrate 25% solution MO 2silver nitrate 50% solution MO 2silver sulfadiazine 1% crm MO 1sod sulfacet-sulfur 10-5% gel MO 3

Page 114: Humana Walmart-Preferred Formulary - Q1Medicare

114 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

sodium sulfacetamide med pads MO 2SOLARAZE 3 % TOPICAL GEL MO 3SORIATANE 10 MG CAP MO 4SORIATANE 17.5 MG CAP MO 4SORIATANE 22.5 MG CAPSULE MO 4SORIATANE 25 MG CAP MO 4SORIATANE CK 10 MG KIT MO 4SORIATANE CK 25 MG KIT MO 4SPRAY AND STRETCH TOPICAL MO 4STELARA 45 MG/0.5 ML SUB-Q SYRINGE SP 4 PA,QL (3 per 84 days)STELARA 45 MG/0.5 ML VIAL SP 4 PA,QL (3 per 84 days)STELARA 90 MG/ML SUB-Q SYRINGE SP 4 PA,QL (3 per 84 days)sulfacetamide sod 10% top susp MO 2sulfacetamide sodium 10% lot MO 2sulfatol cleanser MO 2sulfatol gel MO 2sulzee wash MO 2SURE COMFORT ALCOHOL PREP PADS MO 2SURE-PREP ALCHOLOL PREP PADS TOPICAL PADS MO 2TARGRETIN 1 % TOPICAL GEL SP 4 PATAZORAC 0.05 % TOPICAL CREAM MO 4TAZORAC 0.05 % TOPICAL GEL MO 4TAZORAC 0.1 % TOPICAL CREAM MO 4TAZORAC 0.1 % TOPICAL GEL MO 4terconazole 0.4% cream MO 2terconazole 0.8% cream MO 2terconazole 80 mg suppository MO 2TEXACORT 2.5 % TOPICAL SOLN MO 4THERMAZENE 1 % TOPICAL CREAM MO 1tretinoin 0.01% gel MO 3 PAtretinoin 0.025% cream MO 3 PAtretinoin 0.025% gel MO 3 PAtretinoin 0.05% cream MO 3 PAtretinoin 0.1% cream MO 3 PATRI-CHLOR 80 % TOPICAL SOLN MO 4triamcinolone 0.025% cream MO 1triamcinolone 0.025% lotion MO 2triamcinolone 0.025% oint MO 2triamcinolone 0.05% oint MO 2triamcinolone 0.1% cream MO 1triamcinolone 0.1% lotion MO 2

Page 115: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 115

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

triamcinolone 0.1% ointment MO 1triamcinolone 0.1% paste MO 2triamcinolone 0.5% cream MO 1triamcinolone 0.5% ointment MO 2trichloroacetic acid 25% MO 2trichloroacetic acid powder MO 2triderm 0.1 % topical cream MO 2u-cort 1 %-10 % topical cream MO 2u40 foam MO 2ULTILET ALCOHOL SWAB MO 2UMECTA 40 % TOPICAL MO 4umecta 40 % topical foam MO 4UMECTA 40 % TOPICAL SUSP MO 4UMECTA PD 40 % TOPICAL EMULSION MO 4UMECTA PD 40 % TOPICAL SUSPENSION MO 4URAMAXIN 20 % TOPICAL FOAM MO 4urea 35% lotion MO 3urea 40 gel MO 2urea 40 lotion MO 2urea 40% cream MO 2urea 40% gel MO 2urea 40% lotion MO 2urea 40% nail film susp MO 2urea 42% cloths MO 2urea 50% cream MO 2urea 50% nail gel MO 3urea 50% nail stick MO 2urea 50% nailstik MO 2urea 50% ointment MO 2urealac 35% lotion MO 3urealac 50% cream MO 2urealac 50% nail gel MO 3UVADEX 20 MCG/ML INJECTION MO 4 B vs DVEREGEN 15 % OINTMENT MO 4vitazol 0.75 % topical cream MO 4WEBCOL TOPICAL PADS MO 2x-viate 40 % lotion MO 2x-viate 40 % topical cream MO 2x-viate 40 % topical gel MO 2XERAC AC 6.25 % TOPICAL SOLN MO 4zaclir 4 % lotion MO 2

Page 116: Humana Walmart-Preferred Formulary - Q1Medicare

116 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

zaclir 8 % lotion MO 2ZODERM 4.5% CREAM MO 4ZODERM 4.5% GEL MO 4ZODERM 6.5% CREAM MO 4ZODERM 6.5% GEL MO 4ZODERM 8.5% CREAM MO 4ZODERM 8.5% GEL MO 4ZOVIRAX 5 % OINTMENT MO 3ZOVIRAX 5 % TOPICAL CREAM MO 3 STSMOOTH MUSCLE RELAXANTSaminophylline 100 mg tablet MO 2aminophylline 200 mg tablet MO 2aminophylline 250 mg/10 ml vl MO 2aminophylline 500 mg/20 ml vl MO 2ELIXOPHYLLIN 80 MG/15 ML MO 2flavoxate hcl 100 mg tablet MO 3oxybutynin 5 mg tablet MO 1oxybutynin 5 mg/5 ml syrup MO 2oxybutynin cl er 10 mg tablet MO 3 QL (60 per 30 days)oxybutynin cl er 15 mg tablet MO 3 QL (60 per 30 days)oxybutynin cl er 5 mg tablet MO 3 QL (60 per 30 days)theophylline 200 mg/100 ml d5w MO 2theophylline 200 mg/50 ml d5w MO 2theophylline 400 mg/250 ml d5w MO 2theophylline 400 mg/500 ml d5w MO 2theophylline 80 mg/15 ml soln MO 2theophylline 800 mg/1 l d5w MO 2theophylline 800 mg/250 ml d5w MO 2theophylline 800 mg/500 ml d5w MO 2theophylline er 100 mg tablet MO 2theophylline er 200 mg tablet MO 2theophylline er 300 mg tab MO 2theophylline er 400 mg tablet MO 2theophylline er 450 mg tab MO 2theophylline er 600 mg tablet MO 2trospium chloride 20 mg tablet MO 3VITAMINSadvanced care plus tablet MO 2ATABEX EC 29 MG-1 MG-50 MG TAB MO 4bal-care dha 27 mg-1 mg-430 mg pack,tab&cap,dr MO 3calcitriol 0.25 mcg capsule MO 3 B vs D

Page 117: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 117

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

calcitriol 0.5 mcg capsule MO 3 B vs Dcalcitriol 1 mcg/ml ampul MO 3 B vs Dcalcitriol 1 mcg/ml solution MO 3 B vs Dcavan one omega 27 mg-1 mg-330 mg cap MO 2cavan-ec sod dha 30 mg-1 mg-440 mg pack,tab&cap,dr MO 2cavan-folate dha combo pack MO 2cavan-folate ob tablet MO 2cavan-heme ob tablet MO 2co-natal fa 29 mg-1 mg tab MO 2complete natal dha 29 mg-1 mg-250 mg oral pack MO 2complete-rf prenatal 90 mg-1 mg-50 mg tab MO 2completenate 29 mg-1 mg chewable tab MO 2corenate-dha combo pack MO 2dexpanthenol 250 mg/ml vial MO 2docosavit softgel MO 2ED CYTE F 106 MG-1 MG-50 MG TAB MO 4edge ob caplet MO 2elite-ob 28 mg-1.25 mg-200 mg cap MO 2elite-ob 400 35 mg-5 mg-1.2 mg-400 mg cap MO 2elite-ob 50 mg-1.25 mg tab MO 2fe c plus 100 mg-250 mg-25 mcg-1 mg tab MO 2FEMECAL OB PLUS DHA COMBO PACK MO 4FEMECAL OB TABLET MO 4folbecal 200 mg-75 mg-12 mcg-1 mg 24 hr tab MO 2folcal dha softgel MO 2folcaps care one capsule MO 2folinatal plus b 200 mg-75 mg-12 mcg-1 mg 24 hr tab MO 2folivane-ec calcium dha combo MO 2folivane-ob 85 mg-1 mg cap MO 4folivane-prx dha nf 30 mg-1.24 mg-55 mg-265 mg cap MO 2foltabs 90 plus dha pack MO 2foltabs prenatal plus dha MO 2foltabs prenatal tablet MO 2gentex ade tablet MO 2HECTOROL 0.5 MCG CAP MO 3 B vs DHECTOROL 1 MCG CAP MO 3 B vs DHECTOROL 2 MCG/ML (1 ML) IV MO 3 B vs DHECTOROL 2.5 MCG CAP MO 3 B vs DHECTOROL 4 MCG/2 ML IV MO 3 B vs DICAR-C PLUS SR 100 MG-320 MG-25 MCG-1 MG CAP MO 4inatal advance 90 mg-1 mg-50 mg tab MO 2

Page 118: Humana Walmart-Preferred Formulary - Q1Medicare

118 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

inatal gt 90 mg-1 mg-50 mg tab MO 2inatal ultra 90 mg-1 mg-50 mg tab MO 2kolnatal dha dr combo pack MO 2lactocal-f 65 mg-1 mg tab MO 2levomefolatepnv 29 mg-0.5 mg-1.4 mg-200 mg oral pack MO 3M-VIT 27 MG-1 MG TAB MO 4MARNATAL-F 60 MG (IRON)-1 MG CAP MO 4MARNATAL-F PLUS COMBO PACK MO 4maternity 27 mg-1 mg tab MO 2MAXINATE 20 MG-0.8 MG TAB MO 4MULTI-NATE 30 DHA 430 MG VIT MO 4MULTI-NATE 30 DHA PRENATAL VIT MO 4multi-nate 30 tablet MO 2MULTI-NATE DHA EXTRA PRENATAL MO 4multi-vitamin with fluoride 0.25 mg chewable tab MO 2multi-vitamin with fluoride 0.5 mg chewable tab MO 2multi-vitamin with fluoride 1 mg chewable tab MO 2multinatal plus 30 mg-1 mg tab MO 2multinatal plus 40 mg-1 mg chewable tab MO 2multivit-fluor 0.25 mg tab chw MO 2multivit-fluoride 1 mg tab chw MO 2MYKIDZ IRON FLUORIDE 10 MG-0.25 MG-1,500 UNIT/2 ML ORAL SUSP MO 4MYNATAL 65 MG-1 MG CAP MO 4mynatal 90 mg-1 mg-50 mg tab MO 2mynatal advance 90 mg-1 mg-50 mg tab MO 2mynatal plus 65 mg-1 mg tab MO 2mynatal-z 65 mg-1 mg tab MO 2mynate 90 plus 90 mg-1 mg tab MO 2NATAFORT TABLET MO 4NATALVIT 75 MG-1 MG TAB MO 4navatab + dha pack MO 2NEEVO CAPLET MO 4NEEVO DHA CAPSULE MO 4O-CAL FA 66 MG-1 MG TAB MO 4O-CAL PRENATAL 15 MG-1 MG TAB MO 4ob-natal one 27 mg-1 mg-330 mg cap MO 2obstetrix dha 29 mg-1 mg-50 mg pack,tab&cap,dr MO 2OBSTETRIX EC 29 MG-1 MG-50 MG TAB MO 4paire ob plus dha 22 mg-6 mg-1 mg-200 mg oral pack MO 3pnv ob+dha 27 mg-1 mg-50 mg-250 mg oral pack MO 3pnv-dha 27 mg-1 mg-300 mg cap MO 2

Page 119: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 119

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

pnv-iron tablet MO 2pnv-omega 28 mg-1 mg-300 mg cap MO 2pnv-select 27 mg-1 mg tab MO 2pnv-total 35 mg-5 mg-1.2 mg-400 mg cap MO 2poly iron pn 60 mg (iron)-1 mg tab MO 2poly iron pn forte 60 mg (iron)-1 mg tab MO 2poly-vitamin/fluoride/iron 0.5 mg-10 mg/ml oral drops MO 2pr natal 400 29 mg-1 mg-400 mg oral pack MO 2pr natal 400 ec 29 mg-1 mg-400 mg pack,tab&cap,dr MO 2pr natal 430 29 mg-1 mg-430 mg oral pack MO 2pr natal 430 ec 29 mg-1 mg-430 mg pack,tab&cap,dr MO 2pr natal 440 ec combo pack MO 2prenacare tablet MO 2prenafirst 17 mg-1 mg tab MO 2prenaplus 27 mg-1 mg tab MO 2PRENATABS FA 29 MG-1 MG TAB MO 2PRENATABS RX 29 MG-1 MG TAB MO 2prenatal 19 29 mg-1 mg chewable tab MO 2prenatal 19 29 mg-1 mg tab MO 2prenatal ad 90 mg-1 mg-50 mg tab MO 2prenatal low iron 27 mg-1 mg tab MO 2prenatal plus (calcium carbonate) 27 mg-1 mg tab MO 2prenatal plus with iron (calcium carbonate) 27 mg-1 mg tab MO 2previte rx tablet MO 2pruet dha ec prenatal vitamins MO 2pruet dha ec prenatal vits MO 2pruet dha prenatal vitamins MO 2pruet dha vitamins MO 2re dualvit ob capsule MO 2re multivit-fluor 0.25 mg tab MO 2re multivit-fluor 0.5 mg tab MO 2re multivit-fluor 1 mg tab chw MO 2re ob + dha pack MO 2RE OB 90 + DHA PACK MO 4re prenatal multivit w-iron tb MO 2re previt+dha softgel MO 2re-nata 29 ob prenatal tablet MO 2re-nata 29 prenatal tablet MO 2relnate dha 28 mg-1 mg-200 mg cap MO 3renate caplet MO 4RENATE DHA 430 MG PRENATAL VIT MO 4

Page 120: Humana Walmart-Preferred Formulary - Q1Medicare

120 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

RENATE DHA EXTRA PRENATAL VITS MO 4RENATE DHA EXTRA VITAMINS MO 4RENATE DHA PRENATAL VITAMINS MO 4rovin-nv dha capsule MO 4rovin-nv tablet MO 4se-care 40 mg-1 mg chewable tab MO 2se-care conceive 30 mg-1 mg tab MO 2se-care gesture 28 mg-1 mg 24 hr tab MO 2se-natal 19 29 mg-1 mg chewable tab MO 2se-natal 19 29 mg-1 mg tab MO 2se-natal 90 dr tablet MO 2se-natal one 60 mg (iron)-1 mg tab MO 2se-plete dha 28 mg-1.25 mg-200 mg cap MO 2se-tan dha 30 mg-1 mg-310.1 mg cap MO 2SELECT-OB + DHA 29 MG-1 MG-250 MG ORAL PACK MO 4SELECT-OB 29 MG-1 MG CHEWABLE TAB MO 4setonet 29 mg-1 mg-430 mg oral pack MO 2SETONET-EC 29 MG-1 MG-430 MG PACK,TAB&CAP,DR MO 2taron a prenatal dha comb pack MO 2taron ec calcium dha comb pack MO 2taron-bc 20 mg (iron)-1 mg/25 mg tab MO 2taron-c dha 35 mg-1 mg-200 mg cap MO 2TARON-DUO EC 29 MG-1 MG-400 MG PACK,TAB&CAP,DR MO 2taron-ec cal tablet MO 2taron-prex prenatal-dha 30 mg-1.2 mg-55 mg-265 mg cap MO 2tri rx 27 mg-1 mg-50 mg tab MO 2tri-vit with fluoride & iron 0.25 mg-10 mg/ml oral drops MO 2tri-vitamin w/fluoride & iron 0.25 mg-10 mg/ml oral drops MO 2triadvance 90 mg-1 mg-50 mg tab MO 2tricare 27 mg-1 mg tab MO 2TRICARE DHA 301 CAPSULE MO 4trifera ob tablet MO 2trimesis rx 200 mg-75 mg-12 mcg-1 mg 24 hr tab MO 2trinatal gt 90 mg-1 mg-50 mg tab MO 2trinatal rx 1 60 mg (iron)-1 mg tab MO 2trinatal ultra 90 mg-1 mg-50 mg tab MO 2TRINATE 28 MG-1 MG TAB MO 2triple vitamin with fluoride 0.5 mg/ml oral drops MO 2triveen-duo dha 29 mg-1 mg-400 mg oral pack MO 2triveen-one 27 mg-1 mg-250 mg cap MO 2triveen-prx rnf 26 mg-1.2 mg-55 mg-300 mg cap MO 2

Page 121: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 121

ST - Step Therapy • QL - Quantity Limit • PA - Prior Authorization • B vs D - Part B versus Part D

Need more information about the indicators displayed by the drug names? Please refer to page 8.

DRUG NAME TIERUTILIZATION

MANAGEMENTREQUIREMENTS

triveen-ten 15 mg-0.5 mg-50 mg-50 mg tab MO 3triveen-u 106.5 mg-1 mg cap MO 2trust natal dha 29 mg-1 mg-250 mg oral pack MO 2ultimatecare advantage combo MO 2ultimatecare combo pack MO 2ultimatecare one 27 mg-1 mg-330 mg cap MO 2ultimatecare one nf 27 mg-1 mg-50 mg-500 mg cap MO 2vena-bal dha 27 mg-1 mg-430 mg pack,tab&cap,dr MO 3venatal complete dha 27 mg-1 mg-430 mg pack,tab&cap,dr MO 3vinacal 27 mg-1 mg-50 mg tab MO 2vinate az 27 mg-1 mg tab MO 2vinate az 29 mg-1 mg tab MO 2vinate c 30 mg-1 mg tab MO 2vinate calcium 27 mg-1 mg-50 mg tab MO 2vinate care 40 mg-1 mg chewable tab MO 2vinate gt 90 mg-1 mg-50 mg tab MO 2vinate ic 162 mg-115.2 mg (106 mg)-1 mg cap MO 2vinate ii 29 mg-1 mg tab MO 2vinate iii tablet MO 2vinate m 27 mg-1 mg tab MO 2vinate one 60 mg (iron)-1 mg tab MO 2vinate pn care 30 mg-1 mg-50 mg tab MO 2vinate ultra 90 mg-1 mg-50 mg tab MO 2VITAFOL-PN (UD) 65 MG-1 MG TAB MO 4vitanatal ob + dha combo pack MO 2vitaphil + dha 90 pack MO 2vitaphil + dha pack MO 2vitaphil aide caplet MO 2vitaphil caplet MO 2vitaspire 29 mg-1 mg tab MO 2VIVA DHA 28 MG-1 MG-200 MG CAP MO 4vynatal fa 65 mg-1 mg tab MO 2zatean-ch 27 mg-1 mg-50 mg-250 mg cap MO 2zatean-pn 27 mg-1 mg tab MO 2zatean-pn dha 27 mg-1 mg-300 mg cap MO 2ZEMPLAR 1 MCG CAP MO 3 B vs DZEMPLAR 2 MCG CAP MO 3 B vs DZEMPLAR 2 MCG/ML IV MO 3 B vs DZEMPLAR 4 MCG CAP MO 3 B vs DZEMPLAR 5 MCG/ML IV MO 3 B vs D

Page 122: Humana Walmart-Preferred Formulary - Q1Medicare

122 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

IndexA

a-hydrocort 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

a-methapred 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ABILIFY 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ABILIFY DISCMELT 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ABRAXANE 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acarbose 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACCUSURE INSULIN SYRINGE 57 . . . . . . . . . . . . . . . . . . . . .

acebutolol 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acetaminophen-codeine 37 . . . . . . . . . . . . . . . . . . . . . . . . .

acetasol hc 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acetazolamide 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acetazolamide sodium 76 . . . . . . . . . . . . . . . . . . . . . . . . . . .

acetic acid 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acetic acid-aluminum acetate 76 . . . . . . . . . . . . . . . . . . . . .

acetylcysteine 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acid jelly 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTHAR H.P. 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTHIB 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTHREL 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

acticin 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTIMMUNE 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTIVASE 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTONEL 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTONEL WITH CALCIUM 96 . . . . . . . . . . . . . . . . . . . . . . . .

ACTOPLUS MET 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTOPLUS MET XR 84, 85 . . . . . . . . . . . . . . . . . . . . . . . . . .

ACTOS 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACUFLEX 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACUVAIL 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ACZONE 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ADACEL (ADOLESCENT & ADULT) 102 . . . . . . . . . . . . . . . . .

ADAGEN 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

adapalene 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ADCIRCA 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ADENOCARD 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

adenosine 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

adriamycin 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

adriamycin pfs 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ADVAIR DISKUS 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ADVAIR HFA 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

advanced care plus 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ADVATE 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

afeditab cr 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AFINITOR 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AGGRENOX 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AH-CHEW D 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AH-CHEW II 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AHIST 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AIMSCO INSULIN SYRINGE 57 . . . . . . . . . . . . . . . . . . . . . . .

ak-con 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ak-poly-bac 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ak-tob 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

akorn balanced salt 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AKTEN (PF) 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALA-SCALP 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALBENZA 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

albuterol sulfate 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

alclometasone 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALCOHOL PADS 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALCOHOL PREP PADS 106 . . . . . . . . . . . . . . . . . . . . . . . . . .

ALCOHOL PREP SWABS 106 . . . . . . . . . . . . . . . . . . . . . . . . .

Page 123: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 123

ALCOHOL SWABS 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALCOHOL WIPES 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALDURAZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

alendronate 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

alfentanil 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

alfuzosin 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ali-flex 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aliclen 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALIMTA 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALKERAN 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

allanvan-s 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

allersol 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

allopurinol 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

allopurinol sodium 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALPHANATE 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALPHANINE SD 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ALTABAX 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

altafluor 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

altafrin 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

altavera (28) 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aluvea 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amantadine 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amcinonide 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMERICAINE ANESTHETIC 106 . . . . . . . . . . . . . . . . . . . . . .

AMICAR 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amifostine crystalline 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amiloride 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amiloride-hydrochlorothiazide 66 . . . . . . . . . . . . . . . . . . . . .

AMINOACETIC ACID 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aminocaproic acid 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aminophylline 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN II 10 % 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN II 15% 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN II 3.5% M/DEXTROSE 5% 66 . . . . . . . . . . . . . . .

AMINOSYN II 4.25%-DEXTROSE 10% 67 . . . . . . . . . . . . . . .

AMINOSYN II 4.25%-LYTES-CA-D25 67 . . . . . . . . . . . . . . . .

AMINOSYN II 5%/DEXTROSE 25% 67 . . . . . . . . . . . . . . . . .

AMINOSYN II 7 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN II 8.5 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN II 8.5 %-ELECTROLYTES 67 . . . . . . . . . . . . . . . .

AMINOSYN II-M 4.25% IN D10 67 . . . . . . . . . . . . . . . . . . . .

AMINOSYN M 3.5 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN 10 % 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN 3.5 % 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN 5 % (SULFITE-FREE) 66 . . . . . . . . . . . . . . . . . . .

AMINOSYN 7 % 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN 7 % WITH ELECTROLYTES 66 . . . . . . . . . . . . . .

AMINOSYN 8.5 % 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN 8.5 %-ELECTROLYTES 66 . . . . . . . . . . . . . . . . .

AMINOSYN-HBC 7% 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN-HF 8 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN-PF 10 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMINOSYN-PF 7 % (SULFITE-FREE) 67 . . . . . . . . . . . . . . . . .

AMINOSYN-RF 5.2 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . .

amiodarone 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMITIZA 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amitriptyline 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amlodipine 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amlodipine-benazepril 25 . . . . . . . . . . . . . . . . . . . . . . . . . . .

ammonium chloride 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ammonium lactate 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMMONUL 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

amoxapine 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMPHADASE 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMPYRA 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AMTURNIDE 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 124: Humana Walmart-Preferred Formulary - Q1Medicare

124 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

amyl nitrite 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

anabar 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ANACAINE 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ANADROL-50 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

anagrelide 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ANASPAZ 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

anastrozole 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ANDROGEL 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

androxy 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

antipyrine-benzocaine 76 . . . . . . . . . . . . . . . . . . . . . . . . . . .

antivenin latrodectus mactans 102 . . . . . . . . . . . . . . . . . . . .

antivenin micrurus fulvius 102 . . . . . . . . . . . . . . . . . . . . . . .

ANTIZOL 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

apexicon 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

apexicon e 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

APHTHASOL 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

APLISOL 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

APOKYN 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

apraclonidine 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

apri 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

APRISO 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARALAST 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARALAST NP 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aranelle (28) 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

arbinoxa 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARCALYST 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

argatroban 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARIMIDEX 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARISTOSPAN INTRA-ARTICULAR 85 . . . . . . . . . . . . . . . . . . .

ARISTOSPAN INTRALESIONAL 85 . . . . . . . . . . . . . . . . . . . . .

ARIXTRA 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AROMASIN 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARRANON 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ARZERRA 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ascomp w/codeine 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ASMANEX TWISTHALER 85 . . . . . . . . . . . . . . . . . . . . . . . . .

aspergillus fumi allergen ext 96 . . . . . . . . . . . . . . . . . . . . . .

ASSURE PLATINUM 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

astramorph-pf 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ATABEX EC 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

atenolol 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

atenolol-chlorthalidone 25 . . . . . . . . . . . . . . . . . . . . . . . . . .

atracurium 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

atropine 16, 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ATROPINE-CARE 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ATROVENT HFA 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ATTENUVAX (PF) 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aurodex 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

auroguard 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AUTOJECT 2 57 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AUTOJECT 2 INJECTION DEVICE 57 . . . . . . . . . . . . . . . . . . .

AUTOPEN 1 TO 16 UNITS 57 . . . . . . . . . . . . . . . . . . . . . . . .

AUTOPEN 1 TO 21 UNITS 57 . . . . . . . . . . . . . . . . . . . . . . . .

AUTOPEN 2 TO 32 UNITS 57 . . . . . . . . . . . . . . . . . . . . . . . .

AUTOPEN 2 TO 42 UNITS 57 . . . . . . . . . . . . . . . . . . . . . . . .

AVALIDE 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVANDARYL 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVAPRO 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVASTIN 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVC VAGINAL 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

aviane 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVODART 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVONEX 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AVONEX ADMINISTRATION PACK 97 . . . . . . . . . . . . . . . . . .

AXONA 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AZASITE 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 125: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 125

azathioprine 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

azathioprine sodium 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

azelastine 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AZILECT 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AZMACORT 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AZOPT 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

azurette 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

B

bacitracin 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bacitracin-polymyxin b 76 . . . . . . . . . . . . . . . . . . . . . . . . . . .

baclofen 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BACTROBAN 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BAL IN OIL 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bal-care dha 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

balanced salt 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

balsalazide 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BANZEL 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

baycadron 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BCG VACCINE, LIVE (PF) 103 . . . . . . . . . . . . . . . . . . . . . . . .

BD ALCOHOL SWAB 107 . . . . . . . . . . . . . . . . . . . . . . . . . . .

BD ECLIPSE LUER-LOK 57 . . . . . . . . . . . . . . . . . . . . . . . . . . .

BD INSULIN PEN NEEDLE UF ORIG 57 . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE 57 . . . . . . . . . . . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE HALF UNIT 57 . . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE MICRO-FINE 57 . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE SAFETY-LOK 57 . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE SLIP TIP 57 . . . . . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE ULT-FINE II 57 . . . . . . . . . . . . . . . . . .

BD INSULIN SYRINGE ULTRA-FINE 57 . . . . . . . . . . . . . . . . . .

BD INTEGRA INSULIN SYRINGE 57 . . . . . . . . . . . . . . . . . . . .

BD LO-DOSE MICRO-FINE IV 57 . . . . . . . . . . . . . . . . . . . . . .

BD LO-DOSE ULTRA-FINE 57 . . . . . . . . . . . . . . . . . . . . . . . .

BD SAFETYGLIDE INSULIN SYRINGE 58 . . . . . . . . . . . . . . . .

BD SAFETYGLIDE SYRINGE 58 . . . . . . . . . . . . . . . . . . . . . . .

be-flex plus 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BEBULIN VH 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benazepril 25 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benazepril-hydrochlorothiazide 25 . . . . . . . . . . . . . . . . . . . .

bencort 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BENEFIX 19, 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benprox 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bensal hp 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BENZASHAVE-10 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BENZASHAVE-5 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benzoin 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benzotic 76, 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benzoyl peroxide 107 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

benzoyl peroxide creamy wash 107 . . . . . . . . . . . . . . . . . . . .

benzoyl peroxide microspheres 113 . . . . . . . . . . . . . . . . . . .

benzoyl peroxide-urea 107 . . . . . . . . . . . . . . . . . . . . . . . . . .

benztropine 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BESIVANCE 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BETADINE OPHTHALMIC PREP 76 . . . . . . . . . . . . . . . . . . . .

betamethasone acet & sod phos 85 . . . . . . . . . . . . . . . . . . .

betamethasone dipropionate 107, 108 . . . . . . . . . . . . . . . . .

betamethasone valerate 108 . . . . . . . . . . . . . . . . . . . . . . . .

betamethasone, augmented 108 . . . . . . . . . . . . . . . . . . . . .

BETASERON 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

betaxolol 26, 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bethanechol chloride 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BETIMOL 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bicalutamide 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BICNU 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BIDIL 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BILTRICIDE 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bioregesic 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 126: Humana Walmart-Preferred Formulary - Q1Medicare

126 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

bisoprolol fumarate 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bisoprolol-hydrochlorothiazide 26 . . . . . . . . . . . . . . . . . . . . .

bleomycin 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BLEPHAMIDE 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BLEPHAMIDE S.O.P. 76 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BONIVA 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BOOSTRIX 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

borofair 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bp 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bp 10-1 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bpo 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BRANCHAMIN 4 % 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BREVIBLOC 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BREVIBLOC IN NACL (ISO-OSM) 26 . . . . . . . . . . . . . . . . . . .

brimonidine 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bromax 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bromocriptine 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

brompheniramine-pe tannates 67 . . . . . . . . . . . . . . . . . . . . .

BROVEX 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BROVEX PB 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BSS 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BSS PLUS 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

budeprion sr 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

budeprion xl 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

budesonide 85 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bumetanide 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BUPHENYL 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bupivacaine 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bupivacaine (pf) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bupivacaine-dextrose-water(pf) 95 . . . . . . . . . . . . . . . . . . . .

bupivacaine-epinephrine 95 . . . . . . . . . . . . . . . . . . . . . . . . .

buprenorphine 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

buproban 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

bupropion hcl 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

buspirone 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BUSULFEX 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

butalbital compound w/codeine 38 . . . . . . . . . . . . . . . . . . . .

butorphanol tartrate 38, 39 . . . . . . . . . . . . . . . . . . . . . . . . .

BYETTA 85, 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

C

cabergoline 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CAFCIT 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

caffeine citrated 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

caffeine-sodium benzoate 39 . . . . . . . . . . . . . . . . . . . . . . . .

cafgesic 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cafgesic forte 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcipotriene 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcitonin (salmon) 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcitrene 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcitriol 116, 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcium acetate 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcium chloride 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CALCIUM DISODIUM VERSENATE 84 . . . . . . . . . . . . . . . . . .

calcium folinate 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

calcium gluconate 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

camila 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CAMPATH 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CAMPRAL 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CANASA 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

candida albicans allergen ext 97 . . . . . . . . . . . . . . . . . . . . . .

CANDIN 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CAPITAL WITH CODEINE 39 . . . . . . . . . . . . . . . . . . . . . . . . .

CAPRELSA 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

capsicum 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

captopril 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

captopril-hydrochlorothiazide 26 . . . . . . . . . . . . . . . . . . . . .

Page 127: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 127

CARAC 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CARBAGLU 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

carbamazepine 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CARBATROL 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

carbidopa-levodopa 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

carbinoxamine maleate 67 . . . . . . . . . . . . . . . . . . . . . . . . . .

CARBOCAINE 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CARBOCAINE (PF) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

carboplatin 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CAREONE ULTIGUARD 58 . . . . . . . . . . . . . . . . . . . . . . . . . .

CARESENS N TEST STRIPS 66 . . . . . . . . . . . . . . . . . . . . . . . .

carimune nf nanofiltered 103 . . . . . . . . . . . . . . . . . . . . . . . .

carisoprodol 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

carisoprodol-asa-codeine 16 . . . . . . . . . . . . . . . . . . . . . . . . .

carisoprodol-aspirin 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CARNITOR 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CARNITOR SUGAR-FREE 97 . . . . . . . . . . . . . . . . . . . . . . . . .

carteolol 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cartia xt 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

carvedilol 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CATAPRES-TTS-1 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CATAPRES-TTS-2 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CATAPRES-TTS-3 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CATHFLO ACTIVASE 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavan one omega 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavan-ec sod dha 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavan-folate dha 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavan-folate ob 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavan-heme ob 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavarest 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cavirinse 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

caziant 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CEENU 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CELESTONE SOLUSPAN 86 . . . . . . . . . . . . . . . . . . . . . . . . . .

CELLCEPT 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CELLCEPT INTRAVENOUS 97 . . . . . . . . . . . . . . . . . . . . . . . .

CELLUGEL 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CELONTIN 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CEPROTIN (BLUE BAR) 20 . . . . . . . . . . . . . . . . . . . . . . . . . .

CEPROTIN (GREEN BAR) 20 . . . . . . . . . . . . . . . . . . . . . . . . .

CEREDASE 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CEREZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cerisa 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cerovel 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CERUBIDINE 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CERVARIX VACCINE 103 . . . . . . . . . . . . . . . . . . . . . . . . . . .

CERVIDIL 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CETACAINE MEDICAL KIT E 108 . . . . . . . . . . . . . . . . . . . . . .

cetirizine 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CHANTIX 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CHANTIX CONTINUING MONTH PAK 16 . . . . . . . . . . . . . . .

CHANTIX STARTING MONTH PAK 16 . . . . . . . . . . . . . . . . . .

CHEMET 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CHENODAL 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

chloral hydrate 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

chlorhexidine gluconate 77 . . . . . . . . . . . . . . . . . . . . . . . . . .

chloroprocaine (pf) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

chlorothiazide 67 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

chlorothiazide sodium 67 . . . . . . . . . . . . . . . . . . . . . . . . . . .

chloroxylenol-pramoxine 77 . . . . . . . . . . . . . . . . . . . . . . . . .

chlorped d 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

chlorpheniramine-pseudoephed 67 . . . . . . . . . . . . . . . . . . . .

chlorpromazine 39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

chlorthalidone 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cholestyramine light 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cholestyramine-sucrose 26 . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 128: Humana Walmart-Preferred Formulary - Q1Medicare

128 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

choline & magnesium salicylate 39 . . . . . . . . . . . . . . . . . . . .

choline-mag trisalicylate 39, 40 . . . . . . . . . . . . . . . . . . . . . .

ciclodan 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ciclopirox 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ciclopirox-vite-nail lacq remo 108 . . . . . . . . . . . . . . . . . . . . .

cilostazol 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cimetidine 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ciprofloxacin 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cisplatin 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

citalopram 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cladribine 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clemastine 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CLEVIPREX 26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CLINAC BPO 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clinda-derm 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clindacin p 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clindamax 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clindamycin phosphate 108 . . . . . . . . . . . . . . . . . . . . . . . . .

clindamycin-benzoyl peroxide 108 . . . . . . . . . . . . . . . . . . . .

CLINDAREACH 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clindets 108 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CLINIMIX E 2.75/D10 SULFITFREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX E 2.75/D5 SULFITEFREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX E 4.25/D10 SULFITFREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX E 4.25/D25 SULFITFREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX E 4.25/D5 SULFITEFREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX E 5%/D15 SULFITE FREE 68 . . . . . . . . . . . . . . . . .

CLINIMIX E 5%/D20 SULFITE FREE 68 . . . . . . . . . . . . . . . . .

CLINIMIX E 5%/D25 SULFITE FREE 68 . . . . . . . . . . . . . . . . .

CLINIMIX 2.75%/D5 SULFITE FREE 68 . . . . . . . . . . . . . . . . .

CLINIMIX 4.25/D10 SULFITE FREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX 4.25/D20 SULFITE FREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX 4.25/D25 SULFITE FREE 68 . . . . . . . . . . . . . . . . . .

CLINIMIX 4.25%/D5 SULFITE FREE 68 . . . . . . . . . . . . . . . . .

CLINIMIX 5%/D15 SULFITE FREE 68 . . . . . . . . . . . . . . . . . . .

CLINIMIX 5%/D20 SULFITE FREE 68 . . . . . . . . . . . . . . . . . . .

CLINIMIX 5%/D25 SULFITE FREE 68 . . . . . . . . . . . . . . . . . . .

clobetasol 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clobetasol-emollient 109 . . . . . . . . . . . . . . . . . . . . . . . . . . .

CLOLAR 9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clomipramine 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clonidine 26, 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clonidine (pf) 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clorpres 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clotrimazole 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

clotrimazole-betamethasone 109 . . . . . . . . . . . . . . . . . . . . .

clozapine 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

co-natal fa 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cocaine 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cod-butalbital-acetaminop-caf 38 . . . . . . . . . . . . . . . . . . . . .

codeine phosphate 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

codeine sulfate 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

COGENTIN 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

colchicine-probenecid 73 . . . . . . . . . . . . . . . . . . . . . . . . . . .

COLCRYS 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

colestipol 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

colocort 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

complete natal dha 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

complete-rf prenatal 117 . . . . . . . . . . . . . . . . . . . . . . . . . . .

completenate 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

compro 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

COMTAN 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

COMVAX 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CONSTANT CLENS 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

constulose 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

controlrx 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 129: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 129

COPAXONE 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

corenate-dha 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cormax 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cortalo 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CORTIFOAM 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cortisone 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cortomycin 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CORTROSYN 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CORVERT 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

COSMEGEN 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cosyntropin 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

COUMADIN 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

COVERA-HS 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cpm-pe-msc 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cpm-pse 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CREON 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CRESTOR 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CRESYLATE 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CROFAB 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

crolom 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cromolyn 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cryselle (28) 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CUPRIMINE 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CURITY ALCOHOL SWABS 109 . . . . . . . . . . . . . . . . . . . . . . .

CUROSURF 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyanide antidote 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyclafem 1/35 (28) 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyclafem 7/7/7 (28) 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYCLOGYL 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYCLOMYDRIL 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyclopentolate 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyclophosphamide 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyclosporine 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cyclosporine modified 97 . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYKLOKAPRON 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cylate 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYMBALTA 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYSTADANE 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYSTAGON 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cysteine (l-cysteine) 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cytarabine 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cytarabine (pf) 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYTOGAM 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYTOMEL 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cytra k crystals 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cytra-k 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

cytra-3 68 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

D

dacarbazine 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DACOGEN 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dactinomycin 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

danazol 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dantrolene 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DAPTACEL (PEDIATRIC) (PF) 103 . . . . . . . . . . . . . . . . . . . . .

daunorubicin 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DAUNOXOME 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DEBACTEROL 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DECAVAC 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

deferoxamine 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DEMSER 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DENAVIR 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

denta 5000 plus 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dentagel 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DEPO-ESTRADIOL 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DEPOCYT 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

desipramine 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 130: Humana Walmart-Preferred Formulary - Q1Medicare

130 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

desmopressin 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

desonide 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

desoximetasone 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

desquam-x 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dexamethasone 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dexamethasone intensol 86 . . . . . . . . . . . . . . . . . . . . . . . . .

dexamethasone sodium phosphate 77, 86 . . . . . . . . . . . . . .

dexasol 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dexmethylphenidate 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dexpanthenol 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dexrazoxane 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dextroamphetamine 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dextrose in ringers 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dextrose 10% in water (d10w) 68 . . . . . . . . . . . . . . . . . . . .

dextrose 10%-1/4 normal saline 68 . . . . . . . . . . . . . . . . . . .

dextrose 2.5% in water (d2.5w) 68 . . . . . . . . . . . . . . . . . . .

dextrose 20% in water (d20w) 69 . . . . . . . . . . . . . . . . . . . .

dextrose 25% in water (d25w) 69 . . . . . . . . . . . . . . . . . . . .

dextrose 30% in water (d30w) 69 . . . . . . . . . . . . . . . . . . . .

dextrose 40% in water (d40w) 69 . . . . . . . . . . . . . . . . . . . .

dextrose 5% in water (d5w) 69 . . . . . . . . . . . . . . . . . . . . . .

dextrose 5%-lactated ringers 69 . . . . . . . . . . . . . . . . . . . . . .

dextrose 5%-0.3 % sod.chloride 69 . . . . . . . . . . . . . . . . . . .

dextrose 5%-1/4 normal saline 69 . . . . . . . . . . . . . . . . . . . .

dextrose 50% in water (d50w) 69 . . . . . . . . . . . . . . . . . . . .

dextrose 70% in water (d70w) 69 . . . . . . . . . . . . . . . . . . . .

DICEL 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diclofenac potassium 40 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diclofenac sodium 40, 41,77 . . . . . . . . . . . . . . . . . . . . . . . . . .

diflorasone 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diflunisal 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DIGIBIND 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DIGIFAB 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

digoxin 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dihydrocode-acetaminophen-caff 37 . . . . . . . . . . . . . . . . . . .

dihydroergotamine 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DILANTIN 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DILANTIN EXTENDED 41 . . . . . . . . . . . . . . . . . . . . . . . . . . .

dilantin infatabs 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DILANTIN-125 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DILATRATE-SR 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dilt-cd 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dilt-xr 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diltia xt 27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diltiazem hcl 27, 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diltzac er 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dimenhydrinate 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DIOVAN 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DIOVAN HCT 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

diphenoxylate-atropine 81 . . . . . . . . . . . . . . . . . . . . . . . . . .

DISCOVISC 58 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

disopyramide 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

disulfiram 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DIURIL 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

divalproex 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DOAK TAR DISTILLATE 109 . . . . . . . . . . . . . . . . . . . . . . . . .

dobutamine 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dobutamine in d5w 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DOCEFREZ 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

docetaxel 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

docosavit 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dologesic 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

donepezil 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dopamine 16 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dopamine in d5w 16, 17 . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 131: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 131

DOPRAM 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dorzolamide 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dorzolamide-timolol 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

doxapram 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

doxazosin 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

doxepin 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

doxorubicin 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

doxycycline hyclate 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DRITHO-SCALP 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DRITHOCREME HP 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

dronabinol 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

droperidol 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DROXIA 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DUAC CS 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DUONEB 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DUOVISC VISCO ELASTIC 58 . . . . . . . . . . . . . . . . . . . . . . . .

DURACLON (PF) 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

duradryl 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DURAMORPH 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

duraxin 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DUREZOL 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DYRENIUM 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

d10 %-0.45 % sodium chloride 68 . . . . . . . . . . . . . . . . . . . .

d10 %-0.9 % sodium chloride 68 . . . . . . . . . . . . . . . . . . . . .

d2.5 %-0.45 % sodium chloride 68 . . . . . . . . . . . . . . . . . . .

d5 %-0.45 % sodium chloride 69 . . . . . . . . . . . . . . . . . . . . .

d5 %-0.9 % sodium chloride 69 . . . . . . . . . . . . . . . . . . . . . .

d5-lr with potassium chloride 70, 71 . . . . . . . . . . . . . . . . . .

d5-ns with potassium chloride 71 . . . . . . . . . . . . . . . . . . . . .

d5-1/2 ns & potassium chloride 68, 70 . . . . . . . . . . . . . . . . .

d5-1/3 ns & potassium chloride 70 . . . . . . . . . . . . . . . . . . . .

d5-1/4 ns & potassium chloride 68, 70 . . . . . . . . . . . . . . . . .

d5w with potassium chloride 68, 70,71 . . . . . . . . . . . . . . . . . .

E

EASY COMFORT INSULIN SYRINGE 58 . . . . . . . . . . . . . . . . .

EASY TOUCH 58 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EASY TRAK GLUCOSE TEST 66 . . . . . . . . . . . . . . . . . . . . . . .

econazole 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ED CYTE F 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ed-flex 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ed-spaz 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

edge ob 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

effer-k 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EFFIENT 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EGRIFTA 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ELAPRASE 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

electrolyte-48 in d10w 68 . . . . . . . . . . . . . . . . . . . . . . . . . .

electrolyte-48 in d5w 69 . . . . . . . . . . . . . . . . . . . . . . . . . . .

ELESTAT 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ELIDEL 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

eliphos 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

elite-ob 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

elite-ob 400 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ELITEK 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ELIXOPHYLLIN 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ELOXATIN 10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EMCYT 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EMEND 81, 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

emgel 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

emoquette 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EMSAM 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

enalapril maleate 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

enalapril-hydrochlorothiazide 28 . . . . . . . . . . . . . . . . . . . . . .

enalaprilat 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 132: Humana Walmart-Preferred Formulary - Q1Medicare

132 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

ENBREL 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ENBREL SURECLICK 97 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

endocet 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ENDRATE 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ENGERIX-B (PF) 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

enlon 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

enoxaparin 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

enpresse 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ENTOCORT EC 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

entre-b 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

enulose 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ephedrine sulfate 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EPIDUO 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epiflur 97, 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epiklor 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epinastine 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epinephrine 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epinephrine (pf) 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epinephrine hcl 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EPIPEN 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EPIPEN JR 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epirubicin 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epitol 41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

eplerenone 28, 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EPOGEN 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

epoprostenol 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EQUETRO 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ERBITUX 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ERGOMAR 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ergotamine-caffeine 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ERGOTRATE 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

errin 86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ery pads 109 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

erythromycin 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

erythromycin with ethanol 109 . . . . . . . . . . . . . . . . . . . . . . .

erythromycin-benzoyl peroxide 110 . . . . . . . . . . . . . . . . . . . .

esmolol 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

estradiol 86, 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

estradiol valerate 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

estradiol-norethindrone acet 87 . . . . . . . . . . . . . . . . . . . . . .

ethosuximide 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ETHYOL 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

etidronate disodium 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

etodolac 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ETOPOPHOS 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

etoposide 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

euflexxa 58 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EURAX 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EVAMIST 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EVISTA 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXEL INSULIN 58 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXELON 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

exemestane 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXFORGE 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXFORGE HCT 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXJADE 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

exoderm 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXTAVIA 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EXTRANEAL PERITONEAL DIALYSIS 69 . . . . . . . . . . . . . . . . .

F

FABRAZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

famotidine 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

famotidine (pf) 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

famotidine(pf) in sal (iso-os) 82 . . . . . . . . . . . . . . . . . . . . . .

FANAPT 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FARESTON 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 133: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 133

FASLODEX 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FAZACLO 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fe c plus 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FEIBA VH IMMUNO 20 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FELBATOL 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

felodipine 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FEMARA 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FEMCON FE 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FEMECAL OB 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FEMECAL OB PLUS DHA 117 . . . . . . . . . . . . . . . . . . . . . . . .

fenofibrate 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fenofibrate micronized 29 . . . . . . . . . . . . . . . . . . . . . . . . . . .

fenoldopam 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fenoprofen 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fentanyl 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fentanyl citrate 42, 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fentanyl citrate (pf) 42 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fexofenadine 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fexofenadine-pseudoephedrine 69 . . . . . . . . . . . . . . . . . . . .

FIFTY50 RESERVOIR 58 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

finasteride 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FIRAZYR 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FIRMAGON 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flavoxate 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flebogamma 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLEBOGAMMA DIF 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flecainide 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLOVENT DISKUS 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLOVENT HFA 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

floxuridine 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUARIX 2009-2010 (PF) 103 . . . . . . . . . . . . . . . . . . . . . . .

fludarabine 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fludrocortisone 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLULAVAL 2009-2010 103 . . . . . . . . . . . . . . . . . . . . . . . . . .

flumazenil 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUMIST 2009-2010 103 . . . . . . . . . . . . . . . . . . . . . . . . . . .

flunisolide 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluocinolone 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluocinonide 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluocinonide-e 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluocinonide-emollient 110 . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUORABON 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluorescein-benoxinate 77 . . . . . . . . . . . . . . . . . . . . . . . . . .

fluorescein-proparacaine 77 . . . . . . . . . . . . . . . . . . . . . . . . .

fluoridex daily defense 98 . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluoridex daily defense whiten 98 . . . . . . . . . . . . . . . . . . . . .

fluoritab 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluorometholone 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUOROPLEX 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluorouracil 11, 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluoxetine 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluphenazine decanoate 43 . . . . . . . . . . . . . . . . . . . . . . . . . .

fluphenazine hcl 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLURA-DROPS 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flurate 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flurbiprofen 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flurbiprofen sodium 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flurox 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

flutamide 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fluticasone 77, 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUVIRIN 2009-2010 103 . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUVIRIN 2009-2010 (PF) 103 . . . . . . . . . . . . . . . . . . . . . . .

fluvoxamine 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FLUZONE HIGH-DOSE 2009-2010 103 . . . . . . . . . . . . . . . . .

FLUZONE PEDI 2009-2010 (PF) 103 . . . . . . . . . . . . . . . . . . .

FLUZONE 2009-2010 103 . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 134: Humana Walmart-Preferred Formulary - Q1Medicare

134 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

FLUZONE 2009-2010 (PF) 103 . . . . . . . . . . . . . . . . . . . . . . .

FML FORTE 77 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FML S.O.P. 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

folbecal 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

folcal dha 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

folcaps care one 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

folinatal plus b 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

folivane-ec calcium dha nf 117 . . . . . . . . . . . . . . . . . . . . . . .

folivane-ob 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

folivane-prx dha nf 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

foltabs 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

foltabs prenatal plus dha 117 . . . . . . . . . . . . . . . . . . . . . . . .

foltabs 90 plus dha 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fomepizole 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fondaparinux 20, 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FORA G71A 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FORADIL AEROLIZER 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FORMA-RAY 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FORTEO 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FORTICAL 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fosinopril 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

fosinopril-hydrochlorothiazide 29 . . . . . . . . . . . . . . . . . . . . .

fosphenytoin 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FRAGMIN 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FREAMINE HBC 6.9 % 69 . . . . . . . . . . . . . . . . . . . . . . . . . .

FREAMINE III 10 % 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FREAMINE III 3 %-ELECTROLYTES 69 . . . . . . . . . . . . . . . . . .

FREAMINE III 8.5 % 69 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

frenadol 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FRESHKOTE 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

furosemide 69, 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FUSILEV 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

G

gabapentin 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GABITRIL 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

galantamine 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GAMASTAN S/D 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gammagard liquid 103 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GAMMAGARD S-D (IGA<1UG/ML) 103 . . . . . . . . . . . . . . . .

GAMMAGARD S/D 103, 104 . . . . . . . . . . . . . . . . . . . . . . . .

GAMMAKED 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gammaplex 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GAMUNEX 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GAMUNEX-C 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GARAMYCIN 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GARDASIL 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GAUZE BANDAGE 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gavilyte-c 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gavilyte-g 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gavilyte-n 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gel-kam oral care rinse 98 . . . . . . . . . . . . . . . . . . . . . . . . . .

gemcitabine 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gemfibrozil 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GEMZAR 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

generlac 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gengraf 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gentak 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gentamicin 78, 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gentasol 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gentex ade 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GENTLE DRAW LANCING DEVICE 58 . . . . . . . . . . . . . . . . . .

GEODON 43 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gianvi 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

gildess fe 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLASSIA 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLEEVEC 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 135: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 135

glimepiride 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

glipizide 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

glipizide-metformin 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLUCAGEN 87 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLUCAGEN HYPOKIT 87 . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLUCAGON EMERGENCY 87 . . . . . . . . . . . . . . . . . . . . . . . .

GLUCOPRO 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLUCOPRO ALCOHOL 110 . . . . . . . . . . . . . . . . . . . . . . . . . .

glyburide 87, 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

glyburide micronized 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

glyburide-metformin 87, 88 . . . . . . . . . . . . . . . . . . . . . . . . .

glycopyrrolate 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GLYSET 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GOLYTELY 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GORDOFILM 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GORDONS UREA 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GRALISE 44 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GRALISE 30-DAY STARTER PACK 43 . . . . . . . . . . . . . . . . . .

granisetron 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

granisetron (pf) 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

granisol 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GUAIACOL 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

guanabenz 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

guanfacine 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

guanidine 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

H

halac 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HALAVEN 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HALDOL 44 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HALDOL DECANOATE 44 . . . . . . . . . . . . . . . . . . . . . . . . . . .

HALFLYTELY-BISACODYL BOWEL KIT 82 . . . . . . . . . . . . . . . .

HALFLYTELY-BISACODYL W-FLAV PK 82 . . . . . . . . . . . . . . .

halobetasol propionate 110 . . . . . . . . . . . . . . . . . . . . . . . . .

HALOG 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

halonate 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

halonate pac 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

haloperidol 44 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

haloperidol decanoate 44 . . . . . . . . . . . . . . . . . . . . . . . . . . .

haloperidol lactate 44 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HALOTIN 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HAVRIX (PF) 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

heather 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HECTOROL 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

helistat 110 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HELIXATE FS 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEMABATE 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEMOFIL M HIGH 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEMOFIL M LOW 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEMOFIL M MID 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEMOFIL M SUPER HIGH 21 . . . . . . . . . . . . . . . . . . . . . . . .

hep flush-10 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEP-LOCK FLUSH 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEP-LOCK U/P PF 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEPAGAM B 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

heparin (porcine) 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

heparin (porcine) in d5w 22 . . . . . . . . . . . . . . . . . . . . . . . . .

heparin (porcine) in ns (pf) 22 . . . . . . . . . . . . . . . . . . . . . . . .

heparin (porcine)-0.45% nacl 22 . . . . . . . . . . . . . . . . . . . . .

heparin lock 21 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

heparin lock flush 21, 22 . . . . . . . . . . . . . . . . . . . . . . . . . . .

heparin lock flush (porcine) 22 . . . . . . . . . . . . . . . . . . . . . . .

heparin lockflush(porcine)(pf) 21 . . . . . . . . . . . . . . . . . . . . .

heparin, porcine (pf) 21, 22 . . . . . . . . . . . . . . . . . . . . . . . . .

HEPATAMINE 8% 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HEPATASOL 8 % 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HERCEPTIN 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 136: Humana Walmart-Preferred Formulary - Q1Medicare

136 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

HEXALEN 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HIBERIX 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HISTATROL 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HISTEX SR 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HIZENTRA 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

homatropaire 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

homatropine hbr 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HONEY BEE TREATMENT 98 . . . . . . . . . . . . . . . . . . . . . . . . .

HONEY BEE VENOM PROTEIN 98 . . . . . . . . . . . . . . . . . . . . .

HORIZANT 44 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMALOG 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMALOG KWIKPEN 88 . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMALOG MIX 50-50 88 . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMALOG MIX 50-50 KWIKPEN 88 . . . . . . . . . . . . . . . . . . .

HUMALOG MIX 75-25 88 . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMALOG MIX 75-25 KWIKPEN 88 . . . . . . . . . . . . . . . . . . .

HUMALOG PEN 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMAPEN LUXURA HD 59 . . . . . . . . . . . . . . . . . . . . . . . . .

HUMAPEN MEMOIR 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMIRA 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMIRA CROHN’S DIS START PCK 98 . . . . . . . . . . . . . . . . .

HUMIRA PEN 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMIRA PSORIASIS STARTER PACK 98 . . . . . . . . . . . . . . . .

HUMULIN N 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMULIN N PEN 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMULIN R 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMULIN R U-500 "CONCENTRATED" 88 . . . . . . . . . . . . . .

HUMULIN 50/50 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMULIN 70/30 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUMULIN 70/30 PEN 88 . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYALGAN 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYCAMTIN 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

hydralazine 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

hydrochlorothiazide 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

hydrocodone-acetaminophen 44 . . . . . . . . . . . . . . . . . . . . . .

hydrocodone-ibuprofen 44 . . . . . . . . . . . . . . . . . . . . . . . . . .

hydrocortisone 88, 110,111 . . . . . . . . . . . . . . . . . . . . . . . . . . .

hydrocortisone acet-aloe vera 111 . . . . . . . . . . . . . . . . . . . .

hydrocortisone acetate 111 . . . . . . . . . . . . . . . . . . . . . . . . .

hydrocortisone butyrate 110, 111 . . . . . . . . . . . . . . . . . . . . .

hydrocortisone valerate 111 . . . . . . . . . . . . . . . . . . . . . . . . .

hydrocortisone-acetic acid 76 . . . . . . . . . . . . . . . . . . . . . . . .

hydrocortisone-min oil-wht pet 110 . . . . . . . . . . . . . . . . . . .

hydromorphone 44 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

hydromorphone (pf) 44, 45 . . . . . . . . . . . . . . . . . . . . . . . . . .

hydroxyurea 11 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

hydroxyzine hcl 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYLENEX 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

hypercare 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYPERLYTE-CR 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYPERRAB S/D (PF) 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYPERRHO S/D 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HYPERTET S/D (PF) 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

I

ibuprofen 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ibuprofen-oxycodone 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ibutilide fumarate 29 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ICAR-C PLUS SR 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IDAMYCIN PFS 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

idarubicin 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IFEX 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ifosfamide 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ifosfamide-mesna 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ILOTYCIN 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

imipramine hcl 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 137: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 137

imipramine pamoate 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

imiquimod 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IMOGAM RABIES-HT (PF) 104 . . . . . . . . . . . . . . . . . . . . . . .

IMOVAX RABIES VACCINE 104 . . . . . . . . . . . . . . . . . . . . . .

inamrinone 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

inatal advance 117 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

inatal gt 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

inatal ultra 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INCRELEX 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

indapamide 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INDOCIN 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

indomethacin 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

indomethacin sodium 45 . . . . . . . . . . . . . . . . . . . . . . . . . . .

INFANRIX (PF) 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INFASURF 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INFLUENZA A (H1N1) VAC 09 (PF) 104 . . . . . . . . . . . . . . . .

INFLUENZA A(H1N1)VAC 2009 LIVE 104 . . . . . . . . . . . . . . .

INFUMORPH P/F 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INNOHEP 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INNOVO 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INOVA 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INOVA 4-1 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INPERSOL/1.5% DEXTROSE 70 . . . . . . . . . . . . . . . . . . . . . . .

inpersol/4.25% dextrose 70 . . . . . . . . . . . . . . . . . . . . . . . . .

INS SYRINGE/NEEDLE 0.5CC/27G 60 . . . . . . . . . . . . . . . . . .

INSULIN CARTRIDGE 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INSULIN SYRINGE 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INSULIN SYRINGE MICROFINE 59 . . . . . . . . . . . . . . . . . . . . .

INSULIN SYRINGE NEEDLESS(DISP) 58 . . . . . . . . . . . . . . . . .

INSULIN SYRINGE ULTRAFINE 59 . . . . . . . . . . . . . . . . . . . . .

INSULIN SYRINGE-NEEDLE U-100 57, 58,59, 60,62, 63,

64 . . . . . . . . . . . . . .

INSULIN SYRINGES (DISPOSABLE) 59 . . . . . . . . . . . . . . . . . .

INSUMED 60 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INTAL 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INTEGRILIN 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INTRALIPID 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INTROL 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

introvale 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INVEGA 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

INVEGA SUSTENNA 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IONOSOL-B IN D5W 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IONOSOL-MB IN D5W 70 . . . . . . . . . . . . . . . . . . . . . . . . . . .

IPOL 104 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ipratropium bromide 17, 78 . . . . . . . . . . . . . . . . . . . . . . . . .

ipratropium-albuterol 17 . . . . . . . . . . . . . . . . . . . . . . . . . . .

IRESSA 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

irinotecan 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

isoditrate 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOLYTE-H IN D5W 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOLYTE-M IN D5W 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOLYTE-P IN D5W 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOLYTE-S 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOLYTE-S IN D5W 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOLYTE-S PH 7.4 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

isoproterenol hcl 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISOPTO HYOSCINE 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISORDIL 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

isosorbide dinitrate 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

isosorbide mononitrate 30 . . . . . . . . . . . . . . . . . . . . . . . . . .

isradipine 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISTALOL 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISTODAX 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ISUPREL 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IV PREP WIPES 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 138: Humana Walmart-Preferred Formulary - Q1Medicare

138 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

IXEMPRA 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IXIARO (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

J

JALYN 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

jantoven 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

JANUMET 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

JANUVIA 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

JE-VAX 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

jevantique 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

jinteli 88 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

junel fe 1.5/30 (28) 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

junel fe 1/20 (28) 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

junel 1.5/30 (21) 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

junel 1/20 (21) 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

K

k-effervescent 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

K-PHOS MF 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

K-PHOS NO 2 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

K-PHOS ORIGINAL 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

K-PHOS-NEUTRAL 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

k-prime 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

kalexate 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KAON CL-10 70 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KAPVAY 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

kariva 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

kelnor 1/35 (28) 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KENALOG 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KEPIVANCE 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KERAFOAM 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

keralac 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

keratol plus 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KETALAR 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ketamine 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ketoconazole 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ketoprofen 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ketorolac 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KINLYTIC 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KINRIX 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

kionex 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

klor-con 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

klor-con m10 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

klor-con m15 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

klor-con m20 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KLOR-CON 10 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

klor-con/ef 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KOATE-DVI 22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KOGENATE FS 22, 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

kolnatal dha 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KOMBIGLYZE XR 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

KUVAN 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

L

labetalol 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

laclotion 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LACRISERT 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lactated ringers 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lactocal-f 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lactulose 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LAGESIC 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LAMICTAL 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LAMICTAL ODT 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LAMICTAL ODT STARTER (BLUE) 46 . . . . . . . . . . . . . . . . . . .

LAMICTAL ODT STARTER (GREEN) 46 . . . . . . . . . . . . . . . . . .

LAMICTAL ODT STARTER (ORANGE) 46 . . . . . . . . . . . . . . . .

LAMICTAL STARTER (BLUE) KIT 46 . . . . . . . . . . . . . . . . . . . .

LAMICTAL STARTER (GREEN) KIT 46 . . . . . . . . . . . . . . . . . .

LAMICTAL STARTER (ORANGE) KIT 46 . . . . . . . . . . . . . . . . .

Page 139: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 139

LAMICTAL XR 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LAMICTAL XR STARTER (BLUE) 46 . . . . . . . . . . . . . . . . . . . .

LAMICTAL XR STARTER (GREEN) 46 . . . . . . . . . . . . . . . . . . .

LAMICTAL XR STARTER (ORANGE) 46 . . . . . . . . . . . . . . . . .

lamotrigine 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LANOXIN 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LANOXIN PEDIATRIC 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lansoprazole 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LANTUS 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LANTUS SOLOSTAR 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

latanoprost 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LATUDA 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lavoclen-4 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lavoclen-4 (new cleanser) 111 . . . . . . . . . . . . . . . . . . . . . . .

lavoclen-8 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lavoclen-8 (new cleanser) 111 . . . . . . . . . . . . . . . . . . . . . . .

leflunomide 98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lessina 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LETAIRIS 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

letrozole 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

leucovorin calcium 98, 99 . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEUKERAN 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEUKINE 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

leuprolide 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEUSTATIN 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEVACET 46 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levalbuterol hcl 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEVEMIR 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEVEMIR FLEXPEN 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levetiracetam 46, 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levobunolol 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levocarnitine 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levocarnitine (with sucrose) 99 . . . . . . . . . . . . . . . . . . . . . . .

levocetirizine 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levofloxacin 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levomefolatepnv 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levora-28 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levorphanol tartrate 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEVOTHROID 89 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

levothyroxine 89, 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEVOXYL 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEVULAN 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LEXAPRO 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIALDA 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIBERTY TEST 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine (pf) 30, 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine hcl 78, 95,111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine in d5w (pf) 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine in d7.5w (pf) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine viscous 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine-epinephrine 95 . . . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine-epinephrine (pf) 95 . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine-epinephrine bit 95 . . . . . . . . . . . . . . . . . . . . . . . . .

lidocaine-hydrocortisone ac 111 . . . . . . . . . . . . . . . . . . . . . .

lidocaine-prilocaine 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIDODERM 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIMBITROL 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lindane 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIORESAL 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

liothyronine 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIPITOR 30 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIPOSYN II 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIPOSYN III 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lisinopril 30, 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lisinopril-hydrochlorothiazide 31 . . . . . . . . . . . . . . . . . . . . . .

Page 140: Humana Walmart-Preferred Formulary - Q1Medicare

140 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

LITE TOUCH INSULIN SYRINGE 60 . . . . . . . . . . . . . . . . . . . .

lithium carbonate 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lithium citrate 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lokara 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

loperamide 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

loryna 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

losartan 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

losartan-hydrochlorothiazide 31 . . . . . . . . . . . . . . . . . . . . . .

LOSEASONIQUE 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LOTEMAX 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LOTRONEX 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lovastatin 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LOVAZA 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LOVENOX 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

low-ogestrel (28) 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

loxapine succinate 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lozi-flur 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LTA PRE-ATTACHED 111 . . . . . . . . . . . . . . . . . . . . . . . . . . .

ludent fluoride 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

lugols 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUMIGAN 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUMIZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUPRON DEPOT 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUPRON DEPOT (3 MONTH) 12 . . . . . . . . . . . . . . . . . . . . . .

LUPRON DEPOT (4 MONTH) 12 . . . . . . . . . . . . . . . . . . . . . .

LUPRON DEPOT (6 MONTH) 12 . . . . . . . . . . . . . . . . . . . . . .

LUPRON DEPOT-PED 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUPRON DEPOT-PED (3 MONTH) 12 . . . . . . . . . . . . . . . . . . .

lutera (28) 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUVOX CR 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LYRICA 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LYSODREN 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

M

M-M-R II (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

M-VIT 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MAGELLAN INSULIN SAFETY SYRNG 60 . . . . . . . . . . . . . . . .

MAGELLAN SYRINGE 60 . . . . . . . . . . . . . . . . . . . . . . . . . . .

MAGNEBIND 400 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

magnesium chloride 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

magnesium sulfate 47 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

magnesium sulfate in d5w 47 . . . . . . . . . . . . . . . . . . . . . . . .

malathion 111 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mannitol 10 % 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mannitol 15 % 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mannitol 20 % 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mannitol 25 % 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mannitol 5 % 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

maprotiline 47, 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARCAINE 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARCAINE (PF) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARCAINE SPINAL 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARCAINE-EPINEPHRINE 95, 96 . . . . . . . . . . . . . . . . . . . . .

MARCAINE-EPINEPHRINE (PF) 95 . . . . . . . . . . . . . . . . . . . . .

margesic-h 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARNATAL-F 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARNATAL-F PLUS 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MARPLAN 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

maternity 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MATULANE 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MAXALT 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MAXALT-MLT 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MAXINATE 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MAXITROL 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mebendazole 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

meclofenamate 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MEDI-JECTOR VISION 60 . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 141: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 141

medroxyprogesterone 90 . . . . . . . . . . . . . . . . . . . . . . . . . . .

megestrol 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

meloxicam 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

melphalan 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MEMBRANEBLUE 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MENACTRA (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MENOMUNE - A/C/Y/W-135 105 . . . . . . . . . . . . . . . . . . . . .

MENOMUNE - A/C/Y/W-135 (PF) 105 . . . . . . . . . . . . . . . . .

MENTAX 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MENVEO A-C-Y-W-135-DIP (PF) 105 . . . . . . . . . . . . . . . . . .

mepivacaine (pf) 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

meprolone unipak 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mercaptopurine 12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MERUVAX II (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mesalamine 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mesalamine-cleansing wipes 82 . . . . . . . . . . . . . . . . . . . . . .

mesna 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MESNEX 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metaproterenol 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metaxalone 17 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metformin 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methadex 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methadone 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methadone intensol 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methadose 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methamphetamine 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methazolamide 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

METHERGINE 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methimazole 90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methocarbamol 17, 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methotrexate sodium 12, 13 . . . . . . . . . . . . . . . . . . . . . . . . .

methotrexate sodium (pf) 12 . . . . . . . . . . . . . . . . . . . . . . . .

methscopolamine 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methyclothiazide 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methyl salicylate 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methyldopa 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methyldopa-hydrochlorothiazide 31 . . . . . . . . . . . . . . . . . . .

methyldopate 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methylene blue (antidote) 99 . . . . . . . . . . . . . . . . . . . . . . . .

methylergonovine 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methylphenidate 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

methylprednisolone 90, 91 . . . . . . . . . . . . . . . . . . . . . . . . . .

methylprednisolone acetate 90, 91 . . . . . . . . . . . . . . . . . . . .

methylprednisolone sodium succ 90, 91 . . . . . . . . . . . . . . . .

metipranolol 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metoclopramide 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metolazone 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metoprolol succinate 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metoprolol tartrate 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

metoprolol-hydrochlorothiazide 31 . . . . . . . . . . . . . . . . . . . .

metronidazole 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

METVIXIA 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mexiletine 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

miconazole-3 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MICRHOGAM ULTRA-FILTERED 105 . . . . . . . . . . . . . . . . . . .

MICRHOGAM ULTRA-FILTERED PLUS 105 . . . . . . . . . . . . . .

MICRO-K 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

microgestin fe 1.5/30 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . .

microgestin fe 1/20 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . .

microgestin 1.5/30 (21) 91 . . . . . . . . . . . . . . . . . . . . . . . . . .

microgestin 1/20 (21) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . .

midodrine 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

migergot 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

milrinone 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

milrinone in d5w 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mimvey 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 142: Humana Walmart-Preferred Formulary - Q1Medicare

142 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

MINI ULTRA-THIN II 60 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MINIMED SYRINGE RESERVOIR 60 . . . . . . . . . . . . . . . . . . . .

minitran 31, 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

minoxidil 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MIOCHOL-E 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MIOSTAT 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mirtazapine 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

misoprostol 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mitomycin 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mitoxantrone 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MOBAN 48 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

moexipril 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

moexipril-hydrochlorothiazide 32 . . . . . . . . . . . . . . . . . . . . .

mometasone 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MONOCLATE-P 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MONOJECT INSULIN SAFETY SYRING 60 . . . . . . . . . . . . . . .

MONOJECT INSULIN SYRINGE 59, 60,61 . . . . . . . . . . . . . . . . .

monoject prefill advanced 23 . . . . . . . . . . . . . . . . . . . . . . . .

monoject prefill advanced ns 71 . . . . . . . . . . . . . . . . . . . . . .

monoject prefill saline flush 71 . . . . . . . . . . . . . . . . . . . . . . .

MONOJECT SYRINGE 61 . . . . . . . . . . . . . . . . . . . . . . . . . . .

MONOJECT ULTRA COMFORT INSULIN 61 . . . . . . . . . . . . . .

morphine 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

morphine (pf) 48, 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

morphine (pf) in d5w 48, 49 . . . . . . . . . . . . . . . . . . . . . . . . .

morphine concentrate 49 . . . . . . . . . . . . . . . . . . . . . . . . . . .

MOVIPREP 82 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MOXEZA 78 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MOZOBIL 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mst 600 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MULTAQ 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MULTI-NATE DHA EXTRA 118 . . . . . . . . . . . . . . . . . . . . . . .

multi-nate 30 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MULTI-NATE 30 DHA 118 . . . . . . . . . . . . . . . . . . . . . . . . . .

multi-vitamin with fluoride 118 . . . . . . . . . . . . . . . . . . . . . . .

multinatal plus 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MUMPSVAX (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mupirocin 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MUROCOLL-2 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MUSTARGEN 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

myci chlor-tan 71 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mycophenolate mofetil 99 . . . . . . . . . . . . . . . . . . . . . . . . . .

mydral 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYFORTIC 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYKIDZ IRON FLUORIDE 118 . . . . . . . . . . . . . . . . . . . . . . . .

MYLERAN 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYLOTARG 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYNATAL 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mynatal advance 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mynatal plus 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mynatal-z 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

mynate 90 plus 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYOBLOC 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYOCHRYSINE 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

myophen 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MYOZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

N

NABI-HB 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nabumetone 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nadolol 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nadolol-bendroflumethiazide 32 . . . . . . . . . . . . . . . . . . . . . .

NAGLAZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nalbuphine 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nalex a 12 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NALFON 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 143: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 143

naloxone 49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

naltrexone 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NAMENDA 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NAMENDA TITRATION PAK 50 . . . . . . . . . . . . . . . . . . . . . . .

naproxen 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

naproxen sodium 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

naratriptan 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NARDIL 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NAROPIN 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NAROPIN (PF) 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NASONEX 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NATAFORT 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NATALVIT 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NATAZIA 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nateglinide 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NATRECOR 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NAVANE 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

navatab + dha 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

necon 0.5/35 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

necon 1/35 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

necon 1/50 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

necon 10/11 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEEDLE-PRO EDGE 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEEVO 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEEVO DHA 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nefazodone 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

neo-polycin 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEO-SYNEPHRINE 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

neofrin 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

neomycin-bacitracin-poly-hc 79 . . . . . . . . . . . . . . . . . . . . . .

neomycin-bacitracin-polymyxin 79 . . . . . . . . . . . . . . . . . . . .

neomycin-polymyxin b gu 112 . . . . . . . . . . . . . . . . . . . . . . .

neomycin-polymyxin-dexameth 79 . . . . . . . . . . . . . . . . . . . .

neomycin-polymyxin-gramicidin 79 . . . . . . . . . . . . . . . . . . . .

neomycin-polymyxin-hc 79 . . . . . . . . . . . . . . . . . . . . . . . . . .

neosporin 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

neostigmine methylsulfate 18 . . . . . . . . . . . . . . . . . . . . . . . .

NEPHRAMINE 5.4 % 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEULASTA 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEUMEGA 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEUPOGEN 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEURONTIN 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEUT 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

neutragard 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

neutragard advanced 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEVANAC 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEXAVAR 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEXAVIR 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NEXTERONE 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

niacor 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NIASPAN EXTENDED-RELEASE 32 . . . . . . . . . . . . . . . . . . . .

nicardipine 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NICOTROL NS 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nifediac cc 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nifedical xl 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nifedipine 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NILANDRON 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NIMBEX 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nimodipine 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NIPENT 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nisoldipine 32 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NITRO-DUR 32, 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nitroglycerin 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nitroglycerin in d5w 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NITROLINGUAL 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NITROPRESS 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 144: Humana Walmart-Preferred Formulary - Q1Medicare

144 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

NITROSTAT 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nizatidine 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOREL SR 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

norepinephrine bitartrate 18 . . . . . . . . . . . . . . . . . . . . . . . . .

norethindrone (contraceptive) 91 . . . . . . . . . . . . . . . . . . . . .

norethindrone acetate 91 . . . . . . . . . . . . . . . . . . . . . . . . . . .

NORFLEX 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

norgestimate-ethinyl estradiol 91 . . . . . . . . . . . . . . . . . . . . .

norgestrel-ethinyl estradiol 91 . . . . . . . . . . . . . . . . . . . . . . .

NORINYL 1+50 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NORMOSOL-M IN D5W 72 . . . . . . . . . . . . . . . . . . . . . . . . . .

NORMOSOL-R 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NORMOSOL-R IN D5W 72 . . . . . . . . . . . . . . . . . . . . . . . . . .

NORMOSOL-R PH 7.4 72 . . . . . . . . . . . . . . . . . . . . . . . . . . .

NORPACE CR 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nortrel 0.5/35 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nortrel 1/35 (21) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nortrel 1/35 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nortrel 7/7/7 (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nortriptyline 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVANTRONE 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOFINE AUTOCOVER 61 . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOFINE 30 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOFINE 32 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN N 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN N INNOLET 91 . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN N PENFILL 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN R 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN R INNOLET 91 . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN R PENFILL 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN 70/30 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN 70/30 INNOLET 91 . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLIN 70/30 PENFILL 91 . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLOG 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLOG FLEXPEN 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLOG MIX 70-30 91 . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOLOG MIX 70-30 FLEXPEN 91 . . . . . . . . . . . . . . . . . . .

NOVOLOG PENFILL 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOPEN JR 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOPEN 3 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOPEN 3 PENMATE 61 . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOSEVEN 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOSEVEN RT 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NOVOTWIST 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ns with potassium chloride 71 . . . . . . . . . . . . . . . . . . . . . . .

nulev 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NULOJIX 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NULYTELY WITH FLAVOR PACKS 83 . . . . . . . . . . . . . . . . . . .

NUTRESTORE 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NUTRILYTE 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nutrilyte ii 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nuzole 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ny-tannic 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nyamyc 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nystatin 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

nystatin-triamcinolone 112 . . . . . . . . . . . . . . . . . . . . . . . . . .

nystop 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

O

O-CAL FA 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

O-CAL PRENATAL 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ob-natal one 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

obstetrix dha 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OBSTETRIX EC 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OCTAGAM 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

octreotide acetate 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ocucoat 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 145: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 145

ofloxacin 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OFORTA 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ogestrel (28) 91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OLUX-OLUX-E (100/10) 112 . . . . . . . . . . . . . . . . . . . . . . . . .

omedia otic 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

omeprazole 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OMNITROPE 91, 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ONCASPAR 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ondansetron 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ondansetron (pf) in dextrose 83 . . . . . . . . . . . . . . . . . . . . . .

ondansetron (pf) in nacl (iso) 83 . . . . . . . . . . . . . . . . . . . . . .

ondansetron hcl 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ondansetron hcl (pf) 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ONGLYZA 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ONTAK 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

onxol 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OPTIUM EZ 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORACIT 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oralone 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORAP 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORAPRED ODT 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORASEP 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORFADIN 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

orphenadrine citrate 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORSINI INSULIN SYRINGE 61 . . . . . . . . . . . . . . . . . . . . . . . .

orsythia 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORTHOCLONE OKT3 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ORTHOVISC 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oscion 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OSMITROL 10 % 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OSMITROL 15 % 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OSMITROL 20 % 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OSMITROL 5 % 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OSMOPREP 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

otic edge 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oticin 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

otogesic 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OVACE PLUS SHAMPOO 112 . . . . . . . . . . . . . . . . . . . . . . . .

oxaliplatin 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OXALIS 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxandrolone 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxaprozin 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxcarbazepine 50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OXSORALEN 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

OXSORALEN ULTRA 112 . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxybutynin chloride 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxycodone 50, 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxycodone hcl-oxycodone-asa 51 . . . . . . . . . . . . . . . . . . . . .

oxycodone-acetaminophen 50, 51 . . . . . . . . . . . . . . . . . . . .

oxycodone-aspirin 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

oxytocin 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

P

PACERONE 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

paclitaxel 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PAIN EASE 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

paire ob plus dha 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

palgic 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pamidronate 99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PANCREAZE 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pancrelipase 5000 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pancuronium 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PANHEMATIN 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PANRETIN 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pantoprazole 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

papaverine 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PARADIGM RESERVOIR 61 . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 146: Humana Walmart-Preferred Formulary - Q1Medicare

146 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

parcaine 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

paregoric 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PAREMYD 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

paroxetine hcl 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PATADAY 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PATANOL 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pe-cpm-msn 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pedi mvi no.16 with fluoride 118 . . . . . . . . . . . . . . . . . . . . .

pedi-dri 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PEDIARIX (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PEDVAX HIB (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

peg 3350-electrolytes 83 . . . . . . . . . . . . . . . . . . . . . . . . . . .

peg-electrolyte soln 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

peg-3350 with flavor packs 83 . . . . . . . . . . . . . . . . . . . . . . .

PEGANONE 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PEN NEEDLE 60, 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PENTACEL 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pentostatin 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pentoxifylline 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pentoxil 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

perindopril erbumine 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

periogard 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

permethrin 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

perphenazine 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

perphenazine-amitriptyline 51 . . . . . . . . . . . . . . . . . . . . . . .

phenadoz 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phenazopyridine 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phenelzine 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phentolamine 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phenylephrine hcl 18, 79 . . . . . . . . . . . . . . . . . . . . . . . . . . .

PHENYTEK 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phenytoin 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phenytoin sodium 51 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phenytoin sodium extended 51 . . . . . . . . . . . . . . . . . . . . . . .

PHOSLYRA 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

phospha 250 neutral 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PHOSPHOLINE IODIDE 79 . . . . . . . . . . . . . . . . . . . . . . . . . . .

PHOTOFRIN 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PHYSIOLYTE 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PHYSIOSOL IRRIGATION 72 . . . . . . . . . . . . . . . . . . . . . . . . .

pilocarpine hcl 18, 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PILOPINE HS 79 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pindolol 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pinnacaine 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

piroxicam 51, 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PITOCIN 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PITRESSIN 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PLASMA-LYTE A 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PLASMA-LYTE 148 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PLASMA-LYTE-56 IN D5W 72 . . . . . . . . . . . . . . . . . . . . . . . .

PLAVIX 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pnv ob+dha 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pnv-dha 118 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pnv-iron 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pnv-omega 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pnv-select 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pnv-total 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

podocon 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

podofilox 112 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

polocaine 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

polocaine (pf) 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

poly iron pn 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

poly iron pn forte 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

poly-dex 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

poly-vitamin/fluoride/iron 119 . . . . . . . . . . . . . . . . . . . . . . . .

poly-650 38 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 147: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 147

polycin b 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

polyethylene glycol 3350 83 . . . . . . . . . . . . . . . . . . . . . . . . .

POLYTRIM 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PONTOCAINE 96, 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

portia 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

potassium acetate 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

potassium bicarb & chloride 73 . . . . . . . . . . . . . . . . . . . . . . .

potassium bicarb-citric acid 72 . . . . . . . . . . . . . . . . . . . . . . .

potassium chloride 72, 73 . . . . . . . . . . . . . . . . . . . . . . . . . .

potassium citrate 72 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

potassium citrate-citric acid 72 . . . . . . . . . . . . . . . . . . . . . . .

potassium phosphate dibasic 73 . . . . . . . . . . . . . . . . . . . . . .

pr natal 400 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pr natal 400 ec 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pr natal 430 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pr natal 430 ec 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pr natal 440 ec 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRADAXA 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pramipexole 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pramox 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRANDIN 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pravastatin 33 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prazosin 33, 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRECEDEX 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRECISION 61 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRECISION SURE-DOSE 62 . . . . . . . . . . . . . . . . . . . . . . . . . .

PRECISION SURE-DOSE INSULIN 62 . . . . . . . . . . . . . . . . . . .

PRECISION SUREDOSE PLUS 62 . . . . . . . . . . . . . . . . . . . . . .

PRED MILD 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRED-G 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRED-G S.O.P. 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prednicarbate 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prednisol 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prednisolone 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prednisolone acetate 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prednisolone sodium phosphate 80, 92 . . . . . . . . . . . . . . . .

prednisone 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prednisone intensol 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PREMARIN 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PREMASOL 10 % 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PREMASOL 6 % 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prenacare 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prenafirst 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prenaplus 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRENATABS FA 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRENATABS RX 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prenatal ad 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prenatal low iron 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prenatal multivit with iron 119 . . . . . . . . . . . . . . . . . . . . . . .

prenatal plus (calcium carb) 119 . . . . . . . . . . . . . . . . . . . . . .

prenatal plus with iron (ca) 119 . . . . . . . . . . . . . . . . . . . . . .

prenatal 19 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PREPIDIL 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prevalite 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

previfem 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

previt+dha 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

previte rx 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PREVNAR 13 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRIALT 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

primalev 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

primidone 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRISMASOL BGK 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRISTIQ 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

privigen 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pro-hyo chewable melt 18 . . . . . . . . . . . . . . . . . . . . . . . . . .

PROAIR HFA 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 148: Humana Walmart-Preferred Formulary - Q1Medicare

148 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

probenecid 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

procainamide 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROCALAMINE 3% 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prochlorperazine 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

prochlorperazine edisylate 83 . . . . . . . . . . . . . . . . . . . . . . . .

prochlorperazine maleate 83 . . . . . . . . . . . . . . . . . . . . . . . .

PROCRIT 23, 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

procto-pak 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

proctocream-hc 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

proctosol hc 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

proctozone-hc 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PRODIGY AUTOCODE METER 62 . . . . . . . . . . . . . . . . . . . . .

PRODIGY CONTROL SOLUTION,HIGH 62 . . . . . . . . . . . . . . .

PRODIGY INSULIN SYRINGE 62 . . . . . . . . . . . . . . . . . . . . . .

PRODIGY PEN NEEDLE 62 . . . . . . . . . . . . . . . . . . . . . . . . . .

PRODIGY POCKET METER 62 . . . . . . . . . . . . . . . . . . . . . . . .

PROFILNINE SD 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

progesterone 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

progesterone in oil 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROGLYCEM 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROGRAF 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROLASTIN 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROLASTIN C 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROLEUKIN 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROLIA 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROMACTA 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

promethegan 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

propafenone 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

propantheline 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

proparacaine 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

propranolol 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

propranolol-hydrochlorothiazid 34 . . . . . . . . . . . . . . . . . . . .

propylthiouracil 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROQUAD 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROSTIGMIN 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROSTIN E2 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROSTIN VR PEDIATRIC 34 . . . . . . . . . . . . . . . . . . . . . . . . . .

protamine 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROTID 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PROTONIX 83 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

protriptyline 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

provisc 62 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pruet dha 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pruet dha ec 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PULMOZYME 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pyridostigmine bromide 18 . . . . . . . . . . . . . . . . . . . . . . . . . .

PYRIL D 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

pyril-chlor-phen 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PYROGALLIC ACID 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Q

qflex 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

quasense 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

quinapril 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

quinapril-hydrochlorothiazide 34 . . . . . . . . . . . . . . . . . . . . .

quinidine gluconate 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

quinidine sulfate 34 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

QVAR 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

R

r-tanna 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RABAVERT (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RADIOGARDASE 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ramipril 34, 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RANEXA 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ranitidine hcl 83, 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RAPAMUNE 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re dualvit ob 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 149: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 149

re multivit-fluoride 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re ob + dha 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RE OB 90 + DHA 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re sa 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re urea 40 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re-nata 29 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re-nata 29 ob 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

re-u40 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REBIF 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REBIF TITRATION PACK 100 . . . . . . . . . . . . . . . . . . . . . . . . .

RECLAST 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

reclipsen (28) 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RECOMBINATE 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RECOMBIVAX HB (PF) 105 . . . . . . . . . . . . . . . . . . . . . . . . . .

REFLUDAN 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REGRANEX 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

relagard 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RELION NEEDLES 62 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RELISTOR 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

relnate dha 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

remeven 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REMICADE 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REMODULIN 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RENACIDIN 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

renaf 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RENAMIN 6.5 % 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

renate 119 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RENATE DHA 119, 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RENATE DHA EXTRA 120 . . . . . . . . . . . . . . . . . . . . . . . . . . .

RENVELA 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REOPRO 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RESECTISOL 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

reserpine 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RESTASIS 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REVATIO 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

REVLIMID 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

revonto 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RHEUMATREX 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

rhinoflex 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

rhinoflex-650 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RHOGAM ULTRA-FILTERED 105 . . . . . . . . . . . . . . . . . . . . . .

RHOGAM ULTRA-FILTERED PLUS 105 . . . . . . . . . . . . . . . . . .

RHOPHYLAC 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RIASTAP 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RIDAURA 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RIGHTEST GS550 TEST STRIPS 66 . . . . . . . . . . . . . . . . . . . . .

RILUTEK 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RIMSO-50 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ringers 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RISPERDAL 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RISPERDAL CONSTA 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

risperidone 52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

risperidone m-tab 52, 53 . . . . . . . . . . . . . . . . . . . . . . . . . . .

RITUXAN 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

rivastigmine 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

rocuronium 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ROMAZICON 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

romycin 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ropinirole 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ROTARIX 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ROTATEQ VACCINE 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

rovin-nv 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

rovin-nv dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

roxicet 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ru-tuss 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

RYNATAN PEDIATRIC 73 . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 150: Humana Walmart-Preferred Formulary - Q1Medicare

150 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

S

SABRIL 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SAFESNAP INSULIN SYRINGE 62 . . . . . . . . . . . . . . . . . . . . .

SAIZEN 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SAIZEN CLICK.EASY 92 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

salacyn 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

salicylic acid 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

saline flush 73 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

salitop 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

salsalate 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SAMSCA 73, 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SANDOSTATIN 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SANDOSTATIN LAR DEPOT 100 . . . . . . . . . . . . . . . . . . . . . .

SANTYL 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SAPHRIS 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SAVELLA 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

scalacort 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

scalp treatment kit 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-care 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-care conceive 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-care gesture 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-natal one 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-natal 19 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-natal 90 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-plete dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

se-tan dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SELECT-OB 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SELECT-OB + DHA 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

selegiline hcl 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

selenium sulfide 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

selenos 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SEMPREX-D 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SENSIPAR 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SENSORCAINE 96 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sensorcaine-mpf spinal 96 . . . . . . . . . . . . . . . . . . . . . . . . . .

sensorcaine-mpf/epinephrine 96 . . . . . . . . . . . . . . . . . . . . . .

sensorcaine/epinephrine 96 . . . . . . . . . . . . . . . . . . . . . . . . .

SEREVENT DISKUS 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SEROQUEL 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SEROQUEL XR 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SEROSTIM 92, 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sertraline 53 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

setonet 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SETONET-EC 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sf 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sf 5000 plus 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

silver nitrate 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

silver sulfadiazine 113 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SIMULECT 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

simvastatin 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SINGULAIR 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sinuhist 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SMART CARESENS N TEST STRIPS 66 . . . . . . . . . . . . . . . . . .

sodiphluor 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium acetate 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium bicarbonate 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium chloride 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium chloride 0.45 % 73, 74 . . . . . . . . . . . . . . . . . . . . . .

sodium chloride 0.9 % 74 . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium chloride 3 % 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium chloride 5 % 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SODIUM EDECRIN 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium fluoride 98, 99,100 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium lactate 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium nitrite 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 151: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 151

sodium phosphate 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sodium polystyrene sulfonate 74 . . . . . . . . . . . . . . . . . . . . . .

sodium thiosulfate 100 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SOLARAZE 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SOLU-CORTEF 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SOLU-CORTEF (PF) 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SOLU-MEDROL 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SOLU-MEDROL (PF) 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SOMATULINE DEPOT 100, 101 . . . . . . . . . . . . . . . . . . . . . . .

SOMAVERT 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

somnote 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sorbitol-mannitol 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SORIATANE 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SORIATANE CK 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sorine 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sotalol 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sotalol af 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPIRIVA WITH HANDIHALER 18 . . . . . . . . . . . . . . . . . . . . . .

spironolacton-hydrochlorothiaz 35 . . . . . . . . . . . . . . . . . . . .

spironolactone 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPRAY AND STRETCH 114 . . . . . . . . . . . . . . . . . . . . . . . . . .

sprintec (28) 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPRYCEL 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPS 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sronyx 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STALEVO 100 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STALEVO 125 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STALEVO 150 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STALEVO 200 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STALEVO 50 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STALEVO 75 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

stannous fluoride 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STELARA 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STERILE GAUZE PAD 101 . . . . . . . . . . . . . . . . . . . . . . . . . . .

STERILE PADS 101, 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STERILE STRETCH GAUZE BANDAGE 102 . . . . . . . . . . . . . . .

STIMATE 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STRATTERA 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

STROMECTOL 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sucralfate 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SUDAL 12 TANNATE 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sufentanil citrate 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sulfac 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sulfacetamide sod-sulfur-urea 113 . . . . . . . . . . . . . . . . . . . .

sulfacetamide sodium 80 . . . . . . . . . . . . . . . . . . . . . . . . . . .

sulfacetamide sodium (acne) 114 . . . . . . . . . . . . . . . . . . . . .

sulfacetamide sodium-urea 114 . . . . . . . . . . . . . . . . . . . . . .

sulfacetamide-prednisolone 80 . . . . . . . . . . . . . . . . . . . . . . .

sulfamide 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sulfatol 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sulindac 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sulzee 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sumatriptan 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

sumatriptan succinate 54 . . . . . . . . . . . . . . . . . . . . . . . . . . .

supartz 62 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SURE COMFORT ALCOHOL PREP PADS 114 . . . . . . . . . . . . .

SURE COMFORT INS. SYR. U-100 63 . . . . . . . . . . . . . . . . . .

SURE COMFORT INSULIN SYRINGE 62, 63 . . . . . . . . . . . . . .

SURE-JECT INSULIN SYRINGE 63 . . . . . . . . . . . . . . . . . . . . .

SURE-LANCE 63 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SURE-PREP ALCHOLOL PREP PADS 114 . . . . . . . . . . . . . . . .

SURMONTIL 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SURVANTA 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SUTENT 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

syeda 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYMBICORT 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 152: Humana Walmart-Preferred Formulary - Q1Medicare

152 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

SYMLIN 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYMLINPEN 120 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYMLINPEN 60 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYNAREL 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYNTHROID 93 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYNVISC 63 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYNVISC-ONE 63 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SYPRINE 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

syrex sodium chloride 0.9% 74 . . . . . . . . . . . . . . . . . . . . . . .

T

TABLOID 13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tacrolimus 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tamoxifen 13, 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tamsulosin 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tanahist d 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TARCEVA 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TARGRETIN 14, 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

taron a prenatal-dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . .

taron ec calcium-dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . . .

taron-bc 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

taron-c dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

taron-crystals 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TARON-DUO EC 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

taron-ec cal 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

taron-prex prenatal-dha 120 . . . . . . . . . . . . . . . . . . . . . . . . .

TASIGNA 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TASMAR 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TAXOTERE 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TAZORAC 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

taztia xt 35 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TEGRETOL XR 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TEKAMLO 35, 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TEKTURNA 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TEKTURNA HCT 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TEMODAR 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

terazosin 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

terbutaline 18 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

terconazole 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TERRAMYCIN WITH POLYMYXIN B 80 . . . . . . . . . . . . . . . . .

TERUMO INS SYRINGE 0.5CC/27G 63 . . . . . . . . . . . . . . . . .

TERUMO INSULIN SYRINGE 63 . . . . . . . . . . . . . . . . . . . . . . .

TERUMO SURGUARD 63 . . . . . . . . . . . . . . . . . . . . . . . . . . .

testosterone cypionate 94 . . . . . . . . . . . . . . . . . . . . . . . . . .

testosterone enanthate 94 . . . . . . . . . . . . . . . . . . . . . . . . . .

tetanus toxoid,adsorbed (pf) 105 . . . . . . . . . . . . . . . . . . . . .

tetanus-diphtheria toxoids-td 105 . . . . . . . . . . . . . . . . . . . . .

tetanus,diphtheria toxd ped-pf 103 . . . . . . . . . . . . . . . . . . . .

tetcaine 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tetracaine hcl 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TETRAVISC 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TETRAVISC FORTE 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TEXACORT 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THALOMID 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THAM 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

theophylline 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

theophylline in d5w 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THERACYS 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THERMAZENE 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THINPRO INSULIN SYRINGE 63, 64 . . . . . . . . . . . . . . . . . . .

THINSET RESERVOIR 64 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THIOCYL 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

thioridazine 54 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

thiotepa 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

thiothixene 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THYMOGLOBULIN 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THYROGEN 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 153: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 153

THYROLAR-1 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THYROLAR-1/2 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THYROLAR-1/4 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THYROLAR-2 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THYROLAR-3 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TICE BCG 105 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ticlopidine 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TIKOSYN 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tilia fe 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

timolol maleate 36, 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TIMOPTIC OCUDOSE 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tizanidine 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TNKASE 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TOBRADEX 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TOBRADEX ST 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tobramycin sulfate 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tobramycin-dexamethasone 80 . . . . . . . . . . . . . . . . . . . . . . .

tobrasol 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TOBREX 80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tolazamide 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tolbutamide 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tolmetin 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TOPCARE ULTRA COMFORT 64 . . . . . . . . . . . . . . . . . . . . . .

topiragen 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

topiramate 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

toposar 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

topotecan 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TORISEL 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

torsemide 74, 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TPN ELECTROLYTES 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TPN ELECTROLYTES II 75 . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRACLEER 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tramadol 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tramadol-acetaminophen 55 . . . . . . . . . . . . . . . . . . . . . . . . .

trandolapril 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tranylcypromine 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRAVASOL 10 % 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRAVATAN Z 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trazodone 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

treagan otic 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TREANDA 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRELSTAR 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRELSTAR DEPOT 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRELSTAR LA 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tretinoin 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tretinoin (chemotherapy) 14 . . . . . . . . . . . . . . . . . . . . . . . . .

TREXALL 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tri rx 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRI-CHLOR 114 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tri-legest fe 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tri-previfem (28) 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tri-sprintec (28) 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tri-vit with fluoride & iron 120 . . . . . . . . . . . . . . . . . . . . . . .

tri-vitamin w/fluoride & iron 120 . . . . . . . . . . . . . . . . . . . . . .

triadvance 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triamcinolone acetonide 94, 114,115 . . . . . . . . . . . . . . . . . . . .

triamterene-hydrochlorothiazid 75 . . . . . . . . . . . . . . . . . . . .

tricare 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRICARE DHA 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trichloroacetic acid 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tricitrates 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tricitrates (w/ sucrose) 75 . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRICOR 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triderm 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trifera ob 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 154: Humana Walmart-Preferred Formulary - Q1Medicare

154 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

trifluoperazine 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trifluridine 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trigofen 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trihexyphenidyl 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRIHIBIT PRESERVATIVE FREE 105 . . . . . . . . . . . . . . . . . . . .

trilyte with flavor packets 84 . . . . . . . . . . . . . . . . . . . . . . . .

trimesis rx 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trimethobenzamide 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trimethoprim-polymyxin b 80 . . . . . . . . . . . . . . . . . . . . . . . .

trinatal gt 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trinatal rx 1 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trinatal ultra 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRINATE 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trinessa (28) 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRIPEDIA (PF) 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triple vitamin with fluoride 120 . . . . . . . . . . . . . . . . . . . . . . .

TRISENOX 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trital sr 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triveen-duo dha 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triveen-one 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triveen-prx rnf 120 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triveen-ten 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

triveen-u 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trivora (28) 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TROPHAMINE 10 % 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TROPHAMINE 6% 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tropicacyl 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tropicamide 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

trospium 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TRUERESULT BLOOD GLUCOSE SYSTM 64 . . . . . . . . . . . . . .

TRUETEST HIGH GLUCOSE CONTROL 64 . . . . . . . . . . . . . . .

TRUETEST NORMAL GLUCOSE CNTRL 64 . . . . . . . . . . . . . . .

trust natal dha 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TUBERSOL 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

tubocurarine chloride 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TWINJECT AUTOINJECTOR 19 . . . . . . . . . . . . . . . . . . . . . . .

TWINRIX (PF) 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TYKERB 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TYPHIM VI 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

TYZINE 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

U

u-cort 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ULTICARE 64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ULTIGUARD 64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ULTILET ALCOHOL SWAB 115 . . . . . . . . . . . . . . . . . . . . . . .

ULTILET INSULIN SYRINGE 64, 65 . . . . . . . . . . . . . . . . . . . .

ultimatecare advantage 121 . . . . . . . . . . . . . . . . . . . . . . . . .

ultimatecare combo 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ultimatecare one 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ultimatecare one nf 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ULTIVA 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ULTRA COMFORT INSULIN SYRINGE 65 . . . . . . . . . . . . . . . .

ULTRABAG/DIANEAL PD-2/2.5% DEX 75 . . . . . . . . . . . . . . .

ULTRABAG/DIANEAL PD-2/4.25%DEX 75 . . . . . . . . . . . . . .

ULTRACOMFORT 65 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ULTRACOMFORT W/ CONTAINER 65 . . . . . . . . . . . . . . . . . .

UMECTA 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UMECTA PD 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UNITHROID 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

URAMAXIN 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

urea 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

urea nail stick 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

urea 40 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

urealac 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ursodiol 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UVADEX 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 155: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 155

u40 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

V

valproate sodium 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

valproic acid 55 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

valproic acid (as sodium salt) 55 . . . . . . . . . . . . . . . . . . . . . .

VALSTAR 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VALTURNA 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VANDETANIB 14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VANISHPOINT SYRINGE 66 . . . . . . . . . . . . . . . . . . . . . . . . .

VAQTA (PF) 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VARIVAX (PF) 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vaso 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vasopressin 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VECTIBIX 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vecuronium bromide 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VEHICLE/N 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VEHICLE/N MILD 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VELCADE 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VELETRI 36 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

velivet 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vena-bal dha 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

venatal complete dha 121 . . . . . . . . . . . . . . . . . . . . . . . . . .

venlafaxine 55, 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VENTOLIN HFA 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VERAMYST 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

verapamil 36, 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VEREGEN 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VERIPRED 20 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VICTOZA 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIDAZA 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIGAMOX 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIIBRYD 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIMPAT 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinacal 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate az 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate c 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate calcium 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate care 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate gt 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate ic 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate ii 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate iii 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate m 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate one 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate pn care 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinate ultra 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinblastine 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vincristine 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vinorelbine 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vis-phos n 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VISCOAT 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VISIONBLUE 66 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vistra 650 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VITAFOL-PN (UD) 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitanatal ob + dha 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitaphil 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitaphil + dha 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitaphil + dha 90 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitaphil aide 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitaspire 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vitazol 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VITRASE 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIVA DHA 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VIVAGLOBIN 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VOLUVEN 6 % 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VOTRIENT 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 156: Humana Walmart-Preferred Formulary - Q1Medicare

156 - 2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY

VPRIV 75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VUMON 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

vynatal fa 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

W

warfarin 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

water for irrigation, sterile 74 . . . . . . . . . . . . . . . . . . . . . . . .

WEBCOL 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

WELCHOL 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

WILATE 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

WINRHO SDF 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

X

x-viate 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XALKORI 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XARELTO 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XELODA 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XENAZINE 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XERAC AC 115 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XGEVA 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XIGRIS 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XOLAIR 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XYNTHA 24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

XYREM 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Y

YERVOY 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

YF-VAX 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Z

zaclir 115, 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zafirlukast 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zaleplon 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZANOSAR 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zarah 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zatean-ch 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zatean-pn 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zatean-pn dha 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZAVESCA 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZELBORAF 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zema-pak 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZEMAIRA 102 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZEMPLAR 121 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZEMURON 19 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZENAPAX 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZENPEP 84 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zeosa 94 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZETIA 37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zgesic 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZINOTIC ES (WITH GLYCERIN) 81 . . . . . . . . . . . . . . . . . . . . .

ZIRGAN 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZODERM 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZOLADEX 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZOLINZA 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zolpidem 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZOMETA 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zonisamide 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zorprin 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZORTRESS 101 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZOSTAVAX 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zovia 1/35e (28) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

zovia 1/50e (28) 95 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZOVIRAX 116 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZYLET 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZYMAXID 81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZYPREXA 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZYPREXA RELPREVV 56 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZYPREXA ZYDIS 56, 57 . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ZYTIGA 15 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

#

Page 157: Humana Walmart-Preferred Formulary - Q1Medicare

2012 PRESCRIPTION DRUG GUIDE HUMANA FORMULARY - 157

0.45 % nacl-potassium chloride 72 . . . . . . . . . . . . . . . . . . .

8-MOP 106 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page 158: Humana Walmart-Preferred Formulary - Q1Medicare
Page 159: Humana Walmart-Preferred Formulary - Q1Medicare

Blank Page

Page 160: Humana Walmart-Preferred Formulary - Q1Medicare

Humana.com

Y0040_PDG12b_Final_510C CMS Approved 08092011 S5884145PDG1226512C

A stand-alone prescription drug plan with a Medicare contract available to anyone entitled to Part A and/or enrolled in PartB of Medicare. Medicare beneficiaries may enroll in the plan only during specific times of the year. Contact Humana for

more information. Medicare beneficiaries enrolled in an MA PFFS plan that includes Medicare prescription drugs or an MAcoordinated care (HMO or PPO) plan will be automatically disenrolled from the HMO, PPO, or MA PFFS plan if they enroll ina PDP. Medicare beneficiaries enrolled in a private fee-for-service plan (PFFS) that does not include Medicare prescription

drug coverage may enroll in a PDP and will not be automatically disenrolled from the PFFS. You must use networkpharmacies, except under non-routine circumstances. Quantity limitations, copayments and restrictions may apply. If youare a member of a qualified State Pharmaceutical Assistance Program, please contact the Program to verify that the mail

order pharmacy will coordinate with that Program.

You may be able to get Extra Help to pay for your prescription drug premiums and costs. To see if you qualify for Extra Help,call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/7 days a week; the

Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or Your Medicaid Office.

This document is available for free in alternative formats or languages. Please call Customer Care at 1-800-281-6918.Monday-Friday, 8 a.m. - 8 p.m. Eastern time. If you use a TTY, please call 711.

Este documento está disponible gratis en otros formatos o idiomas. Comuníquese con el Departamento de Servicio alCliente llamando al 1-800-281-6918. Los representantes están disponibles de lunes a viernes de 8 a.m. a 8 p.m., hora del

Este. Si usa un TTY, marque 711.